
<html lang="en"     class="pb-page"  data-request-id="69d81371-4e9b-4c88-8f1d-ff541c59e34d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b01561;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity" /></meta><meta name="dc.Creator" content="Jennifer A.  Borthwick" /></meta><meta name="dc.Creator" content="Carlos  Alemparte" /></meta><meta name="dc.Creator" content="Ian  Wall" /></meta><meta name="dc.Creator" content="Benjamin C.  Whitehurst" /></meta><meta name="dc.Creator" content="Argyrides  Argyrou" /></meta><meta name="dc.Creator" content="Glenn  Burley" /></meta><meta name="dc.Creator" content="Paco  de Dios-Anton" /></meta><meta name="dc.Creator" content="Laura  Guijarro" /></meta><meta name="dc.Creator" content="Maria Candida  Monteiro" /></meta><meta name="dc.Creator" content="Fatima  Ortega" /></meta><meta name="dc.Creator" content="Colin J  Suckling" /></meta><meta name="dc.Creator" content="Julia Castro  Pichel" /></meta><meta name="dc.Creator" content="Monica  Cacho" /></meta><meta name="dc.Creator" content="Robert J.  Young" /></meta><meta name="dc.Description" content="Decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1) is an essential enzyme in Mycobacterium tuberculosis and has recently been studied as a potential drug target, with inhibitors progressing to cl..." /></meta><meta name="Description" content="Decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1) is an essential enzyme in Mycobacterium tuberculosis and has recently been studied as a potential drug target, with inhibitors progressing to cl..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 10, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01561" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01561" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01561" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01561" /></link>
        
    
    

<title>Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01561" /></meta><meta property="og:title" content="Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0016.jpeg" /></meta><meta property="og:description" content="Decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1) is an essential enzyme in Mycobacterium tuberculosis and has recently been studied as a potential drug target, with inhibitors progressing to clinical studies. Here we describe the identification of a novel series of morpholino-pyrimidine DprE1 inhibitors. These were derived from a phenotypic high-throughput screening (HTS) hit with suboptimal physicochemical properties. Optimization strategies included scaffold-hopping, synthesis, and evaluation of fragments of the lead compounds and property-focused optimization. The resulting optimized compounds had much improved physicochemical properties and maintained enzyme and cellular potency. These molecules demonstrated potent efficacy in an in vivo tuberculosis murine infection model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01561"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01561">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01561&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01561&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01561&amp;href=/doi/10.1021/acs.jmedchem.9b01561" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2557-2576</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01547" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01572" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title"><i>Mycobacterium tuberculosis</i> Decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jennifer A. Borthwick</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennifer A. Borthwick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Science and Technology, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>(J.A.B.) Email: <a href="/cdn-cgi/l/email-protection#7d17181313141b180f531f120f09150a141e163d1f111c1e161f1811090905531e1210"><span class="__cf_email__" data-cfemail="315b545f5f585754431f535e4345594658525a71535d50525a53545d4545491f525e5c">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+A.++Borthwick">Jennifer A. Borthwick</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6740-4232" title="Orcid link">http://orcid.org/0000-0002-6740-4232</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carlos Alemparte</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carlos Alemparte</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carlos++Alemparte">Carlos Alemparte</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5521-8304" title="Orcid link">http://orcid.org/0000-0001-5521-8304</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ian Wall</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ian Wall</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Science and Technology, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ian++Wall">Ian Wall</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benjamin C. Whitehurst</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benjamin C. Whitehurst</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Science and Technology, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+C.++Whitehurst">Benjamin C. Whitehurst</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Argyrides Argyrou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Argyrides Argyrou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Science and Technology, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Argyrides++Argyrou">Argyrides Argyrou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3141-9122" title="Orcid link">http://orcid.org/0000-0003-3141-9122</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Glenn Burley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Glenn Burley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pure & Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, Scotland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Glenn++Burley">Glenn Burley</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4896-113X" title="Orcid link">http://orcid.org/0000-0002-4896-113X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paco de Dios-Anton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paco de Dios-Anton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paco++de+Dios-Anton">Paco de Dios-Anton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laura Guijarro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura Guijarro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Guijarro">Laura Guijarro</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maria Candida Monteiro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Candida Monteiro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Candida++Monteiro">Maria Candida Monteiro</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fatima Ortega</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fatima Ortega</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fatima++Ortega">Fatima Ortega</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Colin J Suckling</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Colin J Suckling</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pure & Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, Scotland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Colin+J++Suckling">Colin J Suckling</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Julia Castro Pichel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Julia Castro Pichel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Julia+Castro++Pichel">Julia Castro Pichel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Monica Cacho</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Monica Cacho</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>(M.C.) Email: <a href="/cdn-cgi/l/email-protection#b5d8dadbdcd6d49bdc9bd6d4d6dddaf5d2c6de9bd6dad8"><span class="__cf_email__" data-cfemail="0d606263646e6c2364236e6c6e65624d6a7e66236e6260">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Monica++Cacho">Monica Cacho</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6270-5370" title="Orcid link">http://orcid.org/0000-0001-6270-5370</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Robert J. Young</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert J. Young</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Science and Technology, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>(R.J.Y.) Email: <a href="/cdn-cgi/l/email-protection#a9fbc6cbe9cbc5dccc84cbdcdbcedcc7cdd087cac687dcc2"><span class="__cf_email__" data-cfemail="db89b4b99bb9b7aebef6b9aea9bcaeb5bfa2f5b8b4f5aeb0">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert+J.++Young">Robert J. Young</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7763-0575" title="Orcid link">http://orcid.org/0000-0002-7763-0575</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01561&amp;href=/doi/10.1021%2Facs.jmedchem.9b01561" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2557–2576</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 10, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 September 2019</li><li><span class="item_label"><b>Published</b> online</span>10 January 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01561" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01561</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2557%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJennifer%2BA.%2BBorthwick%252C%2BCarlos%2BAlemparte%252C%2BIan%2BWall%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D5%26contentID%3Dacs.jmedchem.9b01561%26title%3DMycobacterium%2Btuberculosis%2BDecaprenylphosphoryl-%25CE%25B2-d-ribose%2BOxidase%2BInhibitors%253A%2BExpeditious%2BReconstruction%2Bof%2BSuboptimal%2BHits%2Binto%2Ba%2BSeries%2Bwith%2BPotent%2Bin%2BVivo%2BActivity%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2576%26publicationDate%3DMarch%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01561"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1002</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01561" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;A. Borthwick&quot;},{&quot;first_name&quot;:&quot;Carlos&quot;,&quot;last_name&quot;:&quot;Alemparte&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;Wall&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;C. Whitehurst&quot;},{&quot;first_name&quot;:&quot;Argyrides&quot;,&quot;last_name&quot;:&quot;Argyrou&quot;},{&quot;first_name&quot;:&quot;Glenn&quot;,&quot;last_name&quot;:&quot;Burley&quot;},{&quot;first_name&quot;:&quot;Paco&quot;,&quot;last_name&quot;:&quot;de Dios-Anton&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Guijarro&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Candida Monteiro&quot;},{&quot;first_name&quot;:&quot;Fatima&quot;,&quot;last_name&quot;:&quot;Ortega&quot;},{&quot;first_name&quot;:&quot;Colin&quot;,&quot;last_name&quot;:&quot;J Suckling&quot;},{&quot;first_name&quot;:&quot;Julia&quot;,&quot;last_name&quot;:&quot;Castro Pichel&quot;},{&quot;first_name&quot;:&quot;Monica&quot;,&quot;last_name&quot;:&quot;Cacho&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;J. Young&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;2557-2576&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01561&quot;},&quot;abstract&quot;:&quot;Decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1) is an essential enzyme in Mycobacterium tuberculosis and has recently been studied as a potential drug target, with inhibitors progressing to clinical studies. Here we describe the identification of a novel series of morpholino-pyrimidine DprE1 inhibitors. These were derived from a phenotypic high-throughput screening (HTS) hit with suboptimal physicochemical properties. Optimization strategies included scaffold-hopping, synthesis, and evaluation of fragments of the lead compounds and property-focused optimization. The resulting optimized compounds had much improved physicochemical properties and maintained enzyme and cellular potency. These molecules demonstrated potent efficacy in an in vivo tuberculosis murine infection model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01561&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01561" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01561&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01561" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01561&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01561" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01561&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01561&amp;href=/doi/10.1021/acs.jmedchem.9b01561" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01561" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01561" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01561%26sid%3Dliteratum%253Aachs%26pmid%3D31922409%26genre%3Darticle%26aulast%3DBorthwick%26date%3D2020%26atitle%3DMycobacterium%2Btuberculosis%2BDecaprenylphosphoryl-%25CE%25B2-d-ribose%2BOxidase%2BInhibitors%253A%2BExpeditious%2BReconstruction%2Bof%2BSuboptimal%2BHits%2Binto%2Ba%2BSeries%2Bwith%2BPotent%2Bin%2BVivo%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D5%26spage%3D2557%26epage%3D2576%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=291214" title="Bacteria">Bacteria</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291870" title="Piperidines">Piperidines</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/jmcmar.2020.63.issue-5/20200312/jmcmar.2020.63.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01561&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose 2′-epimerase (DprE1) is an essential enzyme in <i>Mycobacterium tuberculosis</i> and has recently been studied as a potential drug target, with inhibitors progressing to clinical studies. Here we describe the identification of a novel series of morpholino-pyrimidine DprE1 inhibitors. These were derived from a phenotypic high-throughput screening (HTS) hit with suboptimal physicochemical properties. Optimization strategies included scaffold-hopping, synthesis, and evaluation of fragments of the lead compounds and property-focused optimization. The resulting optimized compounds had much improved physicochemical properties and maintained enzyme and cellular potency. These molecules demonstrated potent efficacy in an in vivo tuberculosis murine infection model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/63/5"><issue-title>Women in Medicinal Chemistry</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tuberculosis (TB) is the most deadly infectious disease in human history, killing over 1 billion people in the last 200 years, and it continues to kill at a rate of more than 1 million people per year.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Currently treatment options for TB require patients to take a combination of drugs for between 6 months and 3 years.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Some of these drugs can cause serious side effects, and many are increasingly becoming ineffective due to evolving resistance patterns,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> including multidrug resistance (MDR), extremely (XDR) and even totally drug resistant strains (TDR). Therefore, there is an urgent need to develop new drug treatments for TB, especially those with novel mechanisms of action, which would not be expected to suffer from the same resistance mechanisms as marketed drugs.</div><div class="NLM_p">Decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose 2′-epimerase (DprE1) was identified as the target of a series of potent bactericidal molecules, through genetic analysis of resistant strains generated in vitro.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> DprE1 is the key enzyme in the only known biosynthetic pathway by which mycobacteria produce arabinose, which is an essential component of the cell wall arabinogalactan scaffold.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Furthermore, mycobacteria with reduced expression of functional DprE1 were shown to be nonviable,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> and among 240 clinically isolated strains of <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> no mutations were detected in the gene encoding DprE1. This mechanism of arabinose biosynthesis via decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose is unique to mycobacteria, so there is inherent biochemical selectivity over human cells and other bacterial species.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">A number of small-molecule inhibitors of DprE1 have now been published, reflecting the high level of interest in this exciting target (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref4 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref4 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23">(4,9−23)</a> The covalent binders<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> BTZ043<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and PBTZ169 (macozinone)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> have progressed to clinical evaluation, as have the noncovalent compounds AZ7371<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and OPC-167832.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected published DprE1 inhibitors.<a onclick="showRef(event, 'ref4 ref9 ref23 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref4 ref9 ref23 ref27 ref28">(4,9,23,27,28)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01561&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Pyrrolothiadiazole <b>1</b>, one of 177 antitubercular compounds released by GSK,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> was identified as an inhibitor of DprE1 by its reduced activity in a DprE1 overexpressor strain of <i>M. tuberculosis</i>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In this paper, we describe optimization of <b>1</b> into a lead series with an attractive physical profile and highly encouraging in vivo efficacy. We demonstrate how the proposed “attention to decreasing lipophilicity and/or minimising aromatic ring count”<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> was achieved through lead hopping. The progression and quality of the molecules produced in the ensuing deconstruction and reconstruction process were monitored using physicochemical measurements and efficiency metrics.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54441" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54441" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To generate some initial structure–activity relationship (SAR) around initial hit, pyrrolothiadiazole <b>1</b> was truncated to <b>2</b>, retaining reasonable ligand efficiency. Subsequently, a key finding in the move away from the unattractive pyrrolothiadiazole functionality was screening of compounds selected by a similarity search of the GSK collection, based on Tanimoto scores. Of these, piperidinylpyrimidines <b>3</b> and <b>4</b> retained DprE1 activity and showed a minimum inhibitory concentration (MIC). The most productive search used the piperidine-acyl-piperidine moiety as the substructure, generating a range of alternatives for the thiadiazole, pyrrole, and benzyl groups. These searches identified truncated compounds such as <b>2</b>, which retained DprE1 activity in the biochemical assay that translated into an MIC (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of phenotypic screening hit <b>1</b> and analogues identified by substructure and similarity searching.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01561&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A key point in the hits to leads phase was securing DprE1 activity and an MIC with piperidinopyrimidines <b>3</b> and <b>4</b>, which had markedly improved physical properties <named-content content-type="anchor" rid="tbl1" type="simple"></named-content>(<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) and obviated perceived metabolic/toxicological risks with the pyrrole and thiadiazole rings (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The likely common SAR between the thiadiazole- and pyrimidine-containing series was indicated by the benzyl analogues <b>1</b> and <b>5</b>, but further physicochemical improvement was a clear priority. These data supported the notion of a systematic exploration of the SAR and structure–property relationships (SPR) in the series, facilitated by a relatively straightforward synthetic protocol involving amide formation and S<sub>N</sub>Ar elaboration of the aromatic heterocycle (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The strategy is best described in terms of the five constituent rings of the structure, labeled A, B, C, D, and E for convenience, the execution including fragmentation to <20 heavy atom A–C fragment structures to identify key binding interactions and regrowth along defined vectors to optimize activity, property forecast index (PFI), and ligand efficiency.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Measured Properties of Hit <b>1</b> and Analogues <b>2</b>–<b>5</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">DprE1 pIC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>Mtb</i> H37Rv MIC<sub>90</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">PFI<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">solubility CLND (μM)<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">7.3<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">9.4</td><td class="colsep0 rowsep0" align="left"><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">20.8</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="left">328</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char=".">35.6</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="left">>405</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">15.6</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="left">>488</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">8.9</td><td class="colsep0 rowsep0" align="left">28</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">DprE1 pIC<sub>50</sub> is the negative logarithm of the IC<sub>50</sub> concentration expressed in molar (M) obtained in the DprE1-inhibition assay. DprE1 pIC<sub>50</sub> values above 7.3 are approaching the tight binding limit of assay and should be treated with caution.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Compound tested inactive (pIC<sub>50</sub> < 4) on 2 out of 62 test occasions.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Property forecast index (PFI) is the sum of the Chrom log D<sub>7.4</sub> and the number of aromatic rings.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Kinetic solubility measured by CLND (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</p></div></div></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds Containing Replacements for Left Hand Side Piperidine<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01561&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Substituted piperidine (1.2 equiv), COMU (2 equiv), <i>N</i>,<i>N</i>-diisopropylethylamine (3 equiv), <i>N</i>,<i>N</i>-dimethylformamide, room temperature, 2–20 h; (b) hydrochloric acid (4 M in dioxane) (5 equiv), room temperature, 0.5–17 h, 91–100% over twp steps; (c) <i>N</i>,<i>N</i>-diisopropylethylamine (2 equiv), ethanol, microwave, 150 °C, 5 min; (d) amine (5 equiv), <i>N</i>,<i>N</i>-diisopropylethylamine (2 equiv), ethanol, microwave, 150 °C, 1 h, 19–43% over two steps.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Results of Replacement of Piperidine with Alternative Rings in Compounds <b>10</b>–<b>16</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0005.gif" alt="" id="gr4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0006.gif" alt="" id="gr5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">DprE1 pIC<sub>50</sub> is the negative logarithm of the IC<sub>50</sub> concentration expressed in molar (M) obtained in the DprE1-inhibition assay. DprE1 pIC<sub>50</sub> values above 7.3 are approaching tight binding limit of assay and should be treated with caution.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Property forecast index (PFI) is the sum of the Chrom log D<sub>7.4</sub> and the number of aromatic rings.</p></div></div><div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81638" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81638" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The bis-piperidine amides <b>6</b> and <b>7</b> were formed by COMU-mediated amide bond formation, followed by BOC-deprotection. Sequential nucleophilic aromatic substitutions onto 4,6-dichloropyrimidine afforded the final products <b>10</b>–<b>16</b>. The versatility of this route enabled the three steps to be performed in any order, depending on where any structural diversity was to be introduced. The two nucleophilic aromatic substitutions were carried out in one microwave vial, with the second amine simply pipetted into the vial on completion of the first reaction. These reactions were carried out in an appropriate volume of solvent (0.5–0.9 mL) to allow direct injection of the crude reaction mixture onto mass-directed prep-HPLC at the end of the reactions without the need to carry out any workup. The designed route allowed rapid exploration of piperidine replacements, affording panel of compounds <b>10</b>–<b>16</b>.</div><div class="NLM_p">Ring A: A set of small branched and alicyclicamines was selected to explore potential variations in Ring A.</div><div class="NLM_p">The results for ring A variation (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) showed that the SAR was fairly restricted, and most of the groups synthesized were less active than the parent piperidine. Only the morpholine group (<b>10</b>, <b>16</b>) showed a similar level of activity, within assay limits, to piperidine, but with around a 1.5 unit reduction in Chrom logD compared with the piperidine compounds (<b>3</b>–<b>5</b>). In particular, the benzyl compound <b>16</b> represented an important milestone in this series, being the first compound to achieve a sub-micromolar MIC against <i>Mtb</i> H37Rv. This compound was thus more fully profiled as shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Full Profile of Compound <b>16</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">compound <b>16</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DprE1 pIC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PFI<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">7.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Mtb</i> H37Rv MIC<sub>90</sub> (μM)</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intracellular H37Rv MIC<sub>90</sub> (μM)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DprE1 OE MIC<sub>90</sub> (μM)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">>16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">antibacterial panel MIC (μg/mL)</td><td class="colsep0 rowsep0" align="left">>128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CLND solubility (μM)<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">280</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">microsomes Clint h/m (mL/min/g tissue)<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">4.4/13.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">DprE1 pIC<sub>50</sub> is the negative logarithm of the IC<sub>50</sub> concentration expressed in molar (M) obtained in the DprE1-inhibition assay. DprE1 pIC<sub>50</sub> values above 7.3 are approaching the tight binding limit of assay and should be treated with caution.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Property forecast index (PFI) is the sum of the Chrom log D<sub>7.4</sub> and the number of aromatic rings.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">MIC against <i>M. tuberculosis</i> (H37Rv) in infected human THP-1 macrophages.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Overexpressor (OE) MICs are for <i>M. tuberculosis</i> transformed with pMV261:dprE1.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">Kinetic solubility measured by CLND (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">Microsomal fraction stability (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</p></div></div></div><div class="NLM_p">The highly potent compound <b>16</b> translated its enzyme activity into low MIC values both in the cultured mycobacteria assay and the intracellular assay in macrophages. Target engagement was demonstrated with <b>16</b> in a DprE1 overexpressor strain of <i>Mtb</i>; its MIC was shown to increase substantially. Importantly, wider profiling of compound <b>16</b> supported the potential of the series, whereby it was inactive against an antibacterial panel of 19 common bacterial species, including <i>Escherichia coli</i> and <i>Staphylococcus aureus</i>, in line with expectations of this unique mycobacterial process. Encouraged by these findings, further optimization was pursued to address shortcomings such as the high intrinsic clearance in microsomes.</div><div class="NLM_p">Encouraged by these data, a systematic investigation was initiated with tricyclic structures, which, with generally <20 heavy atoms were treated as fragments. These were synthesized to explore the minimum pharmacaphore required for measurable DprE1 inhibition. The ligand efficiency (LE) of the qualified hits suggested that with maintenance of LE measurable activity would be expected in the DprE1 assay for these fragments. The initial set is exemplified in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Removal of rings A and B (<b>18</b>) or A, B, and E (<b>17</b>), by capping <b>6</b> or <b>7</b> using acetic anhydride, gave no demonstrable activity, unlike the A, B, C analogues <b>19</b>–<b>21</b> which showed weak activity, but retaining reasonable LE. An oxidized core was also synthesized (<b>22</b>), which demonstrated similar activity to pyrimidine, along with good LE.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Compounds Synthesized to Identify Efficient Binding Fragments</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0007.gif" alt="" id="gr6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">DprE1 pIC50 is the negative logarithm of the IC50 concentration expressed in molar (M) obtained in the DprE1-inhibition assay. DprE1 pIC50 values above 7.3 are approaching the tight binding limit of assay and should be treated with caution.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">FPR assay data (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for details).</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Ligand efficency (LE) = pIC<sub>50</sub>*1.37/number of heavy atoms.</p></div></div><div></div></div><div class="NLM_p">These results supported growth from the 4-morpholino pyrimidine fragment to find the optimal structure for ring C. The SAR in this region of the molecule appeared to be fairly restricted (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> shows key exemplars), with most of the synthesized compounds tested (44 fragment compounds were synthesized) showing no quantifiable activity in the DprE1 assay, indicating that a piperidine linker was optimal.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Results of Fragments Tested to Explore SAR of Central Piperidine Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0008.gif" alt="" id="gr7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0009.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">DprE1 pIC50 is the negative logarithm of the IC50 concentration expressed in molar (M) obtained in the DprE1-inhibition assay. DprE1 pIC50 values above 7.3 are approaching the tight binding limit of assay and should be treated with caution.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Ligand efficency (LE) = pIC<sub>50</sub>*1.37/number of heavy atoms. Ligand lipophilicity efficiency Astex (LLE<sub>AT</sub>) = 0.111 + 1.36*LLE/number of heavy atoms.</p></div></div><div></div></div><div class="NLM_p">4-Piperidinyl was demonstrated to be the optimum C ring through evaluation of a series of analogues of <b>16</b> (data not shown) with pyrrolidine, piperidine, and piperazine rings that showed little or no activity.</div><div class="NLM_p">Alternatives to ring D were then explored. These analogues (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) all showed reduced activity at DprE1 relative to compound <b>16</b>, with only the pyrrolidine analogue <b>36</b> showing a similar potency, again indicating the likely primacy of a 4-substituted, achiral, piperidine connectivity.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Results of Replacements of Distal Piperidine Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0010.gif" alt="" id="gr9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0011.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">DprE1 pIC<sub>50</sub> is the negative logarithm of the IC<sub>50</sub> concentration expressed in molar (M) obtained in the DprE1-inhibition assay. DprE1 pIC<sub>50</sub> values above 7.3 are approaching the tight binding limit of assay and should be treated with caution.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Property forecast index (PFI) is the sum of the Chrom log D<sub>7.4</sub> and the number of aromatic rings.</p></div></div><div></div></div><div class="NLM_p">Removal or replacement of ring E offered opportunities to further optimize properties, improve potency, or alleviate likely metabolic liabilities of an unsubstituted phenyl ring (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Results of Replacements of Benzyl Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0012.gif" alt="" id="gr11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0013.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">DprE1 pIC<sub>50</sub> is the negative logarithm of the IC<sub>50</sub>-concentration expressed in molar (M) obtained in the DprE1-inhibition assay. DprE1 pIC<sub>50</sub> values above 7.3 are approaching the tight binding limit of assay and should be treated with caution.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">Property forecast index (PFI) is the sum of the Chrom log D<sub>7.4</sub> and the number of aromatic rings.</p></div><div class="footnote" id="t7fn3"><sup><sup>c</sup></sup><p class="last">Microsomal fraction stability (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</p></div></div><div></div></div><div class="NLM_p">Replacement of the benzylic methylene group with a heteroatom was well-tolerated (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>, compounds <b>37</b> and <b>38</b>) and led to reduction in PFI and improved intrinsic clearance. Blocking likely sites of metabolism with halide substituents, such as in compound <b>39</b>, retained activity and gave an improved microsomal clearance. Replacement of the phenyl ring with heterocyclic alternatives (compounds <b>40</b>–<b>41</b>) resulted in fairly restricted SAR, with only pyridine rings retaining any activity against DprE1. Interestingly, the phenyl ring could be replaced entirely with a range of alkyl groups (compounds <b>42</b>–<b>44</b>). Unfortunately, it was not possible to lower logD by introducing heteroatoms into alkyl analogues (e.g., with compounds <b>45</b>–<b>46</b>). All such attempts resulted in the complete loss of DprE1 activity.</div><div class="NLM_p">A further iteration of optimization combined the ether linkage with the improved phenyl replacements. This strategy was very successful in identifying compounds such as <b>47</b>–<b>51</b> which had excellent DprE1 potencies, low MIC values, and very low microsomal clearance values. Within the set available, there were highly potent molecules with encouraging profiles worthy of progression into in vivo studies.</div><div class="NLM_p">To complete the systematic optimization, variation of alternatives to the pyrimidine (ring B) offered means of modulating the physicochemical properties of the molecule, by varying nitrogen count and basicity. This work followed the A, C, D, and E ring optimizations and key substituents from the SAR investigations (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). There were interesting SAR effects observed in these alternative cores: heterocycles containing two nitrogen atoms such as the isomeric pyrimidine <b>52</b> or pyrazine <b>56</b> retained good potency, but the more basic pyridine compounds <b>53</b>–<b>55</b> had much reduced potency. Small substituents on the pyrimidine ring in compounds <b>57</b>–<b>59</b> were well tolerated and offered alternative means of lipophilicity modulation; e.g., the pyrimidinone compound <b>59</b>, maintained good activity and MIC levels with lower logD, which may account for its improved metabolic stability.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Results of Replacements of Pyrimidine Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0014.gif" alt="" id="gr13" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0015.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">DprE1 pIC<sub>50</sub> is the negative logarithm of the IC<sub>50</sub> concentration expressed in molar (M) obtained in the DprE1-inhibition assay. DprE1 pIC<sub>50</sub> values above 7.3 are approaching the tight binding limit of assay and should be treated with caution.</p></div><div class="footnote" id="t8fn2"><sup><sup>b</sup></sup><p class="last">Property forecast index (PFI) is the sum of the Chrom log D<sub>7.4</sub> and the number of aromatic rings.</p></div><div class="footnote" id="t8fn3"><sup><sup>c</sup></sup><p class="last">Microsomal fraction stability (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>).</p></div></div><div></div></div><div class="NLM_p">As a result of the property-focused optimization of the series described here, a number of compounds had potent DprE1 inhibition combined with low MIC values and much improved in vitro DMPK properties, which together supported progression into in vivo efficacy studies. Compounds <b>39</b> and <b>47</b> (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>) were thus progressed into a mouse model of tuberculosis infection.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Profiles of Compounds <b>39</b> and <b>47</b> in a Range of in Vitro and in Vivo Assays</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center">compound</th><th class="colsep0 rowsep0" align="center"><b>39</b></th><th class="colsep0 rowsep0" align="center"><b>47</b></th><th class="colsep0 rowsep0" align="center"><b>60</b><a class="ref internalNav" href="#t9fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">DprE1 pIC<sub>50</sub><a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">7.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">PFI</td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left"><i>Mtb</i> H37Rv MIC<sub>90</sub> (μM)</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">intracellular H37Rv MIC<sub>90</sub> (μM)</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">0.62</td><td class="colsep0 rowsep0" align="left">0.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">DprE1 OE MIC (μM)<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">>125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">cytotoxicity HepG2 pIC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">4.3<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">4.5<a class="ref internalNav" href="#t9fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">CLND solubility (μM)</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">≥364</td><td class="colsep0 rowsep0" align="left">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">FaSSIF solubility (μg/mL)</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">74</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">microsomes Clint h/m (mL/min/g tissue)</td><td class="colsep0 rowsep0" align="left">4.6/3.1</td><td class="colsep0 rowsep0" align="left"><0.5/0.7</td><td class="colsep0 rowsep0" align="left"><0.5/4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo mouse PK<a class="ref internalNav" href="#t9fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">Cl (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">38.9</td><td class="colsep0 rowsep0" align="left">23.5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Vss (L/kg)</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.45</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">%F</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">78.7</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">DprE1 pIC<sub>50</sub> values above 7.3 are approaching the tight binding limit of assay and should be treated with caution.</p></div><div class="footnote" id="t9fn2"><sup><sup>b</sup></sup><p class="last">Compound tested inactive (pIC<sub>50</sub> = 4.0) on 6 out of 10 test occasions.</p></div><div class="footnote" id="t9fn3"><sup><sup>c</sup></sup><p class="last">Compound tested inactive (pIC<sub>50</sub> < 4.0) on 2 out of 4 test occasions.</p></div><div class="footnote" id="t9fn4"><sup><sup>d</sup></sup><p class="last">Compound tested inactive (pIC<sub>50</sub> < 4.0) on 2 out of 7 test occasions.</p></div><div class="footnote" id="t9fn5"><sup><sup>e</sup></sup><p class="last">Clearance (Cl), volume of distribution at steady state (Vss), and half-life (<i>t</i><sub>1/2</sub>) obtained after intravenous administration to CD-1 male mice at 1 mg/kg; bioavailability (%<i>F</i>) obtained after oral administration to CD-1 male mice at 5 mg/kg.</p></div><div class="footnote" id="t9fn6"><sup><sup>f</sup></sup><p class="last">AZ DprE1 inhibitor benchmark (compound <b>9</b> in reference).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></p></div></div></div><div class="NLM_p">In this acute model of TB infection,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> mice were subjected to an intratracheal infection of <i>M. tuberculosis</i> and then were treated every day for 8 days beginning on the day after infection with either compound <b>39</b> or <b>47</b> at varying doses. AZ DprE1 inhibitor <b>60</b> was profiled as a direct comparison, both with and without 1-aminobenzotriazole (ABT), a CYP P450 inhibitor.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> At the end of the experiment, the animals were sacrificed, and the number of colony forming units (CFUs) in the lungs were counted and compared with untreated animals.<named-content content-type="anchor" rid="fig3" type="simple"></named-content></div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0003.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Results from in vivo efficacy experiment for compounds <b>39</b> and <b>47</b>. (a) Calculated ED<sub>99</sub> values; dose response curves for (b) compound <b>39</b> and (c) compound <b>47</b>. CFU number in lungs of untreated mice: 5.8 logCFU.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01561&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The in vivo efficacy study demonstrated that compounds <b>39</b> and <b>47</b> were highly effective at alleviating acute <i>M. tuberculosis</i> infection in mice, with ED<sub>99</sub> values around 30 mg/kg, similar levels of activity to several marketed antituberculosis drugs in this model.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A highly promising series of DprE1 inhibitors was identified through carrying out judicious property- and efficiency-focused optimization of a phenotypic screening hit with suboptimal physicochemical properties. This series includes exemplars that are potent inhibitors of DprE1 in vitro, have a promising developability profile, and are efficacious in vivo in an acute mouse model of tuberculosis infection.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84284" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84284" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div class="NLM_p">Unless stated otherwise, all reagents were used as obtained from commercial sources. All solvents and compounds were of analytical grade and used as supplied.</div><div class="NLM_p">Liquid chromatography–mass spectroscopy (LCMS) was conducted on an Acquity UPLC BEH C18 column (50 mm × 2.1 mm i.d. 1.7 μm packing diameter) at 40 °C, eluting with either 10 mM ammonium bicarbonate in water adjusted to pH 10 with ammonia solution (solvent A) and acetonitrile (solvent B) or 0.1% v/v solution of formic acid in water (solvent A) and 0.1% v/v solution of formic acid in acetonitrile (solvent B). The UV detection is a summed signal from a wavelength of 210–350 nm. This summed wavelength is used for purity measurements quoted. The mass spectra were recorded on a Waters ZQ spectrometer using electrospray positive and negative mode, scanning from 100 to 1000 AMU. The following elution gradients were used. Ammonium bicarbonate 0–1.5 min 1–97% B, 1.5–1.9 min 97% B, 1.9–2 min 97–1% B. Formic acid 0–1.5 min 3–100% B, 1.5–1.9 min 100% B, 1.9–2 min 100–3% B. Alternatively, where a 4.5 min run is specified, LCMS was conducted on an Acquity BEH C18 column (50 mm × 2.1 mm i.d., 1.7 μm packing diameter) at 35 °C eluting with 0.1% v/v solution of formic acid in water (solvent A) and 0.1% v/v solution of formic acid in acetonitrile (solvent B) using the following gradient: 0–0.4 min 3 % B, 0.4–3.2 min 3–98% B, 3.2–3.8 min 98% B, 3.8–4.2 min 98–3% B. Preparative mass directed HPLC was conducted on a Waters MassLynx system comprised of a Waters 515 pump with extended pump heads, Waters 2767 autosampler, Waters 996 photodiode array detector and Gilson 202 fraction collector on a XBridge or Sunfire C18 column (30 mm × 150 mm i.d. Five μm packing diameter) at ambient temperature. The mobile phase was 0.1% formic acid in water or 10 mM ammonium bicarbonate in water adjusted to pH 10 with ammonia solution (solvent A) and 0.1% formic acid in acetonitrile or acetonitrile (solvent B). The UV detection is a summed signal from a wavelength of 210–350 nm. Mass spectra were recorded on Waters ZQ mass spectrometer using alternate-scan positive and negative electrospray ionization. The software used was MassLynx 3.5 with FractionLynx option or using equivalent alternative systems. The elution gradients used were at a flow rate of 40 mL/min over 10 or 20 min. High resolution mass spectra (HRMS) were obtained on a Micromass Q-Tof Ultima hybrid quadrupole time-of-flight mass spectrometer, equipped with a Z-spray interface (ESI), over a mass range of 100–1100 Da, with a scan time of 0.9 s and an interscan delay of 0.1 s. Reserpine was used as the external mass calibrant ([M + H]<sup>+</sup> = 609.2812 Da). The Q-Tof Ultima mass spectrometer was operated in W reflectron mode to give a resolution (fwhm) of 16000–20000. Ionization was achieved with a spray voltage of 3.2 kV and a cone voltage of 50 V, with cone and desolvation gas flows of 10–20 and 600 L/h, respectively. The source block and desolvation temperatures were maintained at 120 and 250 °C, respectively. The elemental composition was calculated using MassLynx v4.1 for the [M + H]<sup>+</sup> and the mass error quoted as ppm,</div><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded using a Bruker DPX250, DPX400, AV400 or referenced to tetramethylsilane. Chemical shifts are reported in parts per million (ppm) and coupling constants (<i>J</i>) in Hz. The following abbreviations are used for multiplicities: s = singlet; br s = broad singlet; d = doublet; t = triplet; m = multiplet; dd = doublet of doublets; ddd = double double doublet; q = quartet; quin = quintet; sext = sextet. The following abbreviations are used to assign <sup>13</sup>C spectra: Ar = aryl; C = O = carbonyl.</div><div class="NLM_p">All microwave reactions were carried out in a Biotage Initiator system in specialist microwave vials supplied by Biotage.</div><div class="NLM_p">The purity of all compounds screened in the biological assays was examined by LC–MS analysis and was found to be ≥95% unless otherwise specified.</div><div class="NLM_p">(1-(5-(1<i>H</i>-Pyrrol-1-yl)-1,3,4-thiadiazol-2-yl)piperidin-4-yl)(4-benzylpiperidin-1-yl)methanone (<b>1</b>), (1-(5-(1<i>H</i>-pyrrol-1-yl)-1,3,4-thiadiazol-2-yl)piperidin-4-yl)(4-methylpiperidin-1-yl)methanone (<b>2</b>), and piperidin-1-yl(1-(6-(piperidin-1-yl)pyrimidin-4-yl)piperidin-4-yl)methanone (<b>3</b>) were purchased from ChemDiv.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Procedure A: Piperidine Amide Formation</h4><div class="NLM_p last">1-(<i>tert</i>-Butoxycarbonyl)piperidine-4-carboxylic acid (1 equiv) was dissolved in DMF (2–10 mL) and treated with COMU (2 equiv) and DIPEA (3 equiv), followed by the appropriately substituted amine (1.2 equiv). The resulting solutions were stirred at room temperature overnight. The intermediates were worked-up as described and then treated with hydrochloric acid (5–10 equiv), and the solutions were stirred at room temperature until reactions were complete. The crude products were worked-up and purified as described.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Procedure B: Nucleophilic Aromatic Substitutions</h4><div class="NLM_p">4,6-Dichloropyrimidine (1 equiv) was dissolved in ethanol and then treated with an amine (1 equiv) and DIPEA (2.5 equiv). The resulting solutions were heated in a microwave reactor at 150 °C for 5 min. A second amine (2–5 equiv) was then added, and the solutions were heated in a microwave reactor at 150 °C for 1 h. Unless otherwise stated, the products were purified by direct injection of the reaction solution onto preparative HPLC purification.</div><div id="sec5_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> (4-Methylpiperidin-1-yl)(1-(6-(piperidin-1-yl)pyrimidin-4-yl)piperidin-4-yl)methanone (<b>4</b>)</h5><div class="NLM_p last">(4-Methylpiperidin-1-yl)(piperidin-4-yl)methanone (6, 48 mg, 0.23 mmol), followed by piperidine (0.11 mL, 1.14 mmol, 5 equiv) were reacted according to general procedure B to afford the title compound (<b>4</b>) as a colorless oil (53 mg, 0.13 mmol, 56%). LCMS (formic): <i>R</i><sub>t</sub> = 0.80 min, [M + H]<sup>+</sup> = 373. HRMS C<sub>21</sub>H<sub>34</sub>N<sub>5</sub>O required 372.2758, found 372.2762. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.04 (s, 1 H) 5.86 (s, 1 H) 4.34 (br d, <i>J</i> = 13.2 Hz, 4 H) 3.98 (d, <i>J</i> = 12 Hz, 2 H) 3.94–4.09 (m, 6 H) 2.79–3.10 (m, 5 H) 1.36–1.80 (m, 10 H) 0.98–1.15 (m, 1 H) 0.91 (d, <i>J</i> = 6.4 Hz, 3 H).</div></div><div id="sec5_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> (4-Benzylpiperidin-1-yl)(1-(6-(piperidin-1-yl)pyrimidin-4-yl)piperidin-4-yl)methanone (<b>5</b>)</h5><div class="NLM_p last">(4-Benzylpiperidin-1-yl)(piperidin-4-yl)methanone (7, 77 mg, 0.27 mmol), followed by piperidine (0.13 mL, 1.34 mmol, 5 equiv), was reacted according to general procedure B to afford the title compound (5) as an orange oil (44 mg, 0.10 mmol, 37%). LCMS (formic): <i>R</i><sub>t</sub> = 0.99 min, [M + H]<sup>+</sup> = 448. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 8.03 (s, 1 H); 7.25–7.31 (m, 2 H); 7.15–7.21 (m, 3 H); 5.85 (br. s, 1 H); 4.29–4.39 (m, 3 H); 3.95–4.02 (m, 1 H); 3.53 (t, <i>J</i> = 5.5 Hz, 4 H); 2.80–3.02 (m, 4 H); 1.70–1.83 (m, 1 H); 1.54–1.67 (m, 7 H); 1.39–1.54 (m, 7 H); 1.05–1.13 (m, 2 H); 0.91–1.02 (m, 1 H).</div></div><div id="sec5_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> (4-Methylpiperidin-1-yl)(piperidin-4-yl)methanone (<b>6</b>)</h5><div class="NLM_p last">4-Methylpiperidine (0.63 mL, 5.3 mmol) was reacted according to general procedure A. The intermediate was worked-up by removing the solvent by evaporation and partitioning the residue between ethyl acetate (20 mL) and water (20 mL). The aqueous layer was extracted with additional ethyl acetate (2 × 20 mL), and the combined organic layers were dried by passing through a hydrophobic frit and concentrated to yield a red oil. The residue was treated with hydrochloric acid (4 M in dioxane) (5.56 mL, 22.2 mmol). When the deprotection was complete, the solution was basified by addition of saturated aqueous sodium bicarbonate (100 mL) and was then extracted with DCM (2 × 100 mL). The combined organic layers were passed through a hydrophobic frit and concentrated. This material was purified on a 150 g C18 GOLD Aq column, eluting with a gradient of 5–85% acetonitrile in 10 mM ammonium bicarbonate (aq.) to afford the title compound (<b>6</b>) in multiple batches of varying purity, all of which were used as intermediates in the following steps. Batch 1 as a brown gum (68 mg, 0.32 mmol, 7%). LCMS (ammonium bicarbonate): <i>R</i><sub>t</sub> = 0.71 min, [M + H]<sup>+</sup> = 211, purity = 100%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 4.57 (d, <i>J</i> = 12.5 Hz, 1 H); 3.87 (d, <i>J</i> = 12.5 Hz, 1 H); 3.17 (d, <i>J</i> = 11.7 Hz, 2 H); 2.93–3.06 (m, 2 H); 2.59–2.76 (m, 3 H); 2.46–2.61 (m, 2 H); 1.25 (s, 3 H); 1.01–1.14 (m, 3 H); 0.95 (d, <i>J</i> = 6.5 Hz, 4 H), purity by NMR approximately 90%. Batch 2 as a brown gum (80 mg, 0.38 mmol, 9%). LCMS (ammonium bicarbonate): <i>R</i><sub>t</sub> = 0.71 min, [M + H]<sup>+</sup> = 211, purity = 33%. NMR consistent with batch 1, purity by NMR approximately 80%. Batch 3 as a brown gum (254 mg, 1.21 mmol, 27%). LCMS (ammonium bicarbonate): <i>R</i><sub>t</sub> = 0.69 min, [M + H]<sup>+</sup> = 211, purity = 75%. NMR consistent with batch 1, purity by NMR approximately 70%. Batch 4 as a brown gum (540 mg, 2.57 mmol, 58%). LCMS (ammonium bicarbonate): <i>R</i><sub>t</sub> = 0.67 min, [M + H]<sup>+</sup> not visible, purity = 100%. NMR consistent with batch 1, purity by NMR < 50%.</div></div><div id="sec5_1_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> (4-Benzylpiperidin-1-yl)(piperidin-4-yl)methanone (<b>7</b>)</h5><div class="NLM_p last">4-Benzylpiperidine (0.516 mL, 2.94 mmol) was reacted according to general procedure A. The intermediate was worked-up by removing the solvent by evaporation and partitioning the residue between ethyl acetate (20 mL) and water (20 mL). The aqueous layer was extracted with additional ethyl acetate (2 × 20 mL), and the combined organic layers were dried by passing through a hydrophobic frit and concentrated. The residue was treated with hydrochloric acid (4 M in dioxane) (3.1 mL, 12.2 mmol). When the deprotection was complete, the solution was basified by addition of saturated aqueous sodium bicarbonate (100 mL) and was then extracted with DCM (2 × 100 mL). The combined organic layers were passed through a hydrophobic frit and concentrated. The crude residue was purified on a 150 g Redisep C18 GOLD column, eluting with a gradient of 20–60% acetonitrile in 10 mM ammonium bicarbonate to afford the title compound (<b>7</b>) as an orange oil (637 mg, 2.22 mmol, 91%). LCMS (ammonium bicarbonate): <i>R</i><sub>t</sub> = 1.00 min (broad peak), [M + H]<sup>+</sup> = 287. (NB. Additional ion in peak for M+ = 316). NMR was broad and could not be assigned, even with heating to 120 °C.</div></div><div id="sec5_1_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> (4-Methylpiperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>10</b>)</h5><div class="NLM_p last">(4-Methylpiperidin-1-yl)(piperidin-4-yl)methanone (<b>6</b>, 40 mg, 0.19 mmol) followed by morpholine (0.08 mL, 0.95 mmol, 5 equiv) were reacted according to general procedure B to afford the title compound (<b>10</b>) as a yellow oil (20 mg, 0.05 mmol, 28%). LCMS (formic): <i>R</i><sub>t</sub> = 0.67 min, [M + H]<sup>+</sup> = 374. HRMS C<sub>20</sub>H<sub>32</sub>N<sub>5</sub>O<sub>2</sub> required 374.2551, found 374.2550. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.23 (s, 1 H); 5.59 (s, 1 H); 4.58 (d, <i>J</i> = 13.0 Hz, 1 H); 4.34 (d, <i>J</i> = 13.0 Hz, 2 H); 3.90 (d, <i>J</i> = 13.2 Hz, 1 H); 3.74–3.80 (m, 4 H); 3.50–3.56 (m, 4 H); 3.04 (t, <i>J</i> = 12.0 Hz, 1 H); 2.89–2.99 (m, 2 H); 2.71–2.83 (m, 1 H); 2.50–2.60 (m, 1 H); 1.56–1.93 (m, 7 H); 1.05–1.19 (m, 2 H); 0.98 (d, <i>J</i> = 6.4 Hz, 3 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 172.0 (C═O); 163.1 (Ar C); 162.4 (Ar C); 156.9 (Ar CH); 81.4 (Ar CH); 65.8 (2 CH<sub>2</sub>); 44.9 (CH<sub>2</sub>); 44.1 (2 CH<sub>2</sub>); 43.3 (2 CH<sub>2</sub>); 41.3 (CH<sub>2</sub>); 37.3 (CH); 34.6 (CH<sub>2</sub>); 33.6 (CH<sub>2</sub>); 30.5 (CH); 27.8 (CH<sub>2</sub>); 27.7 (CH<sub>2</sub>); 21.6 (CH<sub>3</sub>).</div></div><div id="sec5_1_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> (1-(6-(Dimethylamino)pyrimidin-4-yl)piperidin-4-yl)(4-methylpiperidin-1-yl)methanone (<b>11</b>)</h5><div class="NLM_p last">(4-Methylpiperidin-1-yl)(piperidin-4-yl)methanone (<b>6</b>, 68 mg, 0.32 mmol) followed by dimethylamine (2.0 M in THF) (0.54 mL, 1.07 mmol, 5 equiv) were reacted according to general procedure B to afford the title compound (<b>11</b>) as an orange oil (19 mg, 0.06 mmol, 26%). LCMS (formic): <i>R</i><sub>t</sub> = 0.67 min, [M + H]<sup>+</sup> = 332. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.23 (s, 1 H); 5.48 (s, 1 H); 4.59 (d, J = 13.5 Hz, 1 H); 4.35 (d, J = 13.0 Hz, 2 H); 3.91 (d, <i>J</i> = 14.0, 1 H); 3.06 (s, 6 H); 3.00–3.05 (m, 1 H); 2.86–2.97 (m, 3 H); 2.70–2.79 (m, 1 H); 2.55 (t, <i>J</i> = 13.0 Hz, 1 H); 1.56–1.91 (m, 6 H); 1.04–1.18 (m, 2 H); 0.97 (d, <i>J</i> = 6.5 Hz, 3 H).</div></div><div id="sec5_1_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 4-Methylpiperidin-1-yl)(1-(6-(pyrrolidin-1-yl)pyrimidin-4-yl)piperidin-4-yl)methanone (<b>12</b>)</h5><div class="NLM_p last">(4-Methylpiperidin-1-yl)(piperidin-4-yl)methanone (<b>6</b>, 40 mg, 0.19 mmol) followed by pyrrolidine (0.079 mL, 0.95 mmol, 5 equiv) were reacted according to general procedure B to afford the title compound (<b>12</b>) as a yellow oil (22 mg, 0.06 mmol, 33%) . LCMS (formic): <i>R</i><sub>t</sub> = 0.75 min, [M + H]<sup>+</sup> = 358. HRMS C<sub>20</sub>H<sub>32</sub>N<sub>5</sub>O required 358.2601, found 358.2595. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.20 (d, <i>J</i> = 0.5 Hz, 1 H); 5.33 (s, 1 H); 4.56 (d, <i>J</i> = 13.0 Hz, 1 H); 4.32 (d, <i>J</i> = 13.0 Hz, 2 H); 3.89 (d, <i>J</i> = 13.0 Hz, 1 H); 3.35–3.48 (m, 4 H); 3.02 (t, <i>J</i> = 12.0 Hz, 1 H); 2.89 (t, <i>J</i> = 12.0 Hz, 2 H); 2.68–2.78 (m, 1 H); 2.53 (t, <i>J</i> = 12.0 Hz, 1 H); 1.94–2.00 (m, 4 H); 1.53–1.88 (m, 7 H); 1.01–1.17 (m, 2 H); 0.95 (d, <i>J</i> = 6.5 Hz, 3 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 172.0 (C = O); 161.8 (Ar C); 160.7 (Ar C); 156.9 (Ar CH); 81.0 (Ar CH); 45.9 (2 CH<sub>2</sub>); 44.9 (CH<sub>2</sub>); 43.2 (2 CH<sub>2</sub>); 41.3 (CH<sub>2</sub>); 37.3 (CH<sub>2</sub>); 34.7 (CH<sub>2</sub>); 33.5 (CH); 30.5 (CH<sub>2</sub>); 27.8 (CH<sub>2</sub>); 27.6 (CH); 24.7 (2 CH<sub>2</sub>); 21.5 (CH<sub>3</sub>).</div></div><div id="sec5_1_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> (1-(6-(Cyclopentylamino)pyrimidin-4-yl)piperidin-4-yl)(4-methylpiperidin-1-yl)methanone (<b>13</b>)</h5><div class="NLM_p last">(4-Methylpiperidin-1-yl)(piperidin-4-yl)methanone (6, 50 mg, 0.24 mmol) followed by cyclopentanamine (0.12 mL, 1.19 mmol, 5 equiv) was reacted according to general procedure B. After the second amine addition, the reaction was heated at 150 °C for 9 h. The title compound (13) was obtained as a yellow oil (29 mg, 0.08 mmol, 33%). LCMS (formic): RT = 0.86 min, [M + H]<sup>+</sup> = 372, purity = 93%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.12 (s, 1 H); 5.43 (s, 1 H); 4.76 (d, <i>J</i> = 6.5 Hz, 1 H); 4.59 (d, <i>J</i> = 13.0 Hz, 1 H); 4.34 (d, <i>J</i> = 13.0 Hz, 2 H); 3.85–3.96 (m, 2 H); 3.04 (t, <i>J</i> = 12.0 Hz, 1 H); 2.93 (t, <i>J</i> = 12.0 Hz, 2 H); 2.70–2.80 (m, 1 H); 2.55 (t, <i>J</i> = 12.0 Hz, 1 H); 1.96–2.07 (m, 2 H); 1.56–1.92 (m, 11 H); 1.44–1.55 (m, 2 H); 1.01–1.18 (m, 2 H) 0.97 (d, <i>J</i> = 6.5 Hz, 3 H).</div></div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> General Procedure C: Nucleophilic Aromatic Substitutions</h4><div class="NLM_p">An amine (1 equiv) was dissolved in ethanol (0.5–1 mL) and then treated with chloropyrimidine (0.9 equiv) and DIPEA (2 equiv). The resulting solutions were heated in a microwave reactor at 150 °C until the reaction was complete by LCMS. The products were purified by direct injection of the reaction solution onto preparative HPLC purification.</div><div id="sec5_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> (4-Benzylpiperidin-1-yl)(1-(pyrimidin-4-yl)piperidin-4-yl)methanone (<b>14</b>)</h5><div class="NLM_p last">(4-Benzylpiperidin-1-yl)(piperidin-4-yl)methanone (<b>7</b>, 100 mg, 0.35 mmol) and 4-chloropyrimidine (40 mg, 0.35 mmol) were reacted according to general procedure C with a heating time of 1 h to afford the title compound (<b>14</b>) as a yellow oil (45 mg, 0.12 mmol, 35%). LCMS (ammonium bicarbonate): RT = 1.04 min, [M + H]<sup>+</sup> = 365. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.59 (s, 1 H); 8.18 (d, <i>J</i> = 6.4 Hz, 1 H); 7.27–7.35 (m, 2 H); 7.19–7.25 (m, 1 H); 7.11–7.18 (m, 2 H); 6.52 (dd, <i>J</i> = 6.4, 1.0 Hz, 1 H); 4.62 (d, <i>J</i> = 13.2 Hz, 1 H); 4.41 (br. s., 2 H); 3.92 (d, <i>J</i> = 13.2 Hz, 1 H); 2.95–3.07 (m, 3 H); 2.75–2.86 (m, 1 H); 2.45–2.65 (m, 4 H); 1.63–1.91 (m, 6 H); 1.06–1.29 (m, 2 H).</div></div><div id="sec5_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> (4-Benzylpiperidin-1-yl)(1-(6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)piperidin-4-yl)methanone (<b>15</b>)</h5><div class="NLM_p last">(4-Benzylpiperidin-1-yl)(piperidin-4-yl)methanone (<b>7</b>, 100 mg, 0.35 mmol) followed by 1-methylpiperazine (0.19 mL, 1.75 mmol, 5 equiv) were reacted according to general procedure B to afford the title compound (15) as a yellow oil (70 mg, 0.15 mmol, 43%). LCMS (formic): RT = 0.75 min, [M + H]<sup>+</sup> = 463. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.05 (s, 1 H); 7.28 (t, <i>J</i> = 7.0 Hz, 2 H); 7.15–7.21 (m, 3 H); 5.88 (s, 1 H); 4.34 (d, <i>J</i> = 12.0 Hz, 3 H); 3.98 (d, <i>J</i> = 13.0 Hz, 1 H); 3.49–3.55 (m, 4 H) 2.79–3.01 (m, 4 H); 2.40–2.54 (m, 3 H); 2.33 (t, <i>J</i> = 4.9 Hz, 4 H); 2.19 (s, 3 H); 1.69–1.82 (m, 1 H); 1.53–1.66 (m, 4 H); 1.37–1.54 (m, 2 H); 0.88–1.18 (m, 2 H).</div></div><div id="sec5_1_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> (4-Benzylpiperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>16</b>)</h5><div class="NLM_p last">(4-Benzylpiperidin-1-yl)(piperidin-4-yl)methanone (<b>7</b>, 1.0 g, 3.5 mmol) followed by morpholine (1.5 mL, 17.5 mmol, 5 equiv) were reacted according to general procedure B. The solvents were removed by evaporation and then purified on a 80 g Redisep Gold silica column, eluting with a gradient of 10–95% ethyl acetate in cyclohexane, followed by 95–100% (10% methanol in ethyl acetate) in cyclohexane. The appropriate fractions were combined and concentrated to yield the title compound (16) as an off-white solid (1.32 g, 2.94 mmol, 84%). Mp 153–155 °C. LCMS (formic): RT = 0.84 min, [M + H]<sup>+</sup> = 450. HRMS C<sub>26</sub>H<sub>36</sub>N<sub>5</sub>O<sub>2</sub> required 450.2864, found 450.2855. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.07 (s, 1 H); 7.24–7.30 (m, 2 H); 7.14–7.20 (m, 3 H); 5.88 (s, 1 H); 4.34 (br. d, <i>J</i> = 13.0 Hz, 3 H); 3.98 (d, <i>J</i> = 13.0 Hz, 1 H); 3.61–3.66 (m, 4 H); 3.45–3.51 (m, 4 H); 2.81–3.00 (m, 4 H); 2.41–2.54 (m, 3 H); 1.69–1.82 (m, 1 H); 1.53–1.66 (m, 4 H); 1.38–1.51 (m, 2 H); 0.88–1.15 (m, 2 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 178.8 (C = O); 171.9 (Ar C); 163.0 (Ar C); 162.4 (Ar CH); 156.9 (Ar CH); 140.0 (Ar C); 128.9 (2 Ar CH); 128.0 (Ar CH); 125.7 (Ar CH); 81.4 (Ar CH); 65.8 (2 CH<sub>2</sub>); 44.8 (CH<sub>2</sub>); 44.1 (2 CH<sub>2</sub>); 43.2 (CH<sub>2</sub>); 42.0 (CH<sub>2</sub>); 41.2 (CH<sub>2</sub>); 37.5 (CH<sub>2</sub>); 37.3 (CH); 32.6 (CH<sub>2</sub>); 31.4 (CH<sub>2</sub>); 30.3 (CH); 27.8 (CH<sub>2</sub>); 27.7 (CH<sub>2</sub>). IR (ATR) cm<sup>–1</sup> 3024; 2920; 2852; 1628; 1578; 1446; 1200; 1121; 973; 800; 695.</div></div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> General Procedure D: Acetylations</h4><div class="NLM_p">The appropriate amine (20 mg) was dissolved in acetic anhydride (250 μL), and the solution was stirred at room temperature for 17 h. The solvent was removed by evaporation and the crude products were purified.</div><div id="sec5_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 1-(4-(4-Methylpiperidine-1-carbonyl)piperidin-1-yl)ethanone (<b>17</b>)</h5><div class="NLM_p last">(4-Methylpiperidin-1-yl)(piperidin-4-yl)methanone (<b>6</b>, 20 mg, 0.10 mmol) was reacted according to general procedure D. The product was purified by preparative HPLC and then repurified by on a Redisep silica 4 g column, eluting with a gradient of 0–95% (0.1% triethylamine in 10% methanol/DCM) in 0.1% triethylamine in DCM. The appropriate fractions were combined and concentrated to afford the title compound (<b>17</b>) as a colorless gum (9 mg, 0.03 mmol, 36%). LCMS (formic): <i>R</i><sub>t</sub> = 0.70 min, [M + H]<sup>+</sup> = 253. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 4.58 (d, <i>J</i> = 13.0 Hz, 2 H); 3.88 (d, <i>J</i> = 13.0 Hz, 2 H); 2.99–3.16 (m, 2 H); 2.65–2.77 (m, 2 H); 2.55 (t, <i>J</i> = 13.0 Hz, 1 H); 2.10 (s, 3 H); 1.79–1.90 (m, 1 H); 1.59–1.78 (m, 6 H); 1.02–1.16 (m, 2 H); 0.97 (d, <i>J</i> = 6.5 Hz, 3 H).</div></div><div id="sec5_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 1-(4-(4-Benzylpiperidine-1-carbonyl)piperidin-1-yl)ethanone (<b>18</b>)</h5><div class="NLM_p last">(4-Benzylpiperidin-1-yl)(piperidin-4-yl)methanone (<b>7</b>, 20 mg, 0.07 mmol) was reacted according to general procedure D. The product was purified by preparative HPLC to afford the title compound (<b>18</b>) as a colorless oil (7 mg, 0.02 mmol, 24%). LCMS (ammonium bicarbonate): RT = 0.97 min, [M + H]<sup>+</sup> = 329. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.23–7.39 (m, 2 H); 7.13–7.20 (m, 3 H); 4.45–4.58 (m, 2 H); 4.06 (d, <i>J</i> = 13.0 Hz, 1 H); 3.89–3.99 (m, 1 H); 3.12–3.24 (m, 1 H); 3.01–3.10 (m, 1 H); 2.91–3.01 (m, 1 H); 2.66–2.78 (m, 1 H); 2.59–2.62 (m, 1 H); 2.56 (dd, <i>J</i> = 7.0, 3.0 Hz, 3 H); 2.09 (d, <i>J</i> = 1.5 Hz, 3 H); 1.80–1.90 (m, 1 H); 1.64–1.79 (m, 4 H); 1.45–1.64 (m, 1 H); 1.04–1.25 (m, 2 H).</div></div><div id="sec5_1_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 4,6-Di(piperidin-1-yl)pyrimidine (<b>19</b>)</h5><div class="NLM_p last">4,6-Dichloropyrimidine (100 mg, 0.67 mmol) was dissolved in ethanol (0.5 mL) and added to piperidine (0.66 mL, 6.7 mmol). The resulting solution was heated in a microwave reactor at 150 °C for 1 h. A few drops of DMSO was added to the solution to ensure complete dissolution then the solution was directly injected onto preparative HPLC purification in two injections. The appropriate fraction from each run was combined and concentrated to afford the title compound (<b>19</b>) as a white solid (130 mg, 0.53 mmol, 79%). Mp 103–106 °C. LCMS (ammonium bicarbonate): RT = 1.13 min, [M + H]<sup>+</sup> = 247. HRMS C<sub>14</sub>H<sub>23</sub>N<sub>4</sub> required 247.1917, found 247.1921. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.01 (d, <i>J</i> = 0.5 Hz, 1 H); 5.82 (s, 1 H); 3.52 (t, <i>J</i> = 6.0 Hz, 8 H); 1.56–1.63 (m, 4 H); 1.44–1.51 (m, 8 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 163.5 (Ar CH); 156.9 (2 Ar C); 80.7 (Ar CH); 44.6 (4 CH<sub>2</sub>); 25.0 (4 CH<sub>2</sub>); 24.3 (2 CH<sub>2</sub>). IR (ATR) cm<sup>–1</sup> 2923; 2849; 1577; 1490; 1437; 1348; 1215; 1018; 970; 800.</div></div><div id="sec5_1_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> <i>N,N</i>-Dimethyl-6-(piperidin-1-yl)pyrimidin-4-amine (<b>20</b>)</h5><div class="NLM_p last">Dimethylamine (2.0 M in THF) (0.34 mL, 0.67 mmol) followed by piperidine (0.33 mL, 3.4 mmol, 5 equiv) were reacted according to general procedure B. A few drops of DMSO was added to the solution to ensure complete dissolution then purification by mass-directed preparative HPLC in two injections was carried out. Only one injection collected product. The appropriate fraction from this run was concentrated to afford the title compound (<b>20</b>) as a yellow oil (36 mg, 0.18 mmol, 26%). LCMS (formic): RT = 0.58 min, [M + H]<sup>+</sup> = 207. HRMS C<sub>11</sub>H<sub>19</sub>N<sub>4</sub> required 207.1604, found 207.1608. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.02 (d, <i>J</i> = 0.5 Hz, 1 H); 5.64 (s, 1 H); 3.52 (t, <i>J</i> = 5.0 Hz, 4 H); 2.98 (s, 6 H); 1.56–1.64 (m, 2 H); 1.44–1.52 (m, 4 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 162.9 (Ar C); 162.2 (Ar C); 156.7 (Ar CH); 80.1 (Ar CH)l 44.6 (2 CH<sub>2</sub>); 36.8 (2 CH<sub>3</sub>); 25.0 (2 CH<sub>2</sub>); 24.3 (CH<sub>2</sub>). IR (ATR) cm<sup>–1</sup> 3375; 2929; 2852; 1581; 1489; 1428; 1335; 1247; 975; 798.</div></div><div id="sec5_1_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 4-(6-(Piperidin-1-yl)pyrimidin-4-yl)morpholine (<b>21</b>)</h5><div class="NLM_p last">Morpholine (0.059 mL, 0.67 mmol) followed by piperidine (0.332 mL, 3.36 mmol, 5 equiv) were reacted according to general procedure B. Methanol (2 mL) was added to the solution to ensure complete dissolution then purification by preparative HPLC in three injections was carried out. The appropriate fractions from each run were combined and concentrated to afford the title compound (<b>21</b>) as a white solid (96 mg, 0.39 mmol, 58%). Mp 100–102 °C. LCMS (formic): RT = 0.52 min, [M + H]<sup>+</sup> = 249. HRMS C<sub>13</sub>H<sub>21</sub>N<sub>4</sub>O required 249.1710, found 249.1712. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.25 (s, 1 H); 5.58 (s, 1 H); 3.77–3.81 (m, 4 H); 3.51–3.59 (m, 8 H); 1.59–1.72 (m, 6 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 163.1 (Ar C); 162.4 (Ar C); 156.7 (Ar CH); 81.1 (Ar CH); 65.8 (2 CH<sub>2</sub>); 44.6 (2 CH<sub>2</sub>); 44.1 (2 CH<sub>2</sub>); 25.0 (2 CH<sub>2</sub>); 24.3 (CH<sub>2</sub>). IR (ATR) cm<sup>–1</sup> 2938; 2856; 2826; 1574; 1466; 1440; 1211; 1119; 991; 971; 804; 796.</div></div><div id="sec5_1_4_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 4-(2-Chloro-6-((4-methoxybenzyl)oxy)pyrimidin-4-yl)morpholine</h5><div class="NLM_p last">To a solution of 2,4,6-trichloropyrimidine (2.51 mL, 21.8 mmol) and cesium carbonate (21.3 g, 65.4 mmol) in acetonitrile (50 mL) was added (4-methoxyphenyl)methanol (2.71 mL, 21.8 mmol). This mixture was stirred at room temperature for 72 h, after which morpholine (2.28 mL, 26.2 mmol) was added. The resulting mixture was stirred for 16 h, after which the solvent was removed under reduced pressure. The resulting solid was suspended in ethyl acetate (200 mL). Water (200 mL) was added, and the mixture was separated. The organic layer was washed with water (2 × 200 mL) and brine (100 mL) and dried over MgSO<sub>4</sub> and concentrated under reduced pressure. The resulting residue was adsorbed onto diatomaceous earth and purified by flash chromatography, eluting under a gradient of TBME (0–25%) in cyclohexane to afford the three regioisomers, which eluted in the following order: 4-(4-chloro-6-((4-methoxybenzyl)oxy)pyrimidin-2-yl)morpholine (2.95 g, 8.79 mmol, 40%, white solid), 4-(2-chloro-6-((4-methoxybenzyl)oxy)pyrimidin-4-yl)morpholine (412 mg, 1.23 mmol, 6%, opaque gum), 4-(6-chloro-2-((4-methoxybenzyl)oxy)pyrimidin-4-yl)morpholine (1.52 g, 4.53 mmol, 21%, transparent gum). LCMS (ammonium bicarbonate): <i>R</i><sub>t</sub> = 1.29 min, [M + H] <sup>+</sup> = 336. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 7.36–7.38 (m, 2H); 6.93–6.96 (m, 2H); 6.13 (s, 1H); 5.23 (s, 2H); 3.76 (s, 3H); 3.63–3.64 (m, 4H); 3.53–3.55 (m, 4H).</div></div><div id="sec5_1_4_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 4-(2-((4-Methoxybenzyl)oxy)-6-(piperidin-1-yl)pyrimidin-4-yl)morpholine</h5><div class="NLM_p last">To a solution of 4-(6-chloro-2-((4-methoxybenzyl)oxy)pyrimidin-4-yl)morpholine (75 mg, 0.22 mmol) and DIPEA (0.117 mL, 0.67 mmol) in ethanol (0.9 mL) was added piperidine (66 μL, 0.67 mmol). The mixture was heated to 150 °C in the microwave for 5 h, after which time direct purification of the reaction mixture by preparative HPLC afforded the title compound (61 mg, 0.16 mmol, 71%) as a red glass. LCMS (ammonium bicarbonate): RT = 1.35 min, [M + H] <sup>+</sup> = 385. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ ppm 7.34–7.38 (m, 2H); 6.88–6.91 (m, 2H); 5.48 (s, 1H); 5.42 (s, 2H); 3.79 (s, 3H); 3.71–3.73 (m, 4H); 3.55–3.58 (m, 4H); 3.49–3.51 (m, 4H); 1.65–1.72 (m, 2H); 1.55–1.61 (m, 4H).</div></div><div id="sec5_1_4_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 4-Morpholino-6-(piperidin-1-yl)pyrimidin-2(1<i>H</i>)-one (<b>22</b>)</h5><div class="NLM_p last">4-(2-((4-Methoxybenzyl)oxy)-6-(piperidin-1-yl)pyrimidin-4-yl)morpholine (60 mg, 0.16 mmol) was dissolved in a mixture of dichloromethane and trifluoroacetic acid (3 mL, 1:1). This mixture was stirred for 1 h, after which time it was concentrated to dryness under reduced pressure. The residue was dissolved in DMF (1 mL) and subjected to preparative HPLC purification to give the title compound (<b>22</b>) (37 mg, 0.14 mmol, 89%) as a white solid. Mp 259–270 °C (decomp.). LCMS (ammonium bicarbonate): RT = 0.68 min, [M + H] <sup>+</sup> = 265. HR-MS (ESI): C<sub>13</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub> [M + H<sup>+</sup>] required 265.1659, found 265.1665. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 8.39 (s, 1H); 5.18 (s, 1H); 3.60–3.63 (m, 4H); 3.41–3.45 (m, 8H); 1.56–1.62 (m, 2H); 1.47–1.51 (m, 4H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 162.3; 160.6; 157.9; 70.8; 65.8 (2C); 45.7 (2C); 44.9 (2C); 25.1 (2C); 24.0. IR (neat) cm<sup>–1</sup> 2927; 2840; 1596; 1534; 1498; 1427; 1382; 1360; 1265; 1228; 1207; 1115; 1028; 1000; 896; 861; 828; 778; 747.</div></div><div id="sec5_1_4_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 4-(6-Chloropyrimidin-4-yl)morpholine</h5><div class="NLM_p last">To a stirred solution of 4,6-dichloropyrimidine (10 g, 67.1 mmol) in ethanol (100 mL) cooled to 5 °C was added triethylamine (9.36 mL, 67.1 mmol) followed by morpholine (7.02 g, 81 mmol), and the reaction was stirred for 16 h at room temperature. During the reaction solid was formed, which was filtered off and dried over vacuo to obtain 4-(6-chloropyrimidin-4-yl)morpholine (11.74 g, 58.7 mmol, 87%) as a white solid. LCMS (formic 4.5 min run): RT = 1.50 min, [M + H]<sup>+</sup> = 200. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.40 (d, <i>J</i> = 0.7 Hz, 1 H) 6.49 (d, <i>J</i> = 0.9 Hz, 1 H) 3.73–3.85 (m, 4 H) 3.53–3.69 (m, 4 H).</div></div><div id="sec5_1_4_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> <i>N</i>-isopropyl-<i>N</i>-methyl-6-morpholinopyrimidin-4-amine (<b>23</b>)</h5><div class="NLM_p last">A solution of 4-(6-chloropyrimidin-4-yl)morpholine (100 mg, 0.50 mmol), <i>N</i>-methylpropan-2-amine (44. mg, 0.60 mmol) and DIPEA (0.262 mL, 1.50 mmol) in DMSO were irradiated with microwaves at 150 °C for 1 h. The reaction mixture was diluted with water, extracted with ethyl acetate (2 × 10 mL), washed with brine, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The organic layer was evaporated under reduced pressure, and the crude compound was purified by silica-gel (100–200 mesh) column chromatography, eluted with 80% ethyl acetate in hexane. The product was repurified by preparative HPLC using the following conditions: Column: XTERRA RP18 (150 × 19) mm, 5 μm. Mobile Phase: A: 10 mM ammonium bicarbonate (Aq) B: Acetonitrile Flow: 15 mL/min. Method: 0/55, 12/55, 13/100, 18/100. The title compound (23) was obtained as an off-white solid (81 mg, 0.34 mmol, 68%). LCMS (formic): RT = 0.46 min, [M + H]<sup>+</sup> = 237. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.05 (s, 1 H) 5.66 (s, 1 H) 4.73–5.06 (m, 1 H) 3.58–3.75 (m, 4 H) 3.38–3.49 (m, 4 H) 2.76 (s, 3 H) 1.08 (d, <i>J</i> = 6.8 Hz, 6 H).</div></div><div id="sec5_1_4_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 4-(6-(3,3-Difluoropyrrolidin-1-yl)pyrimidin-4-yl)morpholine (<b>24</b>)</h5><div class="NLM_p last">Morpholine (0.029 mL, 0.34 mmol), followed by 3,3-difluoropyrrolidine (96 mg, 0.67 mmol, 2 equiv), were reacted according to general procedure B to afford the title compound (<b>24</b>) as an off-white solid (51 mg, 0.19 mmol, 56%). Mp 140–142 °C. LCMS (ammonium bicarbonate): RT = 0.77 min, [M + H]<sup>+</sup> = 271. HRMS C<sub>12</sub>H<sub>17</sub>F<sub>2</sub>N<sub>4</sub>O required 271.1365, found 271.1370. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.10 (d, <i>J</i> = 0.5 Hz, 1 H); 5.67 (s, 1 H); 3.81 (t, <i>J</i> = 13.5 Hz, 2 H); 3.58–3.67 (m, 6 H); 3.48–3.53 (m, 4 H); additional 2H masked by DMSO peak. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 162.4 (Ar C); 160.7 (Ar C); 156.9 (Ar CH); 128.2 (t, <i>J</i> = 247 Hz, CF<sub>2</sub>); 81.5 (Ar CH); 65.8 (2 CH<sub>2</sub>); 52.8 (t, <i>J</i> = 32 Hz, CH<sub>2</sub>); 44.1 (2 CH<sub>2</sub>); 43.6 (t, <i>J</i> = 4.0 Hz, CH<sub>2</sub>); 32.8 (t, <i>J</i> = 24 Hz, CH<sub>2</sub>). IR (ATR) cm<sup>–1</sup> 2960; 2874; 2838; 1582; 1481; 1310; 1237; 1114; 974; 927; 800.</div></div><div id="sec5_1_4_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 1-(4-(6-Morpholinopyrimidin-4-yl)piperazin-1-yl)ethanone (<b>25</b>)</h5><div class="NLM_p last">Morpholine (0.029 mL, 0.34 mmol), followed by 1-(piperazin-1-yl)ethanone (86 mg, 0.67 mmol, 2 equiv) were reacted according to general procedure B to afford the title compound (<b>25</b>) as a white solid (59 mg, 0.20 mmol, 60%). Mp = 165–166 °C. LCMS (ammonium bicarbonate): RT = 0.58 min, [M + H]<sup>+</sup> = 292. HRMS C<sub>14</sub>H<sub>22</sub>N<sub>5</sub>O<sub>2</sub> required 292.1768 found 292.1780. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.10 (s, 1 H); 5.92 (s, 1 H); 3.59–3.67 (m, 6 H); 3.46–3.55 (m, 10 H); 2.03 (s, 3 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 178.7 (C = O); 163.0 (Ar C); 162.5 (Ar C); 156.9 (Ar CH); 81.6 (Ar CH); 65.8 (2 CH<sub>2</sub>); 45.1 (CH<sub>2</sub>); 44.1 (2 CH<sub>2</sub>); 43.6 (CH<sub>2</sub>); 43.4(CH<sub>2</sub>); 40.4 (CH<sub>2</sub>); 21.0 (CH<sub>3</sub>). IR (ATR) cm<sup>–1</sup> 2967; 2859; 1645; 1591; 1491; 1446; 1420; 1246; 1227; 1206; 1117; 992; 976; 806.</div></div><div id="sec5_1_4_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 4-(6-(3,3-Dimethylpiperidin-1-yl)pyrimidin-4-yl)morpholine (<b>26</b>)</h5><div class="NLM_p last">To a solution of 4-(6-chloropyrimidin-4-yl)morpholine (200 mg, 1.00 mmol) and 3,3-dimethylpiperidine (170 mg, 1.50 mmol) in acetonitrile (3 mL) stirred at room temp was added DIPEA (1.05 mL, 6.01 mmol). The reaction mixture was stirred at 130 °C for 48 h. The reaction mixture was concentrated and dissolved in ethyl acetate (40 mL), and the organic layer was washed with water (2 × 20 mL) and brine solution (10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The crude compound was purified on silica gel (100–200 mesh) column chromatography using 40% ethyl acetate in petroleum ether as an eluent and lyophilized to the title compound (26) as a solid (40 mg, 0.14 mmol, 14%). LCMS (formic): RT = 0.62 min, [M + H]<sup>+</sup> = 277. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.22 (d, <i>J</i> = 0.7 Hz, 1 H) 5.56 (s, 1 H) 3.71–3.87 (m, 4 H) 3.45–3.59 (m, 6 H) 3.27 (s, 2 H) 1.64 (ddd, <i>J</i> = 6.0, 3.6, 2.2 Hz, 2 H) 1.37–1.49 (m, 2 H) 0.94 (s, 6 H).</div></div><div id="sec5_1_4_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 8-(6-Morpholinopyrimidin-4-yl)-1-oxa-8-azaspiro[4.5]decane (<b>27</b>)</h5><div class="NLM_p last">Morpholine (0.029 mL, 0.34 mmol), followed by 1-oxa-8-azaspiro[4.5]decane hydrochloride (obtained from the GSK compound collection, 119 mg, 0.67 mmol, 2 equiv) were reacted according to general procedure B to afford the title compound (<b>27</b>) as a white gum (48 mg, 0.16 mmol, 46%). LCMS (ammonium bicarbonate): RT = 0.82 min, [M + H]<sup>+</sup> = 305. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.06 (s, 1 H); 5.90 (s, 1 H); 3.71–3.79 (m, 4 H); 3.61–3.66 (m, 4 H); 3.39–3.51 (m, 6 H); 1.83–1.93 (m, 2 H); 1.64–1.71 (m, 2 H); 1.44–1.57 (m, 4 H).</div></div><div id="sec5_1_4_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 4-(6-(Azepan-1-yl)pyrimidin-4-yl)morpholine (<b>28</b>)</h5><div class="NLM_p last">A solution of 4-(6-chloropyrimidin-4-yl)morpholine (100 mg, 0.50 mmol), azepane (60 mg, 0.60 mmol) and DIPEA (0.262 mL, 1.50 mmol) in DMSO (5 mL) was irradiated with microwaves at 150 °C for 1 h. The reaction mixture was diluted with water, extracted with ethyl acetate (2 × 10 mL), washed with brine, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The organic layer was evaporated under reduced pressure. The crude compound was purified by silica-gel (100–200 mesh) column chromatography, eluted with 80% ethyl acetate in hexane, as an eluent to afford the title compound (<b>28</b>) as an orange solid (72 mg, 0.27 mmol, 55%). LCMS (formic): RT = 0.54 min, [M + H]<sup>+</sup> = 263. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.04 (d, <i>J</i> = 0.7 Hz, 1 H) 5.66 (s, 1 H) 3.61–3.72 (m, 4 H) 3.53–3.60 (m, 4 H) 3.39–3.49 (m, 4 H) 1.68 (br s, 4 H) 1.37–1.52 (m, 4 H).</div></div><div id="sec5_1_4_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> Ethyl 1-(6-chloropyrimidin-4-yl)piperidine-4-carboxylate</h5><div class="NLM_p last">To a solution of 4,6-dichloropyrimidine (15.00 g, 101 mmol) in ethanol (150 mL), ethylpiperidine-4-carboxylate (15.83 g, 101 mmol) was added at room temperature, then triethylamine (21.05 mL, 151 mmol) was added at 0 °C, and the reaction mixture was stirred at RT for 4 h. The reaction mixture was directly evaporated under reduced pressure, and the residue was diluted with water, extracted with ethyl acetate (2 × 250 mL), washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The organic layer was evaporated under reduced pressure. The crude compound was purified by silica-gel (100–200 mesh) column chromatography, eluting with 12–15% ethyl acetate in hexane. The appropriate fractions were concentrated to yield the title compound as a colorless liquid (19.6 g, 72 mmol, 72%). LCMS (formic 4.5 min run): RT = 2.07 min, [M + H]<sup>+</sup> = 256.</div></div><div id="sec5_1_4_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> Ethyl 1-(6-morpholinopyrimidin-4-yl)piperidine-4-carboxylate</h5><div class="NLM_p last">A solution of ethyl 1-(6-chloropyrimidin-4-yl)piperidine-4-carboxylate (19.00 g, 70.4 mmol) and morpholine (18.41 mL, 211 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (200 mL) was stirred at 100 °C for 18 h. The reaction mixture was diluted with ice-cold water, extracted with ethyl acetate (2 × 500 mL), washed with brine, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The organic layer was evaporated under reduced pressure. The crude compound was purified by silica-gel (100–200 mesh) column chromatography, eluting with 60% ethyl acetate in hexane. The product was repurified by combi-flash column chromatography, eluting with 50% ethyl acetate in hexane. The appropriate fractions were concentrated to yield the title compound as a white solid (12.3 g, 38.4 mmol, 55%). LCMS (formic 4.5 min run): RT = 1.58 min, [M + H]<sup>+</sup> = 321.</div></div><div id="sec5_1_4_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 1-(6-Morpholinopyrimidin-4-yl)piperidine-4-carboxylic Acid</h5><div class="NLM_p last">To a solution of ethyl 1-(6-morpholinopyrimidin-4-yl)piperidine-4-carboxylate (12.00 g, 37.5 mmol) in tetrahydrofuran (60 mL), lithium hydroxide (1.79 g, 75 mmol) in water (60 mL) solution was added at RT, and the reaction mixture was stirred at RT for 3 h. The reaction mixture was acidified with 1 N aqueous HCl solution to pH = 6, extracted with ethyl acetate (2 × 150 mL), washed with brine, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The organic layer was evaporated under reduced pressure. The crude compound was purified by silica-gel (100–200 mesh) column chromatography, eluting with 4% methanol in DCM. The appropriate fractions were concentrated to yield the title compound as a white solid (8.9 g, 30.4 mmol, 81%).</div></div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> General Procedure E: Amide formations</h4><div class="NLM_p last">1-(6-Morpholinopyrimidin-4-yl)piperidine-4-carboxylic acid (1 equiv) was dissolved in DMF (1–2 mL) and treated with COMU (3 equiv), DIPEA (2–4 equiv), and then the appropriate amine (1.2–1.5 equiv). The solutions were stirred at room temperature until reactions were complete by LCMS analysis. The solutions were partitioned between DCM and water, and the layers were separated using hydrophobic frits, and the aqueous layers were re-extracted with additional DCM. The combined organic layers were concentrated to yield crude products, which were purified by preparative HPLC.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> General Procedure F: Amide formations</h4><div class="NLM_p">1-(6-Morpholinopyrimidin-4-yl)piperidine-4-carboxylic acid (1 equiv) was dissolved in DMF and treated with HATU (1.5–3 equiv), DIPEA (3–5 equiv), and then the appropriate amine (1–2 equiv). The solutions were stirred at room temperature until complete. The solutions were partitioned between ethyl acetate and water, and the layers were separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to yield crude products.</div><div id="sec5_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> (2-Benzylpiperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>29</b>)</h5><div class="NLM_p last">2-Benzylpiperidine (36 mg, 0.21 mmol, 1.2 equiv) was reacted according to general procedure E to afford the title compound (<b>29</b>) as a yellow gum (20 mg, 0.04 mmol, 26%). LCMS (formic): RT = 1.04 min, [M + H]<sup>+</sup> = 450. HRMS C<sub>26</sub>H<sub>36</sub>N<sub>5</sub>O<sub>2</sub> required 450.2864 found 450.2860. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.99–8.11 (m, 1 H); 7.12–7.33 (m, 5 H); 5.79–5.92 (m, 1 H); 4.09–4.43 (m, 3 H); 3.59–3.67 (m, 4 H); 3.44–3.51 (m, 4 H); 3.09–3.26 (m, 1 H); 2.66–2.92 (m, 4 H); 2.39–2.48 (m, 1 H); 2.24–2.34 (m, 1 H); 1.63–1.83 (m, 2 H); 1.43–1.63 (m, 4 H); 1.30–1.43 (m, 2 H); 1.13–1.29 (m, 2 H).</div></div><div id="sec5_1_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> (3-Benzylpiperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>30</b>)</h5><div class="NLM_p last">3-Benzyl piperidine (36 mg, 0.21 mmol, 1.2 equiv) was reacted according to general procedure E to afford the title compound (<b>30</b>) as an orange solid (18 mg, 0.04 mmol, 24%). Mp 65–68 °C. LCMS (ammonium bicarbonate): RT = 1.18 min, [M + H]<sup>+</sup> = 450. HRMS C<sub>26</sub>H<sub>36</sub>N<sub>5</sub>O<sub>2</sub> required 450.2864 found 450.2858. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.07 (s, 1 H); 7.25–7.35 (m, 2 H); 7.14–7.24 (m, 3 H); 5.88 (d, <i>J</i> = 3.5 Hz, 1 H); 4.25–4.38 (m, 2 H); 4.13–4.24 (m, 1 H); 3.69–3.92 (m, 1 H); 3.61–3.66 (m, 4 H); 3.46–3.51 (m, 4 H); 2.97–3.10 (m, 1 H); 2.82–2.95 (m, 2 H); 2.64–2.82 (m, 1 H); 2.52–2.63 (m, 1 H); 2.45–2.48 (m, 1 H); 2.34–2.44 (m, 1 H); 1.66–1.76 (m, 2 H); 1.53–1.65 (m, 2 H); 1.38–1.52 (m, 3 H); 1.28–1.38 (m, 1 H); 1.14–1.26 (m, 1 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 171.7 (C═O); 163.0 (Ar C); 162.4 (Ar C); 156.9 (Ar CH); 139.8 (Ar C); 128.9 (2 Ar CH); 128.2 (2 Ar CH); 125.9 (Ar CH); 81.4 (Ar CH); 65.8 (CH<sub>2</sub>); 50.2 (CH<sub>2</sub>); 46.6 (CH<sub>2</sub>); 45.4 (CH<sub>2</sub>); 44.1 (CH<sub>2</sub>); 43.3 (CH<sub>2</sub>); 41.8 (CH<sub>2</sub>); 37.6 (CH<sub>2</sub>); 37.4 (CH); 37.3 (CH); 30.4 (CH<sub>2</sub>); 27.7 (CH<sub>2</sub>); 27.5 (CH<sub>2</sub>); 25.6 (CH<sub>2</sub>); 24.5 (CH<sub>2</sub>).</div></div><div id="sec5_1_6_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> (4-Benzyl-4-hydroxypiperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>31</b>)</h5><div class="NLM_p last">4-Benzylpiperidin-4-ol (196 mg, 1.03 mmol) was reacted according to general procedure F. The crude compound was purified by silica-gel (100–200 mesh) column chromatography eluting with 8% methanol in DCM. The product-containing fractions were evaporated under reduced pressure, and the product was repurified by preparative HPLC under the following conditions. Column: X Bridge C18 (19 mm × 100 mm) 5 μm. Mobile Phase: A: 10 mM ammonium bicarbonate in Water B: acetonitrile. Isocratic: 60:40 (A:B). Flow rate: 17 mL/min. The appropriate fractions were concentrated to yield the title compound (31) as a white solid (87 mg, 0.19 mmol, 18%). LCMS (formic): RT = 0.61 min, [M + H]<sup>+</sup> = 466. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.1 (s, 1H); 7.2–7.3 (m, 5H); 5.9 (s, 1H); 4.4 (s, 1H); 4.3 (d, <i>J</i> = 16 Hz, 2H); 4.1 (d, <i>J</i> = 8 Hz, 1H); 3.8 (d, <i>J</i> = 8 Hz); 3.6–3.7 (m, 4H); 3.6–3.6 (m, 4H); 2.8–2.9 (m, 4H); 2.7 (s, 2H); 1.5–1.7 (m, 2H); 1.2–1.5 (m, 6H).</div></div><div id="sec5_1_6_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> (3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>32</b>)</h5><div class="NLM_p last">1,2,3,4-Tetrahydroisoquinoline (0.067 mL, 0.54 mmol, 1.5 equiv) was reacted according to general procedure E to afford the title compound (<b>32</b>) as a yellow gum (113 mg, 0.28 mmol, 77%). LCMS (formic): RT = 0.63 min, [M + H]<sup>+</sup> = 408.14. HRMS C<sub>23</sub>H<sub>30</sub>N<sub>5</sub>O<sub>2</sub> required 408.2394 found 408.2390. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.08 (s, 1 H); 7.13–7.26 (m, 4 H); 5.90 (s, 1 H); 4.76 (s, 1 H); 4.60 (s, 1 H); 4.32–4.42 (m, 2 H); 3.78 (t, <i>J</i> = 5.5 Hz, 1 H); 3.60–3.70 (m, 5 H); 3.45–3.54 (m, 4 H); 3.04 (br. s., 1 H); 2.84–2.98 (m, 3 H); 2.72–2.78 (m, 1 H); 1.60–1.72 (m, 2 H); 1.42–1.58 (m, 2 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 178.7 (C = O); 163.0 (Ar C); 162.4 (Ar C); 156.8 (Ar CH); 133.6 (Ar C); 128.5 (Ar CH); 128.3 (Ar CH); 126.4 (Ar CH); 126.2 (Ar CH); 126.1 (Ar C); 81.4 (Ar CH); 65.8 (2 CH<sub>2</sub>); 44.1 (2 CH<sub>2</sub>); 43.7 (CH<sub>2</sub>); 43.3 (CH<sub>2</sub>); 42.4 (CH<sub>2</sub>); 37.6 (CH); 29.1 (CH<sub>2</sub>); 27.8 (CH<sub>2</sub>); 27.7 (CH<sub>2</sub>); 27.5 (CH<sub>2</sub>). IR (ATR) cm<sup>–1</sup> 2922; 2851; 1632; 1578; 1440; 1197; 1114; 986; 974; 799; 749.</div></div><div id="sec5_1_6_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> (2-Benzylmorpholino)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>33</b>)</h5><div class="NLM_p last">2-Benzylmorpholine (36 mg, 0.21 mmol, 1.2 equiv) was reacted according to general procedure E to afford the title compound (<b>33</b>) as an orange solid (42 mg, 0.09 mmol, 55%). Mp 82–84 °C. LCMS (ammonium bicarbonate): RT = 1.03 min, [M + H]<sup>+</sup> = 452. HRMS C<sub>25</sub>H<sub>34</sub>N<sub>5</sub>O<sub>3</sub> required 452.2656 found 452.2668. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.07 (s, 1 H); 7.16–7.37 (m, 5 H); 5.89 (s, 1 H); 4.34 (d, <i>J</i> = 13.0 Hz, 2 H); 4.11–4.23 (m, 1 H); 3.78–3.94 (m, 2 H); 3.60–3.66 (m, 4 H); 3.38–3.55 (m, 5 H); 3.10–3.22 (m, 1 H); 2.62–3.00 (m, 6 H); 2.39–2.48 (m, 1 H); 1.56–1.66 (m, 2 H); 1.36–1.55 (m, 2 H). IR (ATR) cm<sup>–1</sup> 2853; 1635; 1579; 1487; 1441; 1199; 1113; 987; 973; 799; 752; 670.</div></div><div id="sec5_1_6_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> (4-(4-Fluorophenyl)piperazin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-l)methanone (<b>34</b>)</h5><div class="NLM_p last">1-(4-Fluorophenyl)piperazine (74 mg, 0.41 mmol) was reacted according to general procedure F. The crude compound was purified by silica-gel (100–200 mesh) column chromatography, eluting with 5% methanol in DCM, and was then repurified by preparative TLC to yield the title compound (<b>34</b>) as an off-white solid (85 mg, 0.19 mmol, 54%). LCMS (formic): RT = 0.66 min, [M + H]<sup>+</sup> = 455. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.1 (s, 1H); 7.0–7.1 (m, 2H); 6.9–7.0 (m, 2H); 5.9 (s, 1H); 4.3–4.4 (d, <i>J</i> = 16 Hz, 2H); 3.6–3.7 (m, 8H); 3.5–3.6 (m, 4H); 3.0–3.2 (m, 5H); 2.8–3.0 (m, 2H); 1.6–1.7 (m, 2H); 1.4–1.6 (m, 2H); 1.2–1.3 (m, 1H).</div></div><div id="sec5_1_6_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> (4-(4-Fluorobenzoyl)piperazin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>35</b>)</h5><div class="NLM_p last">(4-Fluorophenyl)(piperazin-1-yl)methanone (71 mg, 0.34 mmol) was reacted according to general procedure F. The crude compound was purified by silica-gel (100–200 mesh) column chromatography, eluting with 8% methanol in DCM, and then repurified by preparative HPLC using the following conditions. Column: X Bridge C18 (19 mm × 100 mm) 5 μm. Mobile phase: A: 10 mM ammonium bicarbonate in Water B: acetonitrile isocratic: 60:40 (A/B) Flow rate: 17 mL/min. The appropriate fractions were concentrated to yield the title compound (<b>35</b>) as a white solid (80 mg, 0.17 mmol, 48%). LCMS (formic): RT = 0.58 min, [M + H]<sup>+</sup> = 483. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.1 (s, 1H); 7.5–7.6 (m, 2H); 7.2–7.3 (m, 2H); 5.9 (s, 1H); 4.4 (d, <i>J</i> = 16 Hz, 2 H); 3.4–3.7 (m, 16 H); 2.8–3.0 (m, 3H); 1.6–1.7 (m, 2H); 1.4–1.6 (m, 2H).</div></div><div id="sec5_1_6_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> (3-Benzylpyrrolidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>36</b>)</h5><div class="NLM_p last">3-Benzylpyrrolidine (33 mg, 0.21 mmol, 1.2 equiv) was reacted according to general procedure E to afford the title compound (<b>36</b>) as a yellow gum (34 mg, 0.08 mmol, 45%). LCMS (formic): <i>R</i><sub>t</sub> = 0.98 min, [M + H]<sup>+</sup> = 436. HRMS C<sub>25</sub>H<sub>34</sub>N<sub>5</sub>O<sub>2</sub> required 436.2707 found 436.2704. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.07 (s, 1 H); 7.26–7.33 (m, 2 H); 7.17–7.25 (m, 3 H); 5.89 (s, 1 H); 4.31–4.41 (m, 2 H); 3.61–3.69 (m, 5 H); 3.46–3.51 (m, 4 H); 3.35–3.46 (m, 1 H); 3.14–3.22 (m, 1 H); 2.80–2.95 (m, 3 H); 2.61–2.76 (m, 3 H); 1.78–1.99 (m, 1 H); 1.59–1.70 (m, 3 H); 1.38–1.56 (m, 3 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 172.7 (C = O); 163.6 (Ar C); 162.9 (Ar C); 157.4 (Ar CH); 140.9 (Ar C); 129.1 (Ar CH); 128.8 (Ar CH); 128.8 (Ar CH); 126.5 (Ar CH); 126.4 (Ar CH); 81.9 (Ar CH); 66.4 (CH<sub>2</sub>); 51.4 (CH<sub>2</sub>); 51.0 (CH<sub>2</sub>); 45.8 (CH<sub>2</sub>); 45.4 (CH<sub>2</sub>); 44.6 (CH<sub>2</sub>); 43.8 (CH<sub>2</sub>); 43.8 (CH<sub>2</sub>); 39.0 (CH); 38.7 (CH); 31.6 (CH<sub>2</sub>); 29.8 (CH<sub>2</sub>); 27.7 (CH<sub>2</sub>); 27.7 (CH<sub>2</sub>). IR (ATR) cm<sup>–1</sup> 3459; 2949; 2852; 1628; 1577; 1494; 1437; 1337; 1201; 1115; 972; 799; 751; 700.</div></div><div id="sec5_1_6_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> (1-(6-Morpholinopyrimidin-4-yl)piperidin-4-yl)(4-(phenylamino)piperidin-1-yl)methanone (<b>37</b>)</h5><div class="NLM_p last"><i>N</i>-Phenylpiperidin-4-amine (72 mg, 0.41 mmol) was reacted according to general procedure F. The crude product was purified on a silica gel (4 g) column eluting with a gradient of 8–10% methanol in dichloromethane. The appropriate fractions were concentrated, and the solid was then washed with diethyl ether (20 mL) and lypholized to yield the title compound (<b>37</b>) as an off-white solid (64 mg, 0.14 mmol, 41%). LCMS (formic): RT = 0.55 min, [M + H]<sup>+</sup> = 451. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.1 (s, 1H); 7.0–7.1 (m, 2H); 6.6–6.7 (m, 2H); 6.5–6.6 (m, 2H); 5.9 (s, 1H); 5.4–5.5 (m, 1H); 4.3 (d, <i>J</i> = 8 Hz, 2H); 4.2 (d, <i>J</i> = 8 Hz, 1H); 4.0 (d, <i>J</i> = 8 Hz, 1H); 3.6–3.7 (m, 4H); 3.4–3.5 (m, 5H); 3.2–3.3 (m, 1H); 2.7–3.0 (m, 4H); 1.9–2.0 (m, 2H); 1.6–1.7 (m, 2H); 1.4–1.6 (m, 2H); 1.1–1.4 (m, 2H).</div></div><div id="sec5_1_6_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> (1-(6-Morpholinopyrimidin-4-yl)piperidin-4-yl)(4-phenoxypiperidin-1-yl)methanone (<b>38</b>)</h5><div class="NLM_p last">4-Phenoxypiperidine (72 mg, 0.406 mmol) was reacted according to general procedure F. The reaction mixture was diluted with water (5 mL) and extracted with dichloromethane (3 × 10 mL) and then dried under high vacuo. The crude product was triturated with diethyl ether (2 × 30 mL) and then dried under high vacuo to yield the title compound (38) as an off-white solid (102 mg, 0.22 mmol, 65%). LCMS (formic): RT = 0.71 min, [M + H]<sup>+</sup> = 452. NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.1 (s, 1H); 7.2–7.3 (m, 2H); 6.9–7.0 (m, 3H); 5.9 (s, 1H); 4.6–4.7 (m, 1H); 4.4 (d. <i>J</i> = 8 Hz, 2H); 3.9 (br.s, 2H); 3.8–3.9 (m, 4H); 3.5–3.6 (m, 4H); 3.4–3.5 (m, 1H); 3.2–3.3 (m, 1H); 2.8–3.0 (m, 3 H); 1.8–2.0 (m, 2H); 1.6–1.7 (m, 3H); 1.4–1.6 (m, 3H).</div></div><div id="sec5_1_6_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> (4-(4-Fluorobenzyl)piperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>39</b>)</h5><div class="NLM_p last">4-(4-Fluorobenzyl)piperidine hydrochloride (0.40 g, 1.73 mmol) was reacted according to general procedure F. The crude product was purified by HPLC, using a x-bridge column, in basic media, method: 40–100% 10 mM NH<sub>4</sub>HCO<sub>3</sub> in acetonitrile. Appropriate fractions were collected and concentrated to afford the title compound (39) as a white solid (616 mg, 1.25 mmol, 73%). LCMS (formic): RT = 0.81 min, [M + H]<sup>+</sup> = 468. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.14 (d, <i>J</i> = 0.8 Hz, 1 H); 7.27 (br d, <i>J</i> = 5.6 Hz, 2 H); 7.10–7.21 (m, 2 H); 5.97 (s, 1 H); 4.34–4.49 (m, 3 H); 4.00–4.12 (m, 1 H); 3.64–3.77 (m, 4 H); 3.56 (br d, <i>J</i> = 5.1 Hz, 4 H); 2.88–3.09 (m, 4 H); 2.47–2.55 (m, 1 H); 1.80 (br d, <i>J</i> = 3.8 Hz, 1 H); 1.65 (br s, 6 H); 0.94–1.18 (m, 2 H).</div></div><div id="sec5_1_6_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> (1-(6-Morpholinopyrimidin-4-yl)piperidin-4-yl)(4-(pyridin-3-ylmethyl)piperidin-1-yl)methanone (<b>40</b>)</h5><div class="NLM_p last">1-(6-Morpholinopyrimidin-4-yl)piperidine-4-carboxylic acid (352 mg, 1.20 mmol) was dissolved at 0 °C in DMF (10 mL). (<i>Z</i>)-2-(5-(ethylideneamino)-1H-1,2,3-triazol-1-yl)-1,1,3,3-tetramethylisouronium hexafluorophosphate (V) (669 mg, 1.81 mmol) was added at 0 °C followed by DIPEA (1.08 mL, 6.0 mmol). After 20 min 3-(piperidin-4-ylmethyl)pyridine, 2hydrochloride (300 mg, 1.20 mmol) was added to the mixture and reaction stirred for 8 h. DMF was removed under vacuum and the residue was dissolved in ethyl acetate (40 mL) and treated with 1 N NH<sub>4</sub>Cl (20 mL), and the layers were separated. The organic solution was washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed and the residue was purified by chromatography using a SILYCEL cartridge and as mobile phase a gradient cyclohexane/ethyl acetate:ethanol 3:1 from 100/0 to 10/90. Appropriate fractions were combined and solvent removed under vacuum to afford the title compound (40) as a white solid (240 mg, 0.53 mmol, 44%). LCMS (formic): RT = 0.39 min, [M + H]<sup>+</sup> = 451. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.52 (dd, <i>J</i> = 4.8, 1.8 Hz, 1 H); 8.45–8.48 (m, 1 H); 8.28 (d, <i>J</i> = 0.8 Hz, 1 H); 7.50 (dt, <i>J</i> = 7 0.7, 2.1 Hz, 1 H); 7.24–7.29 (m, 1 H); 5.63 (s, 1 H); 4.61–4.73 (m, 1 H); 4.39 (br s, 2 H); 3.97 (br d, <i>J</i> = 12.9 Hz, 1 H); 3.78–3.85 (m, 4 H); 3.52–3.62 (m, 4 H); 2.90–3.10 (m, 3 H); 2.72–2.83 (m, 1 H); 2.61 (s, 3 H); 1.70–1.95 (m, 7 H); 1.47 (s, 2 H); 1.12–1.33 (m, 3 H).</div></div><div id="sec5_1_6_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> (1-(6-Morpholinopyrimidin-4-yl)piperidin-4-yl)(4-(pyridin-2-ylmethyl)piperidin-1-yl)methanone (<b>41</b>)</h5><div class="NLM_p last">2-(Piperidin-4-ylmethyl)pyridine dihydrochloride (102 mg, 0.41 mmol) was reacted according to general procedure F. The crude compound was purified by silica-gel (100–200 mesh) column chromatography, eluting with 8% methanol in DCM. The product was repurified by preparative HPLC using the following conditions: Column: X Bridge C18 (19 mm × 100 mm) 5 μm, Mobile Phase: A: 10 mM ammonium bicarbonate in water B: acetonitrile, isocratic: 60:40 (A:B) Flow rate: 17 mL/min. The appropriate fractions were concentrated to afford the title compound (41) as a white solid (45 mg, 0.10 mmol, 29%). LCMS (formic): RT = 0.37 min, [M + H]<sup>+</sup> = 451. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.5 (m, 1H); 8.1 (s, 1H); 7.6–7.7 (m, 1H); 7.2–7.3 (m, 2H); 5.9 (s, 1H); 4.4 (d, <i>J</i> = 16 Hz, 3H); 4.0 (d, <i>J</i> = 16 Hz, 1H); 3.6–3.7 (m, 4H); 3.5–3.6 (m, 4H); 2.8–3.1 (m, 4H); 2.7 (d, <i>J</i> = 8 Hz, 2H); 2.5 (m, 1H); 1.9–2.1 (m, 1H); 1.5–1.7 (m, 4 H); 1.4–1.5 (m, 1H); 0.9–1.2 (m, 2 H).</div></div><div id="sec5_1_6_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> (4-Ethylpiperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>42</b>)</h5><div class="NLM_p last">4-Ethylpiperidine hydrochloride (35 mg, 0.23 mmol) was reacted according to general procedure F. The product was purified by preparative HPLC to afford the title compound (42) (21 mg, 0.05 mmol, 23%). LCMS (formic): RT = 0.69 min, [M + H]<sup>+</sup> = 388. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.0 (s, 1H); 5.8 (s, 1H); 4.4–4.5 (m, 1H); 4.3–4.4 (m, 2H); 4.0–4.1 (m, 1H); 3.7 (m, 4H); 3.5–3.6 (m, 4H); 3.3 (m, 1H); 2.9–3.2 (m, 4H); 2.5–2.7 (m, 1H); 1.4–1.9 (m, 6 H); 1.2–1.4 (m, 3H); 0.8–1.2 (m, 4 H).</div></div><div id="sec5_1_6_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> (1-(6-Chloropyrimidin-4-yl)piperidin-4-yl)(4-isopropylpiperidin-1-yl)methanone</h5><div class="NLM_p last">To a solution of (4-isopropylpiperidin-1-yl)(piperidin-4-yl)methanone hydrochloride (6.5 g, 23.65 mmol) in ethanol (70 mL) was added triethylamine (6.59 mL, 47.3 mmol) dropwise over 5 min, followed by 4,6-dichloropyrimidine (3.52 g, 23.65 mmol) portion wise over 2 min. The reaction was stirred at room temperature for 24 h. The reaction mixture was concentrated under reduced pressure and then diluted with water (150 mL) and extracted into ethyl acetate (2 × 100 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated under reduced pressure. The crude compound was purified on silica flash chromatography, eluting with 55% ethyl acetate in <i>n</i>-hexane. The product containing fractions were combined and concentrated under reduced pressure to afford (1-(6-chloropyrimidin-4-yl)piperidin-4-yl)(4-isopropylpiperidin-1-yl)methanone (5.83 g, 16.34 mmol, 69%) as an off-white solid. LCMS (formic 4.5 min run): RT = 2.42 min, [M + H]<sup>+</sup> = 351, 353.</div></div><div id="sec5_1_6_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> (4-Isopropylpiperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>43</b>)</h5><div class="NLM_p last">To a suspension of (1-(6-chloropyrimidin-4-yl)piperidin-4-yl)(4-isopropylpiperidin-1-yl)methanone (180 mg, 0.513 mmol) in ethanol (2 mL) in a 2–5 mL microwave vial DIPEA (0.108 mL, 0.616 mmol) was added, and the reaction mixture was heated to dissolve the reagent. Then morpholine (0.054 mL, 0.616 mmol) was added. The vial was heated 6 h at 150 °C with stirring. The solution was concentrated in vacuo, and the residue was purified by chromatography, using a 12 g SILICYCLE cartridge, eluting with cyclohexane/ethyl acetate/ethanol 3:1 from 100/0 to 30/70 gradient. The appropriate fractions were combined and evaporated in vacuo and then was repurified by chromatography, using a 12 g SILICYCLE cartridge, eluting with DCM/methanol 97/3. The appropriate fractions were combined and evaporated in vacuo to afford the title compound (43) as a gum (178 mg, 0.44 mmol, 86%). LCMS (formic): RT = 0.75 min, [M + H]<sup>+</sup> = 402. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.28 (d, <i>J</i> = 0.8 Hz, 1 H); 5.63 (s, 1 H); 5.34 (s, 1 H); 4.71 (br d, <i>J</i> = 12.9 Hz, 1 H); 4.39 (s, 1 H); 4.28–4.50 (m, 2 H); 4.00 (br d, <i>J</i> = 13.1 Hz, 1 H); 3.72–3.84 (m, 4 H); 3.47–3.64 (m, 4 H); 2.88–3.18 (m, 3 H); 2.79 (br d, <i>J</i> = 4.5 Hz, 1 H); 2.39–2.62 (m, 1 H); 1.72–1.99 (m, 6 H); 1.42–1.56 (m, 1 H); 1.26–1.37 (m, 1 H); 1.09–1.26 (m, 2 H); 0.93 (d, <i>J</i> = 6.8 Hz, 6 H).</div></div><div id="sec5_1_6_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 4-(Cyclopentylmethyl)pyridine</h5><div class="NLM_p last">A solution of 4-methylpyridine (5.0 g, 53.7 mmol) in tetrahydrofuran (5 mL) was cooled to −78 °C. LDA (53.7 mL, 107 mmol) was added dropwise to the cooled solution over a period of 4 min. The mixture was then stirred at −40 °C for 20 min and was cooled to −78 °C. Bromocyclopentane (8.00 g, 53.7 mmol) was added dropwise to the reaction solution over a period of 4 min. The reaction mixture was stirred at −78 °C for 1 h. The reaction mixture was warmed to room temperature and stirred for 3 h. Saturated aqueous ammonium chloride solution (500 mL) was then added, and the product was extracted with ethyl acetate (250 mL). The ethyl acetate layer was washed with brine solution (225 mL). The ethyl acetate layer was dried over sodium sulfate and concentrated under reduced pressure. The crude product was purified by column chromatography silica gel (100–200 mesh), eluting with 12% ethyl acetate in petroleum ether. The solvents were removed to yield the title compound as a yellow liquid (3.5 g, 21.7 mmol, 40%). LCMS (formic 4.5 min run): RT = 3.69 min, [M + H]<sup>+</sup> = 162. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.47 (d, <i>J</i> = 6.1 Hz, 2 H); 7.09 (d, <i>J</i> = 5.9 Hz, 2 H); 2.60 (d, <i>J</i> = 7.5 Hz, 2 H); 2.01–2.22 (m, 1 H); 1.44–1.79 (m, 6 H); 1.01–1.28 (m, 2 H).</div></div><div id="sec5_1_6_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> 4-(Cyclopentylmethyl)piperidine Hydrochloride</h5><div class="NLM_p last">To a solution of 4-(cyclopentylmethyl)pyridine (1.0 g, 6.20 mmol) in methanol (20 mL) at RT were added HCl (0.75 mL, 4.50 mmol) and platinum(IV) oxide (130 mg, 0.57 mmol). The reaction mixture was stirred at RT for 24 h under hydrogen (60 psi). The reaction mixture was filtered through a Celite pad and washed with methanol (10 mL). The methanol was concentrated under reduced pressure and the crude product was then triturated with diethyl ether (10 mL). The obtained solid was filtered and washed with diethyl ether (5 mL). The solid was dried under high vacuum to yield the title compound (700 mg, 4.2 mmol, 55%) as an off white solid. LCMS (formic 4.5 min run): RT = 1.88 min, [M + H]<sup>+</sup> = 168.2. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.69–9.00 (m, 2 H); 3.10–3.25 (m, 2 H); 2.72–2.93 (m, 2 H); 1.70–1.93 (m, 5 H); 1.42–1.63 (m, 5 H); 1.12–1.38 (m, 4 H); 0.88–1.11 (m, 2 H).</div></div><div id="sec5_1_6_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> (4-(Cyclopentylmethyl)piperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>44</b>)</h5><div class="NLM_p last">To a solution of 1-(6-morpholinopyrimidin-4-yl)piperidine-4-carboxylic acid (200 mg, 0.684 mmol), 4-(cyclopentylmethyl)piperidine hydrochloride (139 mg, 0.68 mmol) and HATU (390 mg, 1.03 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (8 mL), DIPEA (0.358 mL, 2.05 mmol) was added at RT and stirred at RT for 12 h. Reaction mixture was diluted with water (20 mL), extracted with ethyl acetate (2 × 25 mL). The combined organic layers were washed with brine (50 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure. The crude product was purified by silica-gel (100–200 mesh) column chromatography, eluting with 4% methanol in DCM to yield the title compound (44) as a white solid (100 mg, 0.22 mmol, 33%). LCMS (formic): RT = 0.90 min, [M + H]<sup>+</sup> = 442. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.07 (d, <i>J</i> = 0.7 Hz, 1 H); 5.86–5.92 (m, 1 H); 4.29–4.43 (m, 3 H); 3.93–4.04 (m, 1 H); 3.60–3.68 (m, 4 H); 3.45–3.52 (m, 4 H); 2.83–3.07 (m, 4 H); 1.77–1.96 (m, 2 H); 1.38–1.77 (m, 13 H); 1.18–1.28 (m, 2 H); 0.97–1.14 (m, 3 H); 0.79–0.94 (m, 1 H).</div></div><div id="sec5_1_6_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> (4-(2-(Diethylamino)ethyl)piperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>45</b>)</h5><div class="NLM_p last"><i>N</i>,<i>N</i>-Diethyl-2-(piperidin-4-yl)ethan-1-amine dihydrochloride (77 mg, 0.30 mmol) was reacted according to general procedure F. The product was purified by preparative HPLC to afford the title compound (45) (589 mg, 0.13 mmol, 23%). LCMS (formic): RT = 0.38 min, [M + H]<sup>+</sup> = 459. <sup>1</sup>H 1H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.0 (s, 1H); 5.8 ppm (s, 1H); 4.6–4.5 ppm (br.d, 1/2 CH<sub>2</sub>, 1H, [eq ]); 4.4–4.3 ppm (br.d, CH<sub>2</sub>, 2H, [eq ]); 4.1–4.0 ppm (br.d, 1/2 CH<sub>2</sub>, 1H [eq ]); 3.8–3.7 ppm, (m, 4H, 2 × CH<sub>2</sub>); 3.6–3.5 ppm (m, 4H, 2 x CH<sub>2</sub>); 3.2–2.9 ppm, (2 x br. m, 4H, 2 × CH<sub>2</sub> [Ax.]); 2.7–2.5 ppm, (7H, m + q, 3 x CH<sub>2</sub> + CH [Ax.]); 1.9–1.0 ppm (17H, br. m + t, CH + 5 × CH<sub>2</sub> + 2 × CH<sub>3</sub>).</div></div><div id="sec5_1_6_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> (1-(6-Morpholinopyrimidin-4-yl)piperidin-4-yl)(4-(2-(pyrrolidin-1-yl)ethyl)piperidin-1-yl)methanone (<b>46</b>)</h5><div class="NLM_p last">4-(2-(Pyrrolidin-1-yl)ethyl)piperidine dihydrochloride (70 mg, 0.27 mmol) was reacted according to general procedure F. The product was purified by preparative HPLC to afford the title compound (46) (59 mg, 0.13 mmol, 23%). LCMS (formic): RT = 0.38 min, [M + H]<sup>+</sup> = 459. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 8.0 (s, 1H); 5.8 (s, 1H); 4.4–4.6 (m, 1H); 4.3–4.4 (m, 2H); 4.0–4.2 (m, 1H); 3.7–3.8 (m, 4H); 3.4–3.6 (m, 4H); 2.9–3.2 (m, 4H); 2.5–2.7 (m, 7H); 1.4–1.9 (m, 13H); 1.0–1.3 (m, 2H).</div></div><div id="sec5_1_6_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> (4-(4-Fluorophenoxy)piperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>47</b>)</h5><div class="NLM_p last">4-(4-Fluorophenoxy)piperidine hydrochloride (0.4 g, 1.73 mmol) was reacted according to general procedure F. The crude product was purified by preparative HPLC, using a x-bridge column, in basic media, method: 40–100% 10 mM NH<sub>4</sub>HCO<sub>3</sub>-acetonitrile. Appropriate fractions were collected, affording the title compound (47) as a white solid: (583 mg, 1.24 mmol, 73%). LCMS (formic): RT = 1.15 min, [M + H]<sup>+</sup> = 470. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.15 (s, 1 H); 7.18 (d, <i>J</i> = 8.6 Hz, 2 H); 7.03–7.12 (m, 2 H); 5.98 (s, 1 H); 4.57–4.70 (m, 1 H); 4.33–4.50 (m, 2 H); 3.85–4.00 (m, 2 H); 3.66–3.78 (m, 4 H); 3.53–3.61 (m, 4 H); 3.44–3.52 (m, 1 H); 3.24–3.34 (m, 1 H); 2.90–3.09 (m, 3 H); 1.89–2.11 (m, 2 H); 1.61–1.80 (m, 3 H); 1.45–1.61 (m, 3 H).</div></div><div id="sec5_1_6_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> (4-(4-Chlorophenoxy)piperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>48</b>)</h5><div class="NLM_p last">4-(4-Chlorophenoxy)piperidine (87 mg, 0.410 mmol) was reacted according to general procedure F. The crude compound was purified by silica-gel (100–200 mesh) column chromatography, eluting with 4% methanol in DCM and then repurified by HPLC using the following conditions. Column: XTERRA RP18 (150 × 19) mm, 5 μm, Mobile phase: A: 10 mM ammonium bicarbonate (Aq) B: Acetonitrile, flow: 15 mL/min, Method: 0/55, 12/55, 13/100, 18/100. The appropriate fractions were concentrated to yield the title compound (48) as an off-white solid (84 mg, 0.17 mmol, 51%). LCMS (formic): RT = 0.81 min, [M + H]<sup>+</sup> = 486. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.02–8.14 (m, 1 H); 7.26–7.38 (m, 2 H); 6.93–7.08 (m, 2 H); 5.84–5.93 (m, 1 H); 4.56–4.69 (m, 1 H); 4.30–4.42 (m, 2 H); 3.75–3.92 (m, 2 H); 3.58–3.70 (m, 4 H); 3.45–3.54 (m, 4 H); 3.36–3.45 (m, 1 H); 3.16–3.26 (m, 1 H); 2.83–3.02 (m, 3 H); 1.84–2.03 (m, 2 H); 1.40–1.71 (m, 6 H).</div></div><div id="sec5_1_6_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> <i>tert</i>-Butyl 4-(2,4-difluorophenoxy)piperidine-1-carboxylate</h5><div class="NLM_p last">To <i>tert</i>-butyl 4-hydroxypiperidine-1-carboxylate (1.55 g, 7.7 mmol), triphenylphosphine (3.02 g, 11.5 mmol), and 2,4-difluorophenol (0.734 mL, 7.7 mmol) in THF (50 mL) was added diisopropyl diazene-1,2-dicarboxylate (1.52 mL, 7.7 mmol) dropwise at room temperature. The mixture was stirred overnight. Ethyl acetate was added (50 mL). The organic layer was then washed with 2 N aq. NaOH and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo, and the residue was purified by silica gel flash chromatography, eluting with a gradient of 0–50% [ethyl acetate/ethanol (3:1)] in cyclohexane to provide the title compound <i>tert</i>-butyl 4-(2,4-difluorophenoxy)piperidine-1-carboxylate (1.57 g, 5.0 mmol, 65%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.21–7.35 (m, 2 H); 7.01 (td, <i>J</i> = 2.0, 0.9 Hz, 1 H); 4.48 (br t, <i>J</i> = 3.9 Hz, 1 H); 3.58–3.71 (m, 2 H); 3.16 (br t, <i>J</i> = 9.7 Hz, 2 H); 1.81–1.95 (m, 2 H); 1.52 (dtd, <i>J</i> = 12.9, 8.7, 8.7, 3.9 Hz, 2 H); 1.36–1.43 (s, 9 H).</div></div><div id="sec5_1_6_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> 4-(2,4-Difluorophenoxy)piperidine, Hydrochloride</h5><div class="NLM_p last">In a round-bottom flask, <i>tert</i>-butyl 4-(2,4-difluorophenoxy)piperidine-1-carboxylate (1.57 g, 5.0 mmol) was dissolved in dichloromethane (10 mL) under stirring. 3 M HCl in methanol (20 mL, 60.0 mmol) was added at room temperature and the mixture was stirred at room temperature for 8 h. The solvents were concentrated to yield the title compound 4-(2,4-difluorophenoxy)piperidine, hydrochloride (1.20 g, 4.8 mmol, 96%), as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.77–9.12 (m, 2 H); 7.22–7.41 (m, 2 H); 6.95–7.11 (m, 1 H); 4.57 (dt, <i>J</i> = 7.4, 3.8 Hz, 1 H); 3.20 (br s, 2 H); 2.99–3.10 (m, 2 H); 2.07 (br d, <i>J</i> = 4.0 Hz, 2 H); 1.86 (br s, 2 H).</div></div><div id="sec5_1_6_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> (4-(2,4-Difluorophenoxy)piperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-l)methanone (<b>49</b>)</h5><div class="NLM_p last">Under nitrogen atmosphere, in a 100 mL round-bottom flask, 1-(6-morpholinopyrimidin-4-yl)piperidine-4-carboxylic acid (1.48 g, 5.1 mmol) was dissolved in anhydrous dichloromethane (25 mL) and di(1<i>H</i>-imidazol-1-yl)methanone (0.98 g, 6.1 mmol) was added. The reaction mixture was stirred at room temperature for 2.5 h. 4-(2,4-difluorophenoxy)piperidine (1.08 g, 5.1 mmol) was added, and the reaction mixture stirred at room temperature overnight. Water was added and the reaction mixture was stirred for 10 min. The phases were separated and the organic phase was washed with water and then brine, filtered and evaporated under reduced pressure. The crude obtained was purified by column chromatography (80 g silicycle cartridge), using as eluents a mixture of cyclohexane/ethyl acetate/ethanol (3:1), from 0% to 50% ethyl acetate/ethanol (3:1). The appropriate fractions were collected and evaporated under reduced pressure. This product was then combined with a batch from an identical synthesis by dissolving the solids in DCM and evaporating the solvent under reduced pressure. The solid obtained was triturated mechanically and kept in the oven at 40 °C under high vacuum overnight to afford the title compound (49) as a white solid (3.48 g, 7.1 mmol). LCMS (formic): RT = 0.76 min, [M + H]<sup>+</sup> = 488. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.28 (s, 1 H); 7.01 (td, <i>J</i> = 9.1, 5.6 Hz, 1 H); 6.91 (ddd, <i>J</i> = 11.1, 8.3, 3.0 Hz, 1 H); 6.80–6.87 (m, 1 H); 5.64 (s, 1 H); 4.32–4.50 (m, 3 H); 3.77–3.90 (m, 7 H); 3.62–3.71 (m, 1 H); 3.58 (d, <i>J</i> = 5.1 Hz, 4 H); 3.45–3.54 (m, 1 H); 2.99 (br s, 2 H); 2.77–2.87 (m, 1 H); 1.80–2.03 (m, 8 H); 1.75–2.01 (m, 1 H).</div></div><div id="sec5_1_6_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> 4-(4-Chloro-2-fluorophenoxy)piperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>50</b>)</h5><div class="NLM_p last">4-(4-Chloro-2-fluorophenoxy)piperidine hydrochloride (137 mg, 0.51 mmol) was reacted according to general procedure F. The crude compound was purified by silica-gel (100–200 mesh) column chromatography, eluting with 8% methanol in DCM. The product was repurified by HPLC using the following conditions: MP-A: 10 mM ammonium bicarbonate (Aq) MP-B: acetonitrile, Column: x BRIDGE C18 (250 X30 mm) 5 μm, Method - T/%B 0/10,1/10, 16/89,16.1/100,20.5/100,20.6/10,24/10. Flow: 30 mL/min. The appropriate fractions were combined and concentrated to yield the title compound (50) as a white solid (45 mg, 0.09 mmol, 17% yield). LCMS (formic): RT = 0.82 min, [M + H]<sup>+</sup> = 504. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.08 (s, 1 H); 7.44 (dd, <i>J</i> = 11.1, 2.5 Hz, 1 H); 7.26–7.37 (m, 1 H); 7.15–7.25 (m, 1 H); 5.90 (s, 1 H); 4.58–4.71 (m, 1 H); 4.36 (br d, <i>J</i> = 12.7 Hz, 2 H); 3.83 (br s, 2 H); 3.59–3.70 (m, 4 H); 3.45–3.52 (m, 4 H); 3.35–3.48 (m, 1 H); 3.18–3.28 (m, 1 H); 2.81–3.04 (m, 3 H); 1.84–2.06 (m, 2 H); 1.58–1.72 (m, 3 H); 1.41–1.57 (m, 3 H).</div></div><div id="sec5_1_6_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> 4-((5-Methylpyridin-2-yl)oxy)piperidin-1-yl)(1-(6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>51</b>)</h5><div class="NLM_p last">5-Methyl-2-(piperidin-4-yloxy)pyridine (79 mg, 0.41 mmol) was reacted according to general procedure F. The crude compound was purified by silica-gel (100–200 mesh) column chromatography, eluting with 4% methanol in DCM and then repurified by HPLC using the following conditions: Column: XTERRA RP18 (150 × 19) mm, 5 μ, Mobile Phase: A: 10 mM ammonium bicarbonate (Aq) B: acetonitrile Flow: 15 mL/min Method: 0/55, 12/55, 13/100, 18/10. The appropriate fractions were combined and concentrated to yield the title compound (51) as a white solid (74 mg, 0.16 mmol, 46%). LCMS (formic): RT = 0.65 min, [M + H]<sup>+</sup> = 467. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.08 (s, 1 H); 7.96 (s, 1 H); 7.88–8.00 (m, 1 H); 7.45–7.61 (m, 1 H); 6.70 (d, <i>J</i> = 8.3 Hz, 1 H); 5.90 (s, 1 H); 5.04–5.30 (m, 1 H); 4.36 (br d, <i>J</i> = 12.9 Hz, 2 H); 3.74–3.98 (m, 2 H); 3.63 (br d, <i>J</i> = 5.0 Hz, 4 H); 3.36–3.54 (m, 5 H); 3.19 (br t, <i>J</i> = 9.9 Hz, 1 H); 2.81–3.04 (m, 3 H); 2.20 (s, 3 H); 1.88–2.08 (m, 2 H); 1.63 (br s, 3 H); 1.48 (br d, <i>J</i> = 10.7 Hz, 3 H).</div></div><div id="sec5_1_6_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> (4-Benzylpiperidin-1-yl)(1-(4-(piperidin-1-yl)pyrimidin-2-yl)piperidin-4-yl)methanone (<b>52</b>)</h5><div class="NLM_p last">To a solution of 1-(4-piperidin-1-yl-pyrimidin-2-yl)-piperidine-4-carboxylic acid (100 mg, 0.34 mmol) in DMF (3 mL) was added HATU (157 mg, 0.41 mmol). The mixture was stirred at room temperature for 1 h. 4-Benzylpiperidine (0.073 mL, 0.41 mmol) and DIPEA (0.120 mL, 0.69 mmol) were added, and it was stirred at room temperature overnight. To the reaction mixture were added sat. NaHCO<sub>3</sub> and ethyl acetate. The layers were separated, and the organic layer was washed with 1 N NH<sub>4</sub>Cl. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure. The crude product was purified on silica gel column and was eluted with cyclohexane/ethyl acetate/ethanol 3:1 gradient 0–30%. Collected fractions were evaporated under reduced pressure to give a pale yellow solid, which was dissolved in ethyl acetate and washed with sat. NaHCO<sub>3</sub> and with 1 N NH<sub>4</sub>Cl. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure to afford the title compound (<b>52</b>) as a white solid (91 mg, 0.20 mmol, 59%). LCMS (formic): RT = 0.90 min, [M + H]<sup>+</sup> = 448, purity = 92%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.89 (d, <i>J</i> = 6.3 Hz, 1 H); 7.29 (d, <i>J</i> = 7.6 Hz, 2 H); 7.18–7.26 (m, 1 H); 7.15 (d, <i>J</i> = 7.3 Hz, 2 H); 5.88 (br d, <i>J</i> = 6.1 Hz, 1 H); 4.70–4.82 (m, 2 H); 4.63 (br d, <i>J</i> = 13.6 Hz, 1 H); 3.93 (br d, <i>J</i> = 12.6 Hz, 1 H); 3.71–3.78 (m, 1 H); 3.58 (br d, <i>J</i> = 0.8 Hz, 3 H); 2.99 (br s, 3 H); 2.66–2.79 (m, 1 H); 2.41–2.63 (m, 3 H); 1.65–1.89 (m, 13 H); 1.08–1.24 (m, 2 H).</div></div><div id="sec5_1_6_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> <i>tert</i>-Butyl 4-(4-isopropylpiperidine-1-carbonyl)piperidine-1-carboxylate</h5><div class="NLM_p last">To a solution on N-Boc-isonipecotic acid (1.29 g, 5.6 mmol) in THF (40 mL) was added carbonyl diimidazole (1 g, 6.2 mmol), and the mixture was stirred at 50 °C for 30 min. The solution was cooled to room temperature and 4-isopropylpiperidine (1 g, 7.9 mmol) and triethylamine (0.78 mL, 5.6 mmol) were added, and the mixture was stirred at room temperature for 2 h. The solvent was removed in vacuo, and the residue was taken up in ethyl acetate and washed with water (×4) and dried over Na<sub>2</sub>SO<sub>4</sub>. The crude product was purified by flash chromatography eluting with 50% heptane in ethyl acetate to yield the title compound (<i>tert</i>-butyl 4-(4-isopropylpiperidine-1-carbonyl)piperidine-1-carboxylate) as a white solid (1.88 g, 5.6 mmol, 99%).</div></div><div id="sec5_1_6_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> (4-Isopropylpiperidin-1-yl)(piperidin-4-yl)methanone Hydrochloride</h5><div class="NLM_p last">To a solution of <i>tert</i>-butyl 4-(4-isopropylpiperidine-1-carbonyl)piperidine-1-carboxylate (1.88 g, 5.6 mmol) in dioxane (10 mL) was added 4 M HCl in dioxane (approximately 10 mL,) and the mixture was stirred at room temperature for 2 h. A white precipitate formed. The solid was collected by filtration but was hygroscopic and liquified during filtration. The remaining solid was dissolved in methanol and concentrated in vacuo to yield the title compound ((4-isopropylpiperidin-1-yl)(piperidin-4-yl)methanone) as a white solid (1.44 g, 5.2 mmol, 94%).</div></div><div id="sec5_1_6_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> (4-Isopropylpiperidin-1-yl)(1-(6-morpholinopyridin-2-yl)piperidin-4-yl)methanone (<b>53</b>)</h5><div class="NLM_p last">To a solution of (4-isopropylpiperidin-1-yl)(piperidin-4-yl)methanone hydrochloride (136 mg, 0.49 mmol) in toluene (1 mL) was added 4-(6-bromo-2-yl)morpholine (100 mg, 0.41 mmol), Cs<sub>2</sub>CO<sub>3</sub> (321 mg, 0.98 mmol), Pd(OAc)<sub>2</sub> (1 mg) and BINAP (7.6 mg). The mixture was degassed with argon for 15 min and then heated to reflux overnight. The mixture was cooled to room temperature, filtered through a pad of Celite, washed with methanol and concentrated. The crude product was purified by flash column chromatography, eluting with 10% ethyl acetate in heptane to yield the title compound (53) as a white solid (138 mg, 0.35 mmol, 85%). LCMS (formic): RT = 1.14 min, [M + H]<sup>+</sup> = 401. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 7.3–7.4 (m, 1H); 6.0–6.1 (m, 1H); 5.9–6.0 (m, 1H); 4.6–4.8 (m, 1H); 4.2–4.4 (m, 2H); 3.9–4.1 (m, 1H); 3.7–3.9 (m, 4H); 3.4–3.5 (m, 4H); 2.9–3.1(m, 1H); 2.8–2.9 (m, 2H); 2.6–2.8 (m, 1H); 2.4–2.5 (m, 1H); 1.7–2.0 (m, 6H); 1.4–1.5 (m, 1H); 1.0–1.4 (m, 3H); 0.8–1.0 (m, 6H).</div></div><div id="sec5_1_6_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> (4-Isopropylpiperidin-1-yl)(1-(4-morpholinopyridin-2-yl)piperidin-4-yl)methanone (<b>54</b>)</h5><div class="NLM_p last">To a solution of (4-isopropylpiperidin-1-yl)(piperidin-4-yl)methanone hydrochloride (136 mg, 0.49 mmol) and 2-chloro-4-morpholinopyridine (97 mg, 0.49 mmol) in IMS (5 mL) was added DIPEA (0.21 mL, 1.23 mmol), and the mixture was heated in a microwave reactor at 160 °C for 20 h. The solvent was removed in vacuo, and the residue was purified by flash column chromatography eluting with 10% methanol in ethyl acetate. The appropriate fractions were combined and concentrated to afford the title compound (<b>54</b>) as a white solid (55 mg, 0.14 mmol, 28%). LCMS (formic): RT = 0.75 min, [M + H]<sup>+</sup> = 401. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 7.9–8.0 (m, 1H); 6.1–6.2 (m, 1H); 6.0 (s, 1H); 4.6–4.8 (m, 1H); 4.2–4.4 (m, 2H); 3.9–4.0 (m, 1H); 3.8–3.9 (m, 4H); 3.2–3.3 (m, 4H); 2.9–3.1 (m, 1H); 2.8–2.9 (m, 2H); 2.6–2.8 (m, 1H); 2.4–2.6 (m, 1H); 1.6–2.0 (m, 5H); 1.5–1.6 (m, 1H); 1.0–1.3 (m, 4H); 0.8–0.9 (m, 6 H).</div></div><div id="sec5_1_6_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> (4-Isopropylpiperidin-1-yl)(1-(2-morpholinopyridin-4-yl)piperidin-4-yl)methanone (<b>55</b>)</h5><div class="NLM_p last">To a solution of (4-isopropylpiperidin-1-yl)(piperidin-4-yl)methanone hydrochloride (136 mg, 0.49 mmol) and 4-(4-chloropyridin-2-yl)morpholine (97 mg, 0.49 mmol) in IMS (5 mL) was added DIPEA (0.21 mL, 1.23 mmol), and the mixture was heated in a microwave reactor at 160 °C for 24 h. The solvent was removed in vacuo, and the residue was purified by flash column chromatography eluting with 10% methanol in ethyl acetate. The appropriate fractions were combined and concentrated to afford the title compound (<b>55</b>) as a pale brown solid (31 mg, 0.078 mmol, 16%). LCMS (formic): <i>R</i><sub>t</sub> = 0.75 min, [M + H]<sup>+</sup> = 401. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 7.9–8.0 (m, 1H); 6.1–6.2 (m, 1H); 6.0 (s, 1H); 4.6–4.8 (m, 1H); 4.2–4.4 (m, 2H); 3.9–4.1 (m, 1H); 3.8–3.9 (m, 4H); 3.2–3.3 (m, 4H); 2.9–3.1 (m, 1H); 2.8–2.9 (m, 2H); 2.6–2.8 (m, 1H); 2.4–2.6 (m, 1 H); 1.7–2.0 (m, 5 H); 1.4–1.6 (m, 1H); 1.2–1.3 (m, 2 H); 1.0–1.2 (m, 2H); 0.8–1.0 (m, 6H).</div></div><div id="sec5_1_6_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> (4-Benzylpiperidin-1-yl)(1-(6-morpholinopyrazin-2-yl)piperidin-4-yl)methanone (<b>56</b>)</h5><div class="NLM_p last">To a solution of (4-benzylpiperidin-1-yl)(piperidin-4-yl)methanone hydrochloride (87 mg, 0.27 mmol) in ethanol (1 mL) was added 2,6-dichloropyrazine (40 mg, 0.27 mmol) and DIPEA (0.094 mL, 0.54 mmol), and the mixture was heated at 150 °C in a microwave for 5 min. Morpholine (0.094 mL, 1.07 mmol) was then added, and heating was continued at 150 °C for a further 4 h. The solution was purified by preparative HPLC using formic acid modifier and then repurified by preparative HPLC using ammonium bicarbonate modifier. The appropriate fractions were concentrated to afford the title compound (<b>56</b>) as a black gum. LCMS (formic): RT = 0.98 min, [M + H]<sup>+</sup> = 450. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.52 (s, 1 H); 7.41 (s, 1 H); 7.29 (d, <i>J</i> = 7.3 Hz, 2 H); 7.19–7.25 (m, 1 H); 7.16 (m, 1 H); 7.14 (m, 1 H); 4.63 (br d, <i>J</i> = 13.7 Hz, 1 H); 4.30 (br d, <i>J</i> = 11.7 Hz, 2 H); 3.92 (br d, <i>J</i> = 13.2 Hz, 1 H); 3.78–3.85 (m, 4 H); 3.46–3.53 (m, 4 H); 3.00 (br. m, 1 H); 2.85–2.95 (m, 2 H); 2.67–2.77 (m, 1 H); 2.46–2.64 (m, 3 H); 1.69–1.94 (m, 7 H); 1.09–1.25 (m, 2 H).</div></div><div id="sec5_1_6_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i88" class="anchor-spacer"></div><h5 class="article-section__title" id="_i88"> (4-Benzylpiperidin-1-yl)(1-(5-fluoro-6-morpholinopyrimidin-4-yl)piperidin-4-yl)methanone (<b>57</b>)</h5><div class="NLM_p last">To a solution of (4-benzylpiperidin-1-yl)(piperidin-4-yl)methanone hydrochloride (77 mg, 0.24 mmol) in ethanol (1 mL) was added 4,6-dichloro-5-fluoropyrimidine (40 mg, 0.24 mmol) and DIPEA (0.084 mL, 0.48 mmol), and the mixture was stirred at room temperature overnight. Additional morpholine (0.084 mL, 0.96 mmol) was added, and the reaction was stirred at 140 °C in a microwave reactor for 30 min. A further portion of morpholine (0.084 mL, 0.96 mmol) was added, and heating was continued at 140 °C for a further 1 h. The solution was then purified by preparative HPLC and the appropriate fractions combined and concentrated to afford the title compound (<b>57</b>) as a white solid (75 mg, 0.15 mmol, 66%). LCMS (formic): RT = 1.18 min, [M + H]<sup>+</sup> = 468. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.95 (d, <i>J</i> = 2.0 Hz, 1 H); 7.28 (m, 2 H); 7.11–7.20 (m, 3 H); 4.36 (br d, <i>J</i> = 12.6 Hz, 1 H); 4.18 (br d, <i>J</i> = 12.6 Hz, 2 H); 3.92–4.13 (m, 1 H); 3.62–3.75 (m, 4 H); 3.47–3.57 (m, 4 H); 2.81–3.11 (m, 5 H); 2.52–2.57 (m, 1 H); 2.38–2.48 (m, 1 H); 1.76 (br dd, <i>J</i> = 7.3, 3.8 Hz, 1 H); 1.62 (br s, 6H); 0.91–1.17 (m, 2 H).</div></div><div id="sec5_1_6_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i89" class="anchor-spacer"></div><h5 class="article-section__title" id="_i89"> (1-(2-Amino-6-morpholinopyrimidin-4-yl)piperidin-4-yl)(4-benzylpiperidin-1-yl)methanone (<b>58</b>)</h5><div class="NLM_p last">To a solution of (4-benzylpiperidin-1-yl)(piperidin-4-yl)methanone hydrochloride (120 mg, 0.37 mmol) in EtOH (0.9 mL) was added 4-chloro-6-morpholinopyrimidin-2-amine (40 mg, 0.19 mmol) and DIPEA (98 μL, 0.56 mmol). The mixture was heated at 150 °C in the microwave for 3 h, after which time direct purification of the mixture by preparative HPLC afforded the title compound (<b>58</b>) as a straw-colored foam (64 mg, 0.14 mmol, 74%). HR-MS (ESI): C<sub>26</sub>H<sub>37</sub>N<sub>6</sub>O<sub>2</sub> [M + H<sup>+</sup>] requires 465.2973, found 465.2980. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ ppm 7.27–7.29 (m, 2H); 7.17–7.20 (m, 3H); 5.56 (s, 2H); 5.30 (s, 1H); 4.35 (d, <i>J</i> = 12.6 Hz, 1H); 4.27 (d, <i>J</i> = 12.6 Hz, 2H); 3.97 (d, <i>J</i> = 12.6 Hz, 1H); 3.61–3.62 (m, 4H); 3.40–3.42 (m, 4H); 2.95 (t, <i>J</i> = 12.2 Hz, 1H); 2.85 (tt, <i>J</i> = 3.7, 11.3 Hz, 1H); 2.75–2.80 (m, 2H); 2.52 (s, 2H); 2.45 (t, <i>J</i> = 12.2 Hz, 1H); 1.72–1.77 (m, 1H); 1.56–1.64 (m, 4H); 1.40–1.48 (m, 2H); 1.04–1.12 (m, 1H); 0.93–1.01 (m, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ ppm172.1; 164.6; 164.0; 162.2; 140.0; 129.0 (2C); 128.1 (2C); 125.8; 73.1; 66.0 (2C); 44.8; 44.3 (2C); 43.3 (2C); 42.0; 41.2; 37.5 (2C); 32.6; 31.4; 28.0; 27.8, IR (neat) cm<sup>–1</sup> 3342; 2917; 2848; 1628; 1565; 1418; 1370; 1252; 1210; 1188; 1115; 987; 967; 898; 789; 745; 700..</div></div><div id="sec5_1_6_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> 4-(4-(4-Benzylpiperidine-1-carbonyl)piperidin-1-yl)-6-morpholinopyrimidin-2(1<i>H</i>)-one (<b>59</b>)</h5><div class="NLM_p last">To a solution of 4-(6-chloro-2-((4-methoxybenzyl)oxy)pyrimidin-4-yl)morpholine (75 mg, 0.22 mmol) and DIPEA (0.117 mL, 0.67 mmol) in ethanol (0.9 mL) was added (4-benzylpiperidin-1-yl)(piperidin-4-yl)methanone hydrochloride (144 mg, 0.45 mmol). The mixture was heated to 150 °C in the microwave for 8 h, after which time direct purification of the reaction mixture by preparative HPLC afforded the title compound (<b>59</b>) as a straw colored glass that was scratched to give an amorphous white solid (84 mg, 0.18 mmol, 81%). M.p. 117–123 °C. HR-MS (ESI): C<sub>26</sub>H<sub>36</sub>N<sub>5</sub>O<sub>3</sub> [M + H<sup>+</sup>] requires 466.2813, found 466.2814.<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 9.41 (br.s, 1H); 7.27–7.31 (m, 2H); 7.17–7.21 (m, 3H); 5.21 (s, 1H); 4.36 (d, <i>J</i> = 12.6 Hz, 1H); 4.12–4.17 (m, 2H); 3.98 (d, <i>J</i> = 12.6 Hz, 1H); 3.60–3.63 (m, 4H); 3.42–3.45 (m, 4H); 2.86–2.99 (m, 4H); 2.52–2.54 (m, 2H); 2.42–2.49 (m, 1H); 1.70–1.81 (m, 1H); 1.44–1.65 (m, 6H); 1.05–1.12 (m, 1H); 0.95–1.01 (m, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 171.9; 162.2; 160.6; 158.0; 140.0; 129.0 (2C); 128.1 (2C); 125.8; 71.1; 65.8 (2C); 48.6; 44.9 (2C); 44.8; 44.3; 42.0; 41.2; 37.5; 37.0; 32.6; 31.5; 28.0; 27.8. IR (neat) cm<sup>–1</sup> 2918; 2851; 1596; 1507; 1441; 1366; 1255; 1205; 1115; 967; 747; 701.</div></div><div id="sec5_1_6_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> <i>N</i>-(2-Fluoroethyl)-1-((6-methoxy-5-methylpyrimidin-4-yl)methyl)-1<i>H</i>-pyrrolo[3,2-b]pyridine-3-carboxamide (<b>60</b>)</h5><div class="NLM_p last"><b>60</b> was synthesized by the procedure described previously in Shirude et al.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (no. 9 in the paper).</div></div><div id="sec5_1_6_39_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i92" class="anchor-spacer"></div><h5 class="article-section__title" id="_i92"> Strain and Growth Conditions</h5><div class="NLM_p last"><b>M. tuberculosis</b> H37Rv (ATC25618) wild type was grown in Middlebrook 7H9-ADC broth (Difco) supplemented with 0.05% Tween 80 and on 7H10-OADC or 7H11-OADC agar (Difco) at 37 °C. Isoniazid and hygromycin were purchased from Sigma-Aldrich. When required, hygromycin (50 μg/mL) was added to the culture medium.</div></div><div id="sec5_1_6_39_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i93" class="anchor-spacer"></div><h5 class="article-section__title" id="_i93"> MIC Determination</h5><div class="NLM_p last">MIC determination assay was performed using a resazurin reduction assay with a fluorescent readout as described previously.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Isoniazid was used as a positive control (MIC = 1.8 μM), and rifampicin was used as a no-growth control. MIC determination against bacterial strains was performed as described in Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard M7-A6,Vol 23 No. 2. Intracellular MIC Determination. The assays were performed as described previously<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> using human THP-1macrophages differentiated with phorbol-12-myristate-13-acetate. The human biological samples were sourced ethically and their research use was in accord with the terms of the informed consents under an IRB/EC approved protocol.</div></div><div id="sec5_1_6_39_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i94" class="anchor-spacer"></div><h5 class="article-section__title" id="_i94"> Microsomal Fraction Stability</h5><div class="NLM_p">The assays were performed as described previously.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The human biological samples were sourced ethically, and their research use was in accordance with the terms of the informed consents.</div><div class="NLM_p">The classification of the clearance values (Clint) from mouse microsomes is</div><div class="NLM_p"><1 mL/min/g tissue: low clearance.</div><div class="NLM_p">1–5 mL/min/g tissue: moderate clearance.</div><div class="NLM_p">>5 mL/min/g tissue: high clearance.</div><div class="NLM_p">The classification of the clearance values (Clint) from human microsomes is</div><div class="NLM_p"><0.4 mL/min/g tissue: low clearance.</div><div class="NLM_p">0.4–2 mL/min/g tissue: moderate clearance.</div><div class="NLM_p last">>2 mL/min/g tissue: high clearance.</div></div><div id="sec5_1_6_39_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i95" class="anchor-spacer"></div><h5 class="article-section__title" id="_i95"> DprE1 Enzymatic Inhibition, Time-Dependent DprE1 Inhibition, and DprE1-Overexpressing Strain</h5><div class="NLM_p">Expression and purification of Mt-DprE1 and cloning of Mt-DprE1 were performed as described by Batt et al.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Enzymatic data referred to as FPR in this paper (farnesylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose as substrate) were generated as described. The remaining DprE1 assay data were generated using a modified version of the assay described in that report using geranylgeranyllphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose as substrate. The new protocol is in the process of being submitted for publication.</div><div class="NLM_p last">HepG2 cytotoxicity assay; artificial membrane permeability, kinetic aqueous solubility (CLND), and hydrophobicity (Chrom log D pH7.4). These assays were performed as described previously.<a onclick="showRef(event, 'ref29 ref35'); return false;" href="javascript:void(0);" class="ref ref29 ref35">(29,35)</a></div></div><div id="sec5_1_6_39_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i96" class="anchor-spacer"></div><h5 class="article-section__title" id="_i96"> DprE1 Enzymatic Inhibition and DprE1-Overexpressing Strain</h5><div class="NLM_p">Expression and purification of Mt-DprE1 and cloning of Mt-DprE1 were performed as described by Batt et al.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Enzymatic data referred to as FPR in this paper (farnesylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose as substrate) were generated as described. The remaining DprE1 assay data were generated using a modified version of the assay described in that report using geranylgeranyllphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose as substrate. The new protocol is in the process of being submitted for publication.</div><div class="NLM_p last">HepG2 cytotoxicity assay; artificial membrane permeability, kinetic aqueous solubility (CLND), and hydrophobicity (Chrom log DpH7.4). These assays were performed as described previously.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a></div></div><div id="sec5_1_6_39_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i97" class="anchor-spacer"></div><h5 class="article-section__title" id="_i97"> Phamacokinetics Studies</h5><div class="NLM_p">For pharmacokinetic studies, CD-1 male mice (22–25 g) were used, and compound concentrations were determined using peripheral whole blood. All animal studies were ethically reviewed and carried out in accordance with European Directive 2010/63/EU and the GSK Policy on the Care, Welfare and Treatment of Animals.</div><div class="NLM_p last">Compounds (<b>39</b> and <b>47</b>) were administered by intravenous route at 1 mg/kg single dose in 5% DMSO/20% encapsin and by oral gavage at 5 mg/kg single dose in 1% methyl cellulose (1% MC). Aliquots of 20 μL of blood were taken from the lateral tail vein by puncture from each mouse (<i>n</i> = 3 per route) at 5, 15, and 30 min, 1, 2, 4, 6, 8, and 24 h postdose for intravenous route and at 15, 30, and 45 min, 1, 2, 4, 6, 8, and 24 h postdose for oral route. LC-MS/MS was used as the analytical method for the establishment of compound concentration in blood. Pharmacokinetic analysis was performed by noncompartmental data analysis (NCA) with Phoenix WinNonlin 6.3 (Pharsight, Certara L.P) and supplementary analysis was performed with GraphPad Prism 6 (GraphPad Software, Inc.).</div></div><div id="sec5_1_6_39_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i98" class="anchor-spacer"></div><h5 class="article-section__title" id="_i98"> Therapeutic Efficacy</h5><div class="NLM_p">All animal studies were ethically reviewed and carried out in accordance with European Directive 2010/63/EU and the GSK Policy on the Care, Welfare and Treatment of Animals. Specific pathogen-free, 8–10 week-old female C57BL/6 mice were purchased from Harlan Laboratories and were allowed to acclimate for 1 week. Mice were infected intratracheally with 100.000 CFU/mouse (M. tuberculosis H37Rv strain). Compounds were orally administered for eight consecutive days, starting from day 1 after infection. Lungs were harvested on day 9, 24 h after the last compound administration. All lung lobes were aseptically removed, homogenized and frozen. Homogenates were plated in 10% OADC-7H11 medium supplemented with activated charcoal (0.4%) to avoid product carry over, and incubated for 18 days at 37 °C. No adverse clinical signs were observed in any animal.</div><div class="NLM_p">The number of CFU/mouse measured for each mouse and the differences in the lung microorganism burden (log10 CFUs/lungs) obtained in the treated mice with respect to untreated controls (Day 9 after infection) were calculated. CFU number in lungs of untreated mice: 5.8 logCFU. This value is included in the interval mean ±2 SD of the values of the last experiments. Quality controls: In this experiment, Moxifloxacin (100 mg/kg) was administered for eight consecutive days starting from day 1 after infection as an interassay control. It reduced 2.7 logCFU the bacterial lung number in comparison with the untreated mice (5.8 logCFU).</div><div class="NLM_p">This quality control value is included in the accepted interval.</div><div class="NLM_p">The mouse treated with compound 47 at 300 mg/kg was sacrificed due to bad clinical conditions after the second dosification.</div><div class="NLM_p last">Some mice were pretreated with ABT to inhibit their cytochrome activity in order to increase the exposure of compound 60. ABT was administered by oral route 2 h before the compound.</div></div><div id="sec5_1_6_39_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i99" class="anchor-spacer"></div><h5 class="article-section__title" id="_i99"> Data Analysis</h5><div class="NLM_p last">Nonlinear fitting to logistic equation of log10 (logCFU at day 9 after infection).</div></div><div id="sec5_1_6_39_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i100" class="anchor-spacer"></div><h5 class="article-section__title" id="_i100"> Parameter of Efficacy</h5><div class="NLM_p last">Effective dose 99% (ED99), defined as the dose in mg/kg that reduced bacterial burden at day 9 after infection by 99% with respect to untreated mice.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01561" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08145" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08145" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01561?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01561</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings for all compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01561/suppl_file/jm9b01561_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01561/suppl_file/jm9b01561_si_001.csv">jm9b01561_si_001.csv (3.45 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01561" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44455" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44455" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer A. Borthwick</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Science and Technology, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span>; 
    <span>Present Address:
                        (J.A.B.) Black Belt Tx Ltd., Stevenage Bioscience Catalyst, Accelerator Building, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX, UK</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6740-4232" title="Orcid link">http://orcid.org/0000-0002-6740-4232</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cca6a9a2a2a5aaa9bee2aea3beb8a4bba5afa78caea0adafa7aea9a0b8b8b4e2afa3a1"><span class="__cf_email__" data-cfemail="a9c3ccc7c7c0cfccdb87cbc6dbddc1dec0cac2e9cbc5c8cac2cbccc5ddddd187cac6c4">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monica Cacho</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6270-5370" title="Orcid link">http://orcid.org/0000-0001-6270-5370</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#432e2c2d2a20226d2a6d2022202b2c032430286d202c2e"><span class="__cf_email__" data-cfemail="e28f8d8c8b8183cc8bcc8183818a8da2859189cc818d8f">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert J. Young</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Science and Technology, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span>; 
    <span>Present Address:
                        (R.J.Y.) Blue Burgundy (Drug Discovery Consulting) Ltd</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7763-0575" title="Orcid link">http://orcid.org/0000-0002-7763-0575</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#beecd1dcfedcd2cbdb93dccbccd9cbd0dac790ddd190cbd5"><span class="__cf_email__" data-cfemail="580a373a183a342d3d753a2d2a3f2d363c21763b37762d33">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlos Alemparte</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5521-8304" title="Orcid link">http://orcid.org/0000-0001-5521-8304</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian Wall</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Science and Technology, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin C. Whitehurst</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Science and Technology, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span>; 
    <span>Present Address:
                        (B.C.W.) Medicinal Chemistry, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0FZ, UK</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Argyrides Argyrou</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Science and Technology, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span>; 
    <span>Present Address:
                        (A.A.) Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge CB4 0FZ, UK</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3141-9122" title="Orcid link">http://orcid.org/0000-0003-3141-9122</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Glenn Burley</span> - <span class="hlFld-Affiliation affiliation">Department
of Pure & Applied Chemistry, University
of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, Scotland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4896-113X" title="Orcid link">http://orcid.org/0000-0002-4896-113X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paco de Dios-Anton</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Guijarro</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Candida Monteiro</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fatima Ortega</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colin J Suckling</span> - <span class="hlFld-Affiliation affiliation">Department
of Pure & Applied Chemistry, University
of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, Scotland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julia Castro Pichel</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. J.A.B., M.C., and R.J.Y. and wrote the manuscript with input from all authors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Global Alliance for TB Drug Development for helpful discussions and financial support and all the people at GSK who have contributed to this work.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ABT</td><td class="NLM_def"><p class="first last">1-aminobenzotriazole</p></td></tr><tr><td class="NLM_term">ADC</td><td class="NLM_def"><p class="first last">albumin–dextrose–catalase</p></td></tr><tr><td class="NLM_term">AMU</td><td class="NLM_def"><p class="first last">atomic mass units</p></td></tr><tr><td class="NLM_term">AZ</td><td class="NLM_def"><p class="first last">AstraZeneca</p></td></tr><tr><td class="NLM_term">BEH</td><td class="NLM_def"><p class="first last">ethylene bridged hybrid</p></td></tr><tr><td class="NLM_term">BINAP</td><td class="NLM_def"><p class="first last">2,2′-bis(diphenylphosphino)-1,1′-binaphthalene</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony forming unit</p></td></tr><tr><td class="NLM_term">Clint</td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CLND</td><td class="NLM_def"><p class="first last">chemiluminescent nitrogen detection</p></td></tr><tr><td class="NLM_term">COMU</td><td class="NLM_def"><p class="first last">1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DprE1</td><td class="NLM_def"><p class="first last">decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose 2′-epimerase</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">FPR</td><td class="NLM_def"><p class="first last">farnesylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose</p></td></tr><tr><td class="NLM_term">GSK</td><td class="NLM_def"><p class="first last">GlaxoSmithKline</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate, <i>N</i>-[(dimethylamino)-1<i>H</i>-1,2,3-triazolo-[4,5-b]pyridin-1-ylmethylene]-<i>N</i>-methylmethanaminium hexafluorophosphate N-oxide</p></td></tr><tr><td class="NLM_term">IMS</td><td class="NLM_def"><p class="first last">industrial methylated spririt</p></td></tr><tr><td class="NLM_term">OADC</td><td class="NLM_def"><p class="first last">10% oleic acid–albumin–dextrose–catalase</p></td></tr><tr><td class="NLM_term">OE</td><td class="NLM_def"><p class="first last">overexpressor</p></td></tr><tr><td class="NLM_term">PFI</td><td class="NLM_def"><p class="first last">property forecast index</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">structure property relationship</p></td></tr><tr><td class="NLM_term">TBME</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyl methyl ether</p></td></tr><tr><td class="NLM_term">TDR</td><td class="NLM_def"><p class="first last">totally drug resistant</p></td></tr><tr><td class="NLM_term">Vss</td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr><tr><td class="NLM_term">XDR</td><td class="NLM_def"><p class="first last">extremely drug resistant</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i109">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35413" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35413" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span> <i>WHO Global Tuberculosis Report
2018</i>, <a href="http://www.who.int/tb/publications/global_report/en/" class="extLink">http://www.who.int/tb/publications/global_report/en/</a> (accessed Nov 14, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+WHO+Global+Tuberculosis+Report%0A2018%2C+http%3A%2F%2Fwww.who.int%2Ftb%2Fpublications%2Fglobal_report%2Fen%2F+%28accessed+Nov+14%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DWHO%2520Global%2520Tuberculosis%2520Report%250A2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zumla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raviglione, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fordham von Reyn, C.</span></span> <span> </span><span class="NLM_article-title">Tuberculosis</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1056/NEJMra1200894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1056%2FNEJMra1200894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=23425167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFCntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=745-755&author=A.+Zumlaauthor=M.+Raviglioneauthor=R.+Hafnerauthor=C.+Fordham+von+Reyn&title=Tuberculosis&doi=10.1056%2FNEJMra1200894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculosis</span></div><div class="casAuthors">Zumla, Alimuddin; Raviglione, Mario; Hafner, Richard; von Reyn, Fordham</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">745-755</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozFC-N3T921LVg90H21EOLACvtfcHk0lhiQqpQrQPf3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFCntLY%253D&md5=97dccc7f98e02f4aac1f33c8209823e0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1200894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1200894%26sid%3Dliteratum%253Aachs%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DRaviglione%26aufirst%3DM.%26aulast%3DHafner%26aufirst%3DR.%26aulast%3DFordham%2Bvon%2BReyn%26aufirst%3DC.%26atitle%3DTuberculosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D368%26spage%3D745%26epage%3D755%26doi%3D10.1056%2FNEJMra1200894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zumla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakaya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mwaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyirenda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mfinanga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelscher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeurer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliori, G. B.</span></span> <span> </span><span class="NLM_article-title">Tuberculosis Treatment and Management—an Update on Treatment Regimens, Trials, New Drugs, and Adjunct Therapies</span>. <i>Lancet Respir. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/S2213-2600(15)00063-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1016%2FS2213-2600%2815%2900063-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=25773212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A280%3ADC%252BC2MnktlWkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=220-234&author=A.+Zumlaauthor=J.+Chakayaauthor=R.+Centisauthor=L.+D%E2%80%99Ambrosioauthor=P.+Mwabaauthor=M.+Batesauthor=N.+Kapataauthor=T.+Nyirendaauthor=D.+Chandaauthor=S.+Mfinangaauthor=M.+Hoelscherauthor=M.+Maeurerauthor=G.+B.+Migliori&title=Tuberculosis+Treatment+and+Management%E2%80%94an+Update+on+Treatment+Regimens%2C+Trials%2C+New+Drugs%2C+and+Adjunct+Therapies&doi=10.1016%2FS2213-2600%2815%2900063-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies</span></div><div class="casAuthors">Zumla Alimuddin; Chakaya Jeremiah; Centis Rosella; D'Ambrosio Lia; Migliori Giovanni Battista; Mwaba Peter; Bates Matthew; Chanda Duncan; Kapata Nathan; Nyirenda Thomas; Mfinanga Sayoki; Hoelscher Michael; Maeurer Markus</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Respiratory medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">220-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">WHO estimates that 9 million people developed active tuberculosis in 2013 and 1·5 million people died from it.  Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis continue to spread worldwide with an estimated 480,000 new cases in 2013.  Treatment success rates of MDR and XDR tuberculosis are still low and development of new, more effective tuberculosis drugs and adjunct therapies to improve treatment outcomes are urgently needed.  Although standard therapy for drug-sensitive tuberculosis is highly effective, shorter, more effective treatment regimens are needed to reduce the burden of infectious cases.  We review the latest WHO guidelines and global recommendations for treatment and management of drug-sensitive and drug-resistant tuberculosis, and provide an update on new drug development, results of several phase 2 and phase 3 tuberculosis treatment trials, and other emerging adjunct therapeutic options for MDR and XDR tuberculosis.  The use of fluoroquinolone-containing (moxifloxacin and gatifloxacin) regimens have failed to shorten duration of therapy, and the new tuberculosis drug pipeline is sparse.  Scale-up of existing interventions with increased investments into tuberculosis health services, development of new antituberculosis drugs, adjunct therapies and vaccines, coupled with visionary political leadership, are still our best chance to change the unacceptable status quo of the tuberculosis situation worldwide and the growing problem of drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYne8pMAo195QHPYJuLg8TfW6udTcc2ebP_gDFXw-O8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnktlWkug%253D%253D&md5=d96f8f052699089701997ec722e30e48</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS2213-2600%2815%2900063-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2213-2600%252815%252900063-6%26sid%3Dliteratum%253Aachs%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DChakaya%26aufirst%3DJ.%26aulast%3DCentis%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DL.%26aulast%3DMwaba%26aufirst%3DP.%26aulast%3DBates%26aufirst%3DM.%26aulast%3DKapata%26aufirst%3DN.%26aulast%3DNyirenda%26aufirst%3DT.%26aulast%3DChanda%26aufirst%3DD.%26aulast%3DMfinanga%26aufirst%3DS.%26aulast%3DHoelscher%26aufirst%3DM.%26aulast%3DMaeurer%26aufirst%3DM.%26aulast%3DMigliori%26aufirst%3DG.%2BB.%26atitle%3DTuberculosis%2520Treatment%2520and%2520Management%25E2%2580%2594an%2520Update%2520on%2520Treatment%2520Regimens%252C%2520Trials%252C%2520New%2520Drugs%252C%2520and%2520Adjunct%2520Therapies%26jtitle%3DLancet%2520Respir.%2520Med.%26date%3D2015%26volume%3D3%26spage%3D220%26epage%3D234%26doi%3D10.1016%2FS2213-2600%2815%2900063-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikusova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möllmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryabova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Joanis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucarelli, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dianiskova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordulakova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullam, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrethsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenkrands, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaonkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balganesh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosset, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Benzothiazinones Kill <i>Mycobacterium tuberculosis</i> by Blocking Arabinan Synthesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1126/science.1171583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1126%2Fscience.1171583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=19299584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVeksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=801-804&author=V.+Makarovauthor=G.+Maninaauthor=K.+Mikusovaauthor=U.+M%C3%B6llmannauthor=O.+Ryabovaauthor=B.+Saint-Joanisauthor=N.+Dharauthor=M.+R.+Pascaauthor=S.+Buroniauthor=A.+P.+Lucarelliauthor=A.+Milanoauthor=E.+De+Rossiauthor=M.+Belanovaauthor=A.+Bobovskaauthor=P.+Dianiskovaauthor=J.+Kordulakovaauthor=C.+Salaauthor=E.+Fullamauthor=P.+Schneiderauthor=J.+D.+McKinneyauthor=P.+Brodinauthor=T.+Christopheauthor=S.+Waddellauthor=P.+Butcherauthor=J.+Albrethsenauthor=I.+Rosenkrandsauthor=R.+Broschauthor=V.+Nandiauthor=S.+Bharathauthor=S.+Gaonkarauthor=R.+K.+Shandilauthor=V.+Balasubramanianauthor=T.+Balganeshauthor=S.+Tyagiauthor=J.+Grossetauthor=G.+Riccardiauthor=S.+T.+Cole&title=Benzothiazinones+Kill+Mycobacterium+tuberculosis+by+Blocking+Arabinan+Synthesis&doi=10.1126%2Fscience.1171583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis</span></div><div class="casAuthors">Makarov, Vadim; Manina, Giulia; Mikusova, Katarina; Moellmann, Ute; Ryabova, Olga; Saint-Joanis, Brigitte; Dhar, Neeraj; Pasca, Maria Rosalia; Buroni, Silvia; Lucarelli, Anna Paola; Milano, Anna; De Rossi, Edda; Belanova, Martina; Bobovska, Adela; Dianiskova, Petronela; Kordulakova, Jana; Sala, Claudia; Fullam, Elizabeth; Schneider, Patricia; McKinney, John D.; Brodin, Priscille; Christophe, Thierry; Waddell, Simon; Butcher, Philip; Albrethsen, Jakob; Rosenkrands, Ida; Brosch, Roland; Nandi, Vrinda; Bharath, Sowmya; Gaonkar, Sheshagiri; Shandil, Radha K.; Balasubramanian, Venkataraman; Balganesh, Tanjore; Tyagi, Sandeep; Grosset, Jacques; Riccardi, Giovanna; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5928</span>),
    <span class="NLM_cas:pages">801-804</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">New drugs are required to counter the tuberculosis (TB) pandemic.  Here, we describe the synthesis and characterization of 1,3-benzothiazin-4-ones (BTZs), a new class of antimycobacterial agents that kill Mycobacterium tuberculosis in vitro, ex vivo, and in mouse models of TB.  Using genetics and biochem., we identified the enzyme decaprenylphosphoryl-β-D-ribose 2'-epimerase as a major BTZ target.  Inhibition of this enzymic activity abolishes the formation of decaprenylphosphoryl arabinose, a key precursor that is required for the synthesis of the cell-wall arabinans, thus provoking cell lysis and bacterial death.  The most advanced compd., BTZ043, is a candidate for inclusion in combination therapies for both drug-sensitive and extensively drug-resistant TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZiVvk0T_DOrVg90H21EOLACvtfcHk0ljnntiSQS75dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVeksrY%253D&md5=1d80f14ba88460ef5c8ea31793dbb592</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1171583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1171583%26sid%3Dliteratum%253Aachs%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DManina%26aufirst%3DG.%26aulast%3DMikusova%26aufirst%3DK.%26aulast%3DM%25C3%25B6llmann%26aufirst%3DU.%26aulast%3DRyabova%26aufirst%3DO.%26aulast%3DSaint-Joanis%26aufirst%3DB.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DLucarelli%26aufirst%3DA.%2BP.%26aulast%3DMilano%26aufirst%3DA.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DBelanova%26aufirst%3DM.%26aulast%3DBobovska%26aufirst%3DA.%26aulast%3DDianiskova%26aufirst%3DP.%26aulast%3DKordulakova%26aufirst%3DJ.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DFullam%26aufirst%3DE.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DWaddell%26aufirst%3DS.%26aulast%3DButcher%26aufirst%3DP.%26aulast%3DAlbrethsen%26aufirst%3DJ.%26aulast%3DRosenkrands%26aufirst%3DI.%26aulast%3DBrosch%26aufirst%3DR.%26aulast%3DNandi%26aufirst%3DV.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DGaonkar%26aufirst%3DS.%26aulast%3DShandil%26aufirst%3DR.%2BK.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DBalganesh%26aufirst%3DT.%26aulast%3DTyagi%26aufirst%3DS.%26aulast%3DGrosset%26aufirst%3DJ.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DBenzothiazinones%2520Kill%2520Mycobacterium%2520tuberculosis%2520by%2520Blocking%2520Arabinan%2520Synthesis%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D801%26epage%3D804%26doi%3D10.1126%2Fscience.1171583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Crellin, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brammananth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppel, R. L.</span></span> <span> </span><span class="NLM_article-title">Decaprenylphosphoryl-β-D-Ribose 2’-Epimerase, the Target of Benzothiazinones and Dinitrobenzamides, Is an Essential Enzyme in Mycobacterium smegmatis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e16869</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0016869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1371%2Fjournal.pone.0016869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=21346818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlOqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=P.+K.+Crellinauthor=R.+Brammananthauthor=R.+L.+Coppel&title=Decaprenylphosphoryl-%CE%B2-D-Ribose+2%E2%80%99-Epimerase%2C+the+Target+of+Benzothiazinones+and+Dinitrobenzamides%2C+Is+an+Essential+Enzyme+in+Mycobacterium+smegmatis&doi=10.1371%2Fjournal.pone.0016869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Decaprenylphosphoryl-β-D-ribose 2'-epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in Mycobacterium smegmatis</span></div><div class="casAuthors">Crellin, Paul K.; Brammananth, Rajini; Coppel, Ross L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e16869</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: The unique cell wall of bacteria of the suborder Corynebacterineae is essential for the growth and survival of significant human pathogens including Mycobacterium tuberculosis and Mycobacterium leprae.  Drug resistance in mycobacteria is an increasingly common development, making identification of new antimicrobials a priority.  Recent studies have revealed potent anti-mycobacterial compds., the benzothiazinones and dinitrobenzamides, active against DprE1, a subunit of decaprenylphosphoribose 2' epimerase which forms decaprenylphosphoryl arabinose, the arabinose donor for mycobacterial cell wall biosynthesis.  Despite the exploitation of Mycobacterium smegmatis in the identification of DprE1 as the target of these new antimicrobials and its use in the exploration of mechanisms of resistance, the essentiality of DprE1 in this species has never been examd.  Indeed, direct exptl. evidence of the essentiality of DprE1 has not been obtained in any species of mycobacterium.  Methodol./Principal Findings: In this study we constructed a conditional gene knockout strain targeting the ortholog of dprE1 in M. smegmatis, MSMEG_6382.  Disruption of the chromosomal copy of MSMEG_6382 was only possible in the presence of a plasmid-encoded copy of MSMEG_6382.  Curing of this "rescue" plasmid from the bacterial population resulted in a cessation of growth, demonstrating gene essentiality.  Conclusions/Significance: This study provides the first direct exptl. evidence for the essentiality of DprE1 in mycobacteria.  The essentiality of DprE1 in M. smegmatis, combined with its conservation in all sequenced mycobacterial genomes, suggests that decaprenylphosphoryl arabinose synthesis is essential in all mycobacteria.  Our findings indicate a lack of redundancy in decaprenylphosphoryl arabinose synthesis in M. smegmatis, despite the relatively large coding capacity of this species, and suggest that no alternative arabinose donors for cell wall biosynthesis exist.  Overall, this study further validates DprE1 as a promising target for new anti-mycobacterial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5G6QmgUM6bLVg90H21EOLACvtfcHk0lh5gqAtHX1J3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlOqsbk%253D&md5=855e13cfb136098ff27265b10188bcd5</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0016869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0016869%26sid%3Dliteratum%253Aachs%26aulast%3DCrellin%26aufirst%3DP.%2BK.%26aulast%3DBrammananth%26aufirst%3DR.%26aulast%3DCoppel%26aufirst%3DR.%2BL.%26atitle%3DDecaprenylphosphoryl-%25CE%25B2-D-Ribose%25202%25E2%2580%2599-Epimerase%252C%2520the%2520Target%2520of%2520Benzothiazinones%2520and%2520Dinitrobenzamides%252C%2520Is%2520an%2520Essential%2520Enzyme%2520in%2520Mycobacterium%2520smegmatis%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0016869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jankute, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grover, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span> <span> </span><span class="NLM_article-title">Arabinogalactan and Lipoarabinomannan Biosynthesis: Structure, Biogenesis and their Potential as Drug Targets</span>. <i>Future Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.2217/fmb.11.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.2217%2Ffmb.11.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=22191451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Krsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=129-147&author=M.+Jankuteauthor=S.+Groverauthor=A.+K.+Ranaauthor=G.+S.+Besra&title=Arabinogalactan+and+Lipoarabinomannan+Biosynthesis%3A+Structure%2C+Biogenesis+and+their+Potential+as+Drug+Targets&doi=10.2217%2Ffmb.11.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Arabinogalactan and lipoarabinomannan biosynthesis: structure, biogenesis and their potential as drug targets</span></div><div class="casAuthors">Jankute, Monika; Grover, Shipra; Rana, Amrita K.; Besra, Gurdyal S.</div><div class="citationInfo"><span class="NLM_cas:title">Future Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-147</span>CODEN:
                <span class="NLM_cas:coden">FMUIAR</span>;
        ISSN:<span class="NLM_cas:issn">1746-0913</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Mycobacterium tuberculosis, the etiol. agent of TB, remains the leading cause of mortality from a single infectious organism.  The persistence of this human pathogen is assocd. with its distinctive lipid-rich cell wall structure that is highly impermeable to hydrophilic chem. drugs.  This highly complex and unique structure is crucial for the growth, viability and virulence of M. tuberculosis, thus representing an attractive target for vaccine and drug development.  It contains a large macromol. structure known as the mycolyl-arabinogalactan-peptidoglycan complex, as well as phosphatidyl-myo-inositol derived glycolipids with potent immunomodulatory activity, notably lipomannan and lipoarabinomannan.  These cell wall components are often the targets of effective chemotherapeutic agents against TB, such as ethambutol.  This review focuses on the structural details and biosynthetic pathways of both arabinogalactan and lipoarabinomannan, as well as the effects of potent drugs on these important (lipo)polysaccharides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1TB_NT8hva7Vg90H21EOLACvtfcHk0lh5gqAtHX1J3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Krsr3J&md5=f4d1b91b46f65481d3dc992e699ec05c</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.2217%2Ffmb.11.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffmb.11.123%26sid%3Dliteratum%253Aachs%26aulast%3DJankute%26aufirst%3DM.%26aulast%3DGrover%26aufirst%3DS.%26aulast%3DRana%26aufirst%3DA.%2BK.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26atitle%3DArabinogalactan%2520and%2520Lipoarabinomannan%2520Biosynthesis%253A%2520Structure%252C%2520Biogenesis%2520and%2520their%2520Potential%2520as%2520Drug%2520Targets%26jtitle%3DFuture%2520Microbiol.%26date%3D2012%26volume%3D7%26spage%3D129%26epage%3D147%26doi%3D10.2217%2Ffmb.11.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faray-Kele, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, T.</span></span> <span> </span><span class="NLM_article-title">Identifying Vulnerable Pathways in <i>Mycobacterium tuberculosis</i> by Using a Knockdown Approach</span>. <i>Appl. Environ. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">5040</span>– <span class="NLM_lpage">5043</span>, <span class="refDoi"> DOI: 10.1128/AEM.02880-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1128%2FAEM.02880-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=21642404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWlsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=5040-5043&author=P.+Carrollauthor=M.+C.+Faray-Keleauthor=T.+Parish&title=Identifying+Vulnerable+Pathways+in+Mycobacterium+tuberculosis+by+Using+a+Knockdown+Approach&doi=10.1128%2FAEM.02880-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying vulnerable pathways in Mycobacterium tuberculosis by using a knockdown approach</span></div><div class="casAuthors">Carroll, Paul; Faray-Kele, Marie-Claire; Parish, Tanya</div><div class="citationInfo"><span class="NLM_cas:title">Applied and Environmental Microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5040-5043</span>CODEN:
                <span class="NLM_cas:coden">AEMIDF</span>;
        ISSN:<span class="NLM_cas:issn">0099-2240</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We constructed recombinant strains of Mycobacterium tuberculosis in which expression of specific genes was downregulated to identify vulnerable drug targets.  Growth phenotypes in macrophages and culture were used to rank targets: the dprE1, clpP1, and fadD32 operons were the best targets and glnA1, glnE, pknL, regX3, and senX3 were poor targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqaQyMyeiB27Vg90H21EOLACvtfcHk0lh5gqAtHX1J3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWlsbjF&md5=d7c137d893dc8eb7b8b6c38a909fd16a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1128%2FAEM.02880-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAEM.02880-10%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DP.%26aulast%3DFaray-Kele%26aufirst%3DM.%2BC.%26aulast%3DParish%26aufirst%3DT.%26atitle%3DIdentifying%2520Vulnerable%2520Pathways%2520in%2520Mycobacterium%2520tuberculosis%2520by%2520Using%2520a%2520Knockdown%2520Approach%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D2011%26volume%3D77%26spage%3D5040%26epage%3D5043%26doi%3D10.1128%2FAEM.02880-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boldrin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Assessing the Essentiality of the Decaprenyl-phospho-d-arabinofuranose Pathway in <i>Mycobacterium tuberculosis</i> Using Conditional Mutants</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1111/mmi.12546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1111%2Fmmi.12546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=24517327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltVSgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2014&pages=194-211&author=G.+S.+Kollyauthor=F.+Boldrinauthor=C.+Salaauthor=N.+Dharauthor=R.+C.+Hartkoornauthor=M.+Venturaauthor=A.+Serafiniauthor=J.+D.+McKinneyauthor=R.+Manganelliauthor=S.+T.+Cole&title=Assessing+the+Essentiality+of+the+Decaprenyl-phospho-d-arabinofuranose+Pathway+in+Mycobacterium+tuberculosis+Using+Conditional+Mutants&doi=10.1111%2Fmmi.12546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the essentiality of the decaprenyl-phospho-D-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants</span></div><div class="casAuthors">Kolly, Gaelle S.; Boldrin, Francesca; Sala, Claudia; Dhar, Neeraj; Hartkoorn, Ruben C.; Ventura, Marcello; Serafini, Agnese; McKinney, John D.; Manganelli, Riccardo; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">194-211</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In Mycobacterium tuberculosis the decaprenyl-phospho-D-arabinofuranose (DPA) pathway is a validated target for the drugs ethambutol and benzothiazinones.  To identify other potential drug targets in the pathway, we generated conditional knock-down mutants of each gene involved using the TET-PIP OFF system.  DprE1, dprE2, ubiA, prsA, rv2361c, tkt and rpiB were confirmed to be essential under non-permissive conditions, whereas rv3807c was not required for survival.  In the most vulnerable group, DprE1-depleted cells died faster in vitro and intracellularly than those lacking UbiA and PrsA.  Downregulation of DprE1 and UbiA resulted in similar phenotypes, namely swelling of the bacteria, cell wall damage and lysis as obsd. at the single cell level, by real time microscopy and electron microscopy.  By contrast, depletion of PrsA led to cell elongation and implosion, which was suggestive of a more pleiotropic effect.  Drug sensitivity assays with known DPA-inhibitors supported the use of conditional knock-down strains for target-based whole-cell screens.  Together, our work provides strong evidence for the vulnerability of all but one of the enzymes in the DPA pathway and generates valuable tools for the identification of lead compds. targeting the different biosynthetic steps.  PrsA, phosphoribosyl-pyrophosphate synthetase, appears to be a particularly attractive new target for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvma-CyKwwdbVg90H21EOLACvtfcHk0lh5gqAtHX1J3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltVSgtbw%253D&md5=ff61bee837cadb44e8688ebd907b927d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fmmi.12546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fmmi.12546%26sid%3Dliteratum%253Aachs%26aulast%3DKolly%26aufirst%3DG.%2BS.%26aulast%3DBoldrin%26aufirst%3DF.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DVentura%26aufirst%3DM.%26aulast%3DSerafini%26aufirst%3DA.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DManganelli%26aufirst%3DR.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DAssessing%2520the%2520Essentiality%2520of%2520the%2520Decaprenyl-phospho-d-arabinofuranose%2520Pathway%2520in%2520Mycobacterium%2520tuberculosis%2520Using%2520Conditional%2520Mutants%26jtitle%3DMol.%2520Microbiol.%26date%3D2014%26volume%3D92%26spage%3D194%26epage%3D211%26doi%3D10.1111%2Fmmi.12546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span> <span> </span><span class="NLM_article-title">Decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-Ribose 2′-Epimerase from <i>Mycobacterium tuberculosis</i> is a Magic Drug Target</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.2174/092986710791959693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.2174%2F092986710791959693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=20629622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtF2rtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=3099-3108&author=G.+Maninaauthor=R.+Pascaauthor=S.+Buroniauthor=E.+De+Rossiauthor=G.+Riccardi&title=Decaprenylphosphoryl-%CE%B2-d-Ribose+2%E2%80%B2-Epimerase+from+Mycobacterium+tuberculosis+is+a+Magic+Drug+Target&doi=10.2174%2F092986710791959693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Decaprenylphosphoryl-β-D-ribose 2'-epimerase from Mycobacterium tuberculosis is a magic drug target</span></div><div class="casAuthors">Manina, G.; Pasca, M. R.; Buroni, S.; De Rossi, E.; Riccardi, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3099-3108</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tuberculosis is still a leading cause of death in developing countries and a resurgent disease in developed countries.  The selection and soaring spread of Mycobacterium tuberculosis multidrug-resistant (MDR-TB) and extensively drug-resistant strains (XDR-TB) is a severe public health problem.  Currently, there is an urgent need of new drugs for tuberculosis treatment, with novel mechanisms of action and, moreover, the necessity to identify new drug targets.  Several enzymes involved in various metabolic processes have been described as potential targets for the development of new drugs.  Recently, two different classes of most promising drugs, the benzothiazinones (BTZ) and the dinitrobenzamide derivs. (DNB), have been found to be highly active against M. tuberculosis, including XDR-TB strains.  Both drugs have the same target: the heteromeric decaprenylphosphoryl-β-D-ribose 2'-epimerase encoded by dprE1 (Rv3790) and dprE2 (Rv3791) genes, resp.  DprE1 and DprE2 are involved in the biosynthesis of D-arabinose and, in particular, they are essential to perform the transformation of decaprenylphosphoryl-D-ribose to decaprenylphosphoryl-D-arabinose, which is a substrate for arabinosyltransferases in the synthesis of the cell-envelope arabinogalactan and liporabinomannan polysaccharides of mycobacteria.  Arabinogalactan is a fundamental component of the mycobacterial cell wall, which covalently binds the outer layer of mycolic acids to peptidoglycan.  The heteromeric decaprenylphosphoryl-β-D-ribose 2'-epimerase thus represents a valid vulnerable antimycobacterial drug target which could result "magic" for tuberculosis treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV5N5U2ufDWbVg90H21EOLACvtfcHk0lg_iGPDaAvqFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtF2rtbfN&md5=ea158a6785eca6c7ce4a98e4260100c7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F092986710791959693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791959693%26sid%3Dliteratum%253Aachs%26aulast%3DManina%26aufirst%3DG.%26aulast%3DPasca%26aufirst%3DR.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DRiccardi%26aufirst%3DG.%26atitle%3DDecaprenylphosphoryl-%25CE%25B2-d-Ribose%25202%25E2%2580%25B2-Epimerase%2520from%2520Mycobacterium%2520tuberculosis%2520is%2520a%2520Magic%2520Drug%2520Target%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D3099%26epage%3D3108%26doi%3D10.2174%2F092986710791959693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solapure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KR, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mdluli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span> <span> </span><span class="NLM_article-title">1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5325</span>– <span class="NLM_lpage">5331</span>, <span class="refDoi"> DOI: 10.1128/AAC.03233-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1128%2FAAC.03233-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=24957839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eqsL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=5325-5331&author=M.+Chatterjiauthor=R.+Shandilauthor=M.+R.+Manjunathaauthor=S.+Solapureauthor=V.+Ramachandranauthor=N.+Kumarauthor=R.+Saralayaauthor=V.+Pandugaauthor=J.+Reddyauthor=P.+KRauthor=S.+Sharmaauthor=C.+Sadlerauthor=C.+B.+Cooperauthor=K.+Mdluliauthor=P.+S.+Iyerauthor=S.+Narayananauthor=P.+S.+Shirude&title=1%2C4-Azaindole%2C+a+Potential+Drug+Candidate+for+Treatment+of+Tuberculosis&doi=10.1128%2FAAC.03233-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-azaindole, a potential drug candidate for treatment of tuberculosis</span></div><div class="casAuthors">Chatterji, Monalisa; Shandil, Radha; Manjunatha, M. R.; Solapure, Suresh; Ramachandran, Vasanthi; Kumar, Naveen; Saralaya, Ramanatha; Panduga, Vijender; Reddy, Jitendar; Prabhakar, K. R.; Sharma, Sreevalli; Sadler, Claire; Cooper, Christopher B.; Mdluli, Khisi; Iyer, Pravin S.; Narayanan, Shridhar; Shirude, Pravin S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5325-5331, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">New therapeutic strategies against multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis are urgently required to combat the global tuberculosis (TB) threat.  Toward this end, we previously reported the identification of 1,4-azaindoles, a promising class of compds. with potent antitubercular activity through noncovalent inhibition of decaprenylphosphoryl-β-d-ribose 2'-epimerase (DprE1).  Further, this series was optimized to improve its physicochem. properties and pharmacokinetics in mice.  Here, we describe the short-listing of a potential clin. candidate, compd. 2, that has potent cellular activity, drug-like properties, efficacy in mouse and rat chronic TB infection models, and minimal in vitro safety risks.  We also demonstrate that the compds., including compd. 2, have no antagonistic activity with other anti-TB drugs.  Moreover, compd. 2 shows synergy with PA824 and TMC207 in vitro, and the synergy effect is translated in vivo with TMC207.  The series is predicted to have a low clearance in humans, and the predicted human dose for compd. 2 is ≤ 1 g/day.  Altogether, our data suggest that a 1,4-azaindole (compd. 2) is a promising candidate for the development of a novel anti-TB drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW_tEuW_mDx7Vg90H21EOLACvtfcHk0lg_iGPDaAvqFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eqsL7N&md5=992bbd235d99bb1f8f05612966f76bc9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FAAC.03233-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03233-14%26sid%3Dliteratum%253Aachs%26aulast%3DChatterji%26aufirst%3DM.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DSolapure%26aufirst%3DS.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DKR%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DMdluli%26aufirst%3DK.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DShirude%26aufirst%3DP.%2BS.%26atitle%3D1%252C4-Azaindole%252C%2520a%2520Potential%2520Drug%2520Candidate%2520for%2520Treatment%2520of%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D5325%26epage%3D5331%26doi%3D10.1128%2FAAC.03233-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenistein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras-Dominguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genovesio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carralot, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Škovierová, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsollier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joly-Guillou, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">No, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehrbass, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span> <span> </span><span class="NLM_article-title">High Content Screening Identifies Decaprenyl-Phosphoribose 2’ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e1000645</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1000645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1371%2Fjournal.ppat.1000645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=19876393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A280%3ADC%252BD1Mjis1GgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&author=T.+Christopheauthor=M.+Jacksonauthor=H.+K.+Jeonauthor=D.+Fenisteinauthor=M.+Contreras-Dominguezauthor=J.+Kimauthor=A.+Genovesioauthor=J.+P.+Carralotauthor=F.+Ewannauthor=E.+H.+Kimauthor=S.+Y.+Leeauthor=S.+Kangauthor=M.+J.+Seoauthor=E.+J.+Parkauthor=H.+%C5%A0kovierov%C3%A1author=H.+Phamauthor=G.+Riccardiauthor=J.+Y.+Namauthor=L.+Marsollierauthor=M.+Kempfauthor=M.+L.+Joly-Guillouauthor=T.+Ohauthor=W.+K.+Shinauthor=Z.+Noauthor=U.+Nehrbassauthor=R.+Broschauthor=S.+T.+Coleauthor=P.+Brodin&title=High+Content+Screening+Identifies+Decaprenyl-Phosphoribose+2%E2%80%99+Epimerase+as+a+Target+for+Intracellular+Antimycobacterial+Inhibitors&doi=10.1371%2Fjournal.ppat.1000645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors</span></div><div class="casAuthors">Christophe Thierry; Jackson Mary; Jeon Hee Kyoung; Fenistein Denis; Contreras-Dominguez Monica; Kim Jaeseung; Genovesio Auguste; Carralot Jean-Philippe; Ewann Fanny; Kim Eun Hye; Lee Sae Yeon; Kang Sunhee; Seo Min Jung; Park Eun Jung; Skovierova Henrieta; Pham Ha; Riccardi Giovanna; Nam Ji Youn; Marsollier Laurent; Kempf Marie; Joly-Guillou Marie-Laure; Oh Taegwon; Shin Won Kyung; No Zaesung; Nehrbass Ulf; Brosch Roland; Cole Stewart T; Brodin Priscille</div><div class="citationInfo"><span class="NLM_cas:title">PLoS pathogens</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1000645</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A critical feature of Mycobacterium tuberculosis, the causative agent of human tuberculosis (TB), is its ability to survive and multiply within macrophages, making these host cells an ideal niche for persisting microbes.  Killing the intracellular tubercle bacilli is a key requirement for efficient tuberculosis treatment, yet identifying potent inhibitors has been hampered by labor-intensive techniques and lack of validated targets.  Here, we present the development of a phenotypic cell-based assay that uses automated confocal fluorescence microscopy for high throughput screening of chemicals that interfere with the replication of M. tuberculosis within macrophages.  Screening a library of 57,000 small molecules led to the identification of 135 active compounds with potent intracellular anti-mycobacterial efficacy and no host cell toxicity.  Among these, the dinitrobenzamide derivatives (DNB) showed high activity against M. tuberculosis, including extensively drug resistant (XDR) strains.  More importantly, we demonstrate that incubation of M. tuberculosis with DNB inhibited the formation of both lipoarabinomannan and arabinogalactan, attributable to the inhibition of decaprenyl-phospho-arabinose synthesis catalyzed by the decaprenyl-phosphoribose 2' epimerase DprE1/DprE2.  Inhibition of this new target will likely contribute to new therapeutic solutions against emerging XDR-TB.  Beyond validating the high throughput/content screening approach, our results open new avenues for finding the next generation of antimicrobials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7NZPIQh0EAub6AVA-44PTfW6udTcc2ebKKDeJUgHvG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mjis1GgsA%253D%253D&md5=0af29177a0462df467382d288161ef8c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1000645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1000645%26sid%3Dliteratum%253Aachs%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DM.%26aulast%3DJeon%26aufirst%3DH.%2BK.%26aulast%3DFenistein%26aufirst%3DD.%26aulast%3DContreras-Dominguez%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DGenovesio%26aufirst%3DA.%26aulast%3DCarralot%26aufirst%3DJ.%2BP.%26aulast%3DEwann%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DE.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DSeo%26aufirst%3DM.%2BJ.%26aulast%3DPark%26aufirst%3DE.%2BJ.%26aulast%3D%25C5%25A0kovierov%25C3%25A1%26aufirst%3DH.%26aulast%3DPham%26aufirst%3DH.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DNam%26aufirst%3DJ.%2BY.%26aulast%3DMarsollier%26aufirst%3DL.%26aulast%3DKempf%26aufirst%3DM.%26aulast%3DJoly-Guillou%26aufirst%3DM.%2BL.%26aulast%3DOh%26aufirst%3DT.%26aulast%3DShin%26aufirst%3DW.%2BK.%26aulast%3DNo%26aufirst%3DZ.%26aulast%3DNehrbass%26aufirst%3DU.%26aulast%3DBrosch%26aufirst%3DR.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DBrodin%26aufirst%3DP.%26atitle%3DHigh%2520Content%2520Screening%2520Identifies%2520Decaprenyl-Phosphoribose%25202%25E2%2580%2599%2520Epimerase%2520as%2520a%2520Target%2520for%2520Intracellular%2520Antimycobacterial%2520Inhibitors%26jtitle%3DPLoS%2520Pathog.%26date%3D2009%26volume%3D5%26doi%3D10.1371%2Fjournal.ppat.1000645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L. T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Structure Activity Relationships Evaluation of Benzothiazinone Derivatives as Potential Anti-tubercular Agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4919</span>– <span class="NLM_lpage">4922</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1016%2Fj.bmcl.2013.06.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=23886691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOitLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4919-4922&author=C.+Gaoauthor=T.+H.+Yeauthor=N.+Y.+Wangauthor=X.+X.+Zengauthor=L.+D.+Zhangauthor=Y.+Xiongauthor=X.+Y.+Youauthor=Y.+Xiaauthor=Y.+Xuauthor=C.+T.+Pengauthor=W.+Q.+Zuoauthor=Y.+Weiauthor=L.+T.+Yu&title=Synthesis+and+Structure+Activity+Relationships+Evaluation+of+Benzothiazinone+Derivatives+as+Potential+Anti-tubercular+Agents&doi=10.1016%2Fj.bmcl.2013.06.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents</span></div><div class="casAuthors">Gao, Chao; Ye, Ting-Hong; Wang, Ning-Yu; Zeng, Xiu-Xiu; Zhang, Li-Dan; Xiong, Ying; You, Xin-Yu; Xia, Yong; Xu, Ying; Peng, Cui-Ting; Zuo, Wei-Qiong; Wei, Yuquan; Yu, Luo-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4919-4922</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-Alkyl and heterocycle substituted 1,3-benzothiazin-4-ones I [R1 = H, Me; R2 = EtNH, PrNH, BuNH, etc.] were synthesized.  The antimycobacterial activities of these compds. were evaluated by detn. of minimal inhibitory concn. (MIC) for Mycobacterium tuberculosis H37Ra and M. tuberculosis H37Rv.  It was found that an extended or branched alkyl chain analog could enhance the potency, and activities of N-alkyl substituted I were not affected by either nitro or trifluoromethyl at 6-position.  Trifluoromethyl plays an important role in maintaining antitubercular activity in the piperazine or piperidine analogs.  Compd. II, which contains an azaspirodithiolane group, showed a MIC of 0.0001 μM against M. tuberculosis H37Rv, 20-fold more potent than BTZ043 racemate.  These results suggested that the vol. and lipophilicity of the substituents were important in maintaining activity.  In addn., compd. II was nontoxic to Vero cells and orally bioavailable in a preliminary pharmacokinetics study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWDReDIBDe1LVg90H21EOLACvtfcHk0lgvK0s8d_GCzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOitLrI&md5=2d5e4cf15479ac9fa7bb12b1da56b2b0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.069%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DT.%2BH.%26aulast%3DWang%26aufirst%3DN.%2BY.%26aulast%3DZeng%26aufirst%3DX.%2BX.%26aulast%3DZhang%26aufirst%3DL.%2BD.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DX.%2BY.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DC.%2BT.%26aulast%3DZuo%26aufirst%3DW.%2BQ.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%2BT.%26atitle%3DSynthesis%2520and%2520Structure%2520Activity%2520Relationships%2520Evaluation%2520of%2520Benzothiazinone%2520Derivatives%2520as%2520Potential%2520Anti-tubercular%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4919%26epage%3D4922%26doi%3D10.1016%2Fj.bmcl.2013.06.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullick, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagalapur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbulakshmi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellows, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachaspati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrapatna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balganesh, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarkar, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandodkar, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span> <span> </span><span class="NLM_article-title">Discovery of Benzothiazoles as Antimycobacterial Agents: Synthesis, Structure–activity Relationships and Binding Studies with Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose 2′-oxidase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7694</span>– <span class="NLM_lpage">7710</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.11.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1016%2Fj.bmc.2015.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=26643218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFerur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=7694-7710&author=S.+Landgeauthor=A.+B.+Mullickauthor=K.+Nagalapurauthor=J.+Neresauthor=V.+Subbulakshmiauthor=K.+Muruganauthor=A.+Ghoshauthor=C.+Sadlerauthor=M.+D.+Fellowsauthor=V.+Humnabadkarauthor=J.+Mahadevaswamyauthor=P.+Vachaspatiauthor=S.+Sharmaauthor=P.+Kaurauthor=M.+Mallyaauthor=S.+Rudrapatnaauthor=D.+Awasthyauthor=V.+K.+Sambandamurthyauthor=F.+Pojerauthor=S.+T.+Coleauthor=T.+S.+Balganeshauthor=B.+G.+Ugarkarauthor=V.+Balasubramanianauthor=B.+S.+Bandodkarauthor=M.+Pandaauthor=V.+Ramachandran&title=Discovery+of+Benzothiazoles+as+Antimycobacterial+Agents%3A+Synthesis%2C+Structure%E2%80%93activity+Relationships+and+Binding+Studies+with+Mycobacterium+tuberculosis+Decaprenylphosphoryl-%CE%B2-d-ribose+2%E2%80%B2-oxidase&doi=10.1016%2Fj.bmc.2015.11.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase</span></div><div class="casAuthors">Landge, Sudhir; Mullick, Amrita B.; Nagalapur, Kavitha; Neres, Joao; Subbulakshmi, Venkita; Murugan, Kannan; Ghosh, Anirban; Sadler, Claire; Fellows, Mick D.; Humnabadkar, Vaishali; Mahadevaswamy, Jyothi; Vachaspati, Prakash; Sharma, Sreevalli; Kaur, Parvinder; Mallya, Meenakshi; Rudrapatna, Suresh; Awasthy, Disha; Sambandamurthy, Vasan K.; Pojer, Florence; Cole, Stewart T.; Balganesh, Tanjore S.; Ugarkar, Bheemarao G.; Balasubramanian, V.; Bandodkar, Balachandra S.; Panda, Manoranjan; Ramachandran, Vasanthi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7694-7710</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the discovery of benzothiazoles, a novel anti-mycobacterial series, identified from a whole cell based screening campaign.  Benzothiazoles exert their bactericidal activity against Mycobacterium tuberculosis (Mtb) through potent inhibition of decaprenylphosphoryl-β-D-ribose 2'-oxidase (DprE1), the key enzyme involved in arabinogalactan synthesis.  Specific target linkage and mode of binding were established using co-crystn. and protein mass spectrometry studies.  Most importantly, the current study provides insights on the utilization of systematic medicinal chem. approaches to mitigate safety liabilities while improving potency during progression from an initial genotoxic hit, the benzothiazole N-oxides (BTOs) to the lead-like AMES neg., crowded benzothiazoles (cBTs).  These findings offer opportunities for development of safe clin. candidates against tuberculosis.  The design strategy adopted could find potential application in discovery of safe drugs in other therapy areas too.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS7rEts75x7bVg90H21EOLACvtfcHk0lgvK0s8d_GCzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFerur3E&md5=cea6212afa6aee18530c45717f98b5c6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DLandge%26aufirst%3DS.%26aulast%3DMullick%26aufirst%3DA.%2BB.%26aulast%3DNagalapur%26aufirst%3DK.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DSubbulakshmi%26aufirst%3DV.%26aulast%3DMurugan%26aufirst%3DK.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DFellows%26aufirst%3DM.%2BD.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DVachaspati%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DMallya%26aufirst%3DM.%26aulast%3DRudrapatna%26aufirst%3DS.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DBalganesh%26aufirst%3DT.%2BS.%26aulast%3DUgarkar%26aufirst%3DB.%2BG.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DBandodkar%26aufirst%3DB.%2BS.%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DRamachandran%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520Benzothiazoles%2520as%2520Antimycobacterial%2520Agents%253A%2520Synthesis%252C%2520Structure%25E2%2580%2593activity%2520Relationships%2520and%2520Binding%2520Studies%2520with%2520Mycobacterium%2520tuberculosis%2520Decaprenylphosphoryl-%25CE%25B2-d-ribose%25202%25E2%2580%25B2-oxidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D7694%26epage%3D7710%26doi%3D10.1016%2Fj.bmc.2015.11.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lechartier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Sar, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raadsen, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryabova, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decosterd, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widmer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buclin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitter, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andries, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Towards a New Combination Therapy for Tuberculosis with Next Generation Benzothiazinones</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1002/emmm.201303575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1002%2Femmm.201303575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=24500695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvVyjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=372-383&author=V.+Makarovauthor=B.+Lechartierauthor=M.+Zhangauthor=J.+Neresauthor=A.+M.+van+der%0ASarauthor=S.+A.+Raadsenauthor=R.+C.+Hartkoornauthor=O.+B.+Ryabovaauthor=A.+Vocatauthor=L.+A.+Decosterdauthor=N.+Widmerauthor=T.+Buclinauthor=W.+Bitterauthor=K.+Andriesauthor=F.+Pojerauthor=P.+J.+Dysonauthor=S.+T.+Cole&title=Towards+a+New+Combination+Therapy+for+Tuberculosis+with+Next+Generation+Benzothiazinones&doi=10.1002%2Femmm.201303575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a new combination therapy for tuberculosis with next generation benzothiazinones</span></div><div class="casAuthors">Makarov, Vadim; Lechartier, Benoit; Zhang, Ming; Neres, Joao; van der Sar, Astrid M.; Raadsen, Susanne A.; Hartkoorn, Ruben C.; Ryabova, Olga B.; Vocat, Anthony; Decosterd, Laurent A.; Widmer, Nicolas; Buclin, Thierry; Bitter, Wilbert; Andries, Koen; Pojer, Florence; Dyson, Paul J.; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">372-383</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The benzothiazinone lead compd., BTZ043, kills Mycobacterium tuberculosis by inhibiting the essential flavo-enzyme DprE1, decaprenylphosphoryl-beta-D-ribose 2-epimerase.  Here, we synthesized a new series of piperazine-contg. benzothiazinones (PBTZ) and show that, like BTZ043, the preclin. candidate PBTZ169 binds covalently to DprE1.  The crystal structure of the DprE1-PBTZ169 complex reveals formation of a semimercaptal adduct with Cys387 in the active site and explains the irreversible inactivation of the enzyme.  Compared to BTZ043, PBTZ169 has improved potency, safety and efficacy in zebrafish and mouse models of tuberculosis (TB).  When combined with other TB drugs, PBTZ169 showed additive activity against M. tuberculosis in vitro except with bedaquiline (BDQ) where synergy was obsd.  A new regimen comprising PBTZ169, BDQ and pyrazinamide was found to be more efficacious than the std. three drug treatment in a murine model of chronic disease.  PBTZ169 is thus an attractive drug candidate to treat TB in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_BD_M46wCiLVg90H21EOLACvtfcHk0lhz672UjnxQ0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvVyjtLw%253D&md5=5393e68ca6f35be17ae10a397b443907</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Femmm.201303575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201303575%26sid%3Dliteratum%253Aachs%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DLechartier%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BSar%26aufirst%3DA.%2BM.%26aulast%3DRaadsen%26aufirst%3DS.%2BA.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DRyabova%26aufirst%3DO.%2BB.%26aulast%3DVocat%26aufirst%3DA.%26aulast%3DDecosterd%26aufirst%3DL.%2BA.%26aulast%3DWidmer%26aufirst%3DN.%26aulast%3DBuclin%26aufirst%3DT.%26aulast%3DBitter%26aufirst%3DW.%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DTowards%2520a%2520New%2520Combination%2520Therapy%2520for%2520Tuberculosis%2520with%2520Next%2520Generation%2520Benzothiazinones%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D372%26epage%3D383%26doi%3D10.1002%2Femmm.201303575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tantry, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjrekar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, L. k.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koushik, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanbhag, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jatheendranath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathula, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrapatna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravishankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorino-Gelo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinesh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghorpade, S. R.</span></span> <span> </span><span class="NLM_article-title">4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5419</span>– <span class="NLM_lpage">5434</span>, <span class="refDoi"> DOI: 10.1021/jm5005978</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5005978" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Wqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5419-5434&author=M.+Naikauthor=V.+Humnabadkarauthor=S.+J.+Tantryauthor=M.+Pandaauthor=A.+Narayanauthor=S.+Gupthaauthor=V.+Pandugaauthor=P.+Manjrekarauthor=L.+k.+Jenaauthor=K.+Koushikauthor=G.+Shanbhagauthor=S.+Jatheendranathauthor=M.+R.+Manjunathaauthor=G.+Goraiauthor=C.+Bathulaauthor=S.+Rudrapatnaauthor=V.+Acharauthor=S.+Sharmaauthor=A.+Ambadyauthor=N.+Hegdeauthor=J.+Mahadevaswamyauthor=P.+Kaurauthor=V.+K.+Sambandamurthyauthor=D.+Awasthyauthor=C.+Narayanauthor=S.+Ravishankarauthor=P.+Madhavapeddiauthor=J.+Reddyauthor=K.+R.+Prabhakarauthor=R.+Saralayaauthor=M.+Chatterjiauthor=J.+Whiteakerauthor=B.+McLaughlinauthor=L.+R.+Chiarelliauthor=G.+Riccardiauthor=M.+R.+Pascaauthor=C.+Bindaauthor=J.+Neresauthor=N.+Dharauthor=F.+Signorino-Geloauthor=J.+D.+McKinneyauthor=V.+Ramachandranauthor=R.+Shandilauthor=R.+Tommasiauthor=P.+S.+Iyerauthor=S.+Narayananauthor=V.+Hosagraharaauthor=S.+Kavanaghauthor=N.+Dineshauthor=S.+R.+Ghorpade&title=4-Aminoquinolone+Piperidine+Amides%3A+Noncovalent+Inhibitors+of+DprE1+with+Long+Residence+Time+and+Potent+Antimycobacterial+Activity&doi=10.1021%2Fjm5005978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity</span></div><div class="casAuthors">Naik, Maruti; Humnabadkar, Vaishali; Tantry, Subramanyam J.; Panda, Manoranjan; Narayan, Ashwini; Guptha, Supreeth; Panduga, Vijender; Manjrekar, Praveena; Jena, Lalit kumar; Koushik, Krishna; Shanbhag, Gajanan; Jatheendranath, Sandesh; Manjunatha, M. R.; Gorai, Gopinath; Bathula, Chandramohan; Rudrapatna, Suresh; Achar, Vijayashree; Sharma, Sreevalli; Ambady, Anisha; Hegde, Naina; Mahadevaswamy, Jyothi; Kaur, Parvinder; Sambandamurthy, Vasan K.; Awasthy, Disha; Narayan, Chandan; Ravishankar, Sudha; Madhavapeddi, Prashanti; Reddy, Jitendar; Prabhakar, K. R.; Saralaya, Ramanatha; Chatterji, Monalisa; Whiteaker, James; McLaughlin, Bob; Chiarelli, Laurent R.; Riccardi, Giovanna; Pasca, Maria Rosalia; Binda, Claudia; Neres, Joao; Dhar, Neeraj; Signorino-Gelo, Francois; McKinney, John D.; Ramachandran, Vasanthi; Shandil, Radha; Tommasi, Ruben; Iyer, Pravin S.; Narayanan, Shridhar; Hosagrahara, Vinayak; Kavanagh, Stefan; Dinesh, Neela; Ghorpade, Sandeep R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5419-5434</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4-Aminoquinolone piperidine amides (AQs) were identified as a novel scaffold starting from a whole cell screen, with potent cidality on Mycobacterium tuberculosis (Mtb).  Evaluation of the min. inhibitory concns., followed by whole genome sequencing of mutants raised against AQs, identified decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1) as the primary target responsible for the antitubercular activity.  Mass spectrometry and enzyme kinetic studies indicated that AQs are noncovalent, reversible inhibitors of DprE1 with slow on rates and long residence times of ∼100 min on the enzyme.  In general, AQs have excellent leadlike properties and good in vitro secondary pharmacol. profile.  Although the scaffold started off as a single active compd. with moderate potency from the whole cell screen, structure-activity relationship optimization of the scaffold led to compds. with potent DprE1 inhibition (IC50 < 10 nM) along with potent cellular activity (MIC = 60 nM) against Mtb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo427Eycvs4I7Vg90H21EOLACvtfcHk0lhZacWHjvqxCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Wqt7g%253D&md5=05e9a7f75679397a124088023762fe20</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm5005978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5005978%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DTantry%26aufirst%3DS.%2BJ.%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DManjrekar%26aufirst%3DP.%26aulast%3DJena%26aufirst%3DL.%2Bk.%26aulast%3DKoushik%26aufirst%3DK.%26aulast%3DShanbhag%26aufirst%3DG.%26aulast%3DJatheendranath%26aufirst%3DS.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DGorai%26aufirst%3DG.%26aulast%3DBathula%26aufirst%3DC.%26aulast%3DRudrapatna%26aufirst%3DS.%26aulast%3DAchar%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DNarayan%26aufirst%3DC.%26aulast%3DRavishankar%26aufirst%3DS.%26aulast%3DMadhavapeddi%26aufirst%3DP.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPrabhakar%26aufirst%3DK.%2BR.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DChatterji%26aufirst%3DM.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DB.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DSignorino-Gelo%26aufirst%3DF.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DKavanagh%26aufirst%3DS.%26aulast%3DDinesh%26aufirst%3DN.%26aulast%3DGhorpade%26aufirst%3DS.%2BR.%26atitle%3D4-Aminoquinolone%2520Piperidine%2520Amides%253A%2520Noncovalent%2520Inhibitors%2520of%2520DprE1%2520with%2520Long%2520Residence%2520Time%2520and%2520Potent%2520Antimycobacterial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5419%26epage%3D5434%26doi%3D10.1021%2Fjm5005978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadupudi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venturelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delorme, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jesus Lopes Ribeiro, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1021/cb5007163</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5007163" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyqt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=705-714&author=J.+Neresauthor=R.+C.+Hartkoornauthor=L.+R.+Chiarelliauthor=R.+Gadupudiauthor=M.+R.+Pascaauthor=G.+Moriauthor=A.+Venturelliauthor=S.+Savinaauthor=V.+Makarovauthor=G.+S.+Kollyauthor=E.+Molteniauthor=C.+Bindaauthor=N.+Dharauthor=S.+Ferrariauthor=P.+Brodinauthor=V.+Delormeauthor=V.+Landryauthor=A.+L.+de+Jesus+Lopes+Ribeiroauthor=D.+Farinaauthor=P.+Saxenaauthor=F.+Pojerauthor=A.+Cartaauthor=R.+Lucianiauthor=A.+Portaauthor=G.+Zanoniauthor=E.+De+Rossiauthor=M.+P.+Costiauthor=G.+Riccardiauthor=S.+T.+Cole&title=2-Carboxyquinoxalines+Kill+Mycobacterium+tuberculosis+through+Noncovalent+Inhibition+of+DprE1&doi=10.1021%2Fcb5007163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1</span></div><div class="casAuthors">Neres, Joao; Hartkoorn, Ruben C.; Chiarelli, Laurent R.; Gadupudi, Ramakrishna; Pasca, Maria Rosalia; Mori, Giorgia; Venturelli, Alberto; Savina, Svetlana; Makarov, Vadim; Kolly, Gaelle S.; Molteni, Elisabetta; Binda, Claudia; Dhar, Neeraj; Ferrari, Stefania; Brodin, Priscille; Delorme, Vincent; Landry, Valerie; de Jesus Lopes Ribeiro, Ana Luisa; Farina, Davide; Saxena, Puneet; Pojer, Florence; Carta, Antonio; Luciani, Rosaria; Porta, Alessio; Zanoni, Giuseppe; De Rossi, Edda; Costi, Maria Paola; Riccardi, Giovanna; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">705-714</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phenotypic screening of a quinoxaline library against replicating Mycobacterium tuberculosis led to the identification of lead compd. Ty38c (3-((4-methoxybenzyl)amino)-6-(trifluoromethyl)quinoxaline-2-carboxylic acid).  With an MIC99 and MBC of 3.1 μM, Ty38c is bactericidal and active against intracellular bacteria.  To investigate its mechanism of action, we isolated mutants resistant to Ty38c and sequenced their genomes.  Mutations were found in rv3405c, coding for the transcriptional repressor of the divergently expressed rv3406 gene.  Biochem. studies clearly showed that Rv3406 decarboxylates Ty38c into its inactive keto metabolite.  The actual target was then identified by isolating Ty38c-resistant mutants of an M. tuberculosis strain lacking rv3406.  Here, mutations were found in dprE1, encoding the decaprenylphosphoryl-D-ribose oxidase DprE1, essential for biogenesis of the mycobacterial cell wall.  Genetics, biochem. validation, and X-ray crystallog. revealed Ty38c to be a noncovalent, noncompetitive DprE1 inhibitor.  Structure-activity relationship studies generated a family of DprE1 inhibitors with a range of IC50's and bactericidal activity.  Co-crystal structures of DprE1 in complex with eight different quinoxaline analogs provided a high-resoln. interaction map of the active site of this extremely vulnerable target in M. tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUParezeusZ7Vg90H21EOLACvtfcHk0lhZacWHjvqxCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyqt7rL&md5=83e64a019613003778c80079e4f8b978</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcb5007163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5007163%26sid%3Dliteratum%253Aachs%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DGadupudi%26aufirst%3DR.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DMori%26aufirst%3DG.%26aulast%3DVenturelli%26aufirst%3DA.%26aulast%3DSavina%26aufirst%3DS.%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DKolly%26aufirst%3DG.%2BS.%26aulast%3DMolteni%26aufirst%3DE.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DDelorme%26aufirst%3DV.%26aulast%3DLandry%26aufirst%3DV.%26aulast%3Dde%2BJesus%2BLopes%2BRibeiro%26aufirst%3DA.%2BL.%26aulast%3DFarina%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DP.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DCarta%26aufirst%3DA.%26aulast%3DLuciani%26aufirst%3DR.%26aulast%3DPorta%26aufirst%3DA.%26aulast%3DZanoni%26aufirst%3DG.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3D2-Carboxyquinoxalines%2520Kill%2520Mycobacterium%2520tuberculosis%2520through%2520Noncovalent%2520Inhibition%2520of%2520DprE1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D705%26epage%3D714%26doi%3D10.1021%2Fcb5007163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagalapur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrapatna, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raichurkar, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4761</span>– <span class="NLM_lpage">4771</span>, <span class="refDoi"> DOI: 10.1021/jm5002937</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5002937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVShtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4761-4771&author=M.+Pandaauthor=S.+Ramachandranauthor=V.+Ramachandranauthor=P.+S.+Shirudeauthor=V.+Humnabadkarauthor=K.+Nagalapurauthor=S.+Sharmaauthor=P.+Kaurauthor=S.+Gupthaauthor=A.+Narayanauthor=J.+Mahadevaswamyauthor=A.+Ambadyauthor=N.+Hegdeauthor=S.+S.+Rudrapatnaauthor=V.+P.+Hosagraharaauthor=V.+K.+Sambandamurthyauthor=A.+Raichurkar&title=Discovery+of+Pyrazolopyridones+as+a+Novel+Class+of+Noncovalent+DprE1+Inhibitor+with+Potent+Anti-Mycobacterial+Activity&doi=10.1021%2Fjm5002937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity</span></div><div class="casAuthors">Panda, Manoranjan; Ramachandran, Sreekanth; Ramachandran, Vasanthi; Shirude, Pravin S.; Humnabadkar, Vaishali; Nagalapur, Kavitha; Sharma, Sreevalli; Kaur, Parvinder; Guptha, Supreeth; Narayan, Ashwini; Mahadevaswamy, Jyothi; Ambady, Anisha; Hegde, Naina; Rudrapatna, Suresh S.; Hosagrahara, Vinayak P.; Sambandamurthy, Vasan K.; Raichurkar, Anandkumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4761-4771</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel pyrazolopyridone class of inhibitors was identified from whole cell screening against Mycobacterium tuberculosis (Mtb).  The series exhibits excellent bactericidality in vitro, resulting in a 4 log redn. in colony forming units following compd. exposure.  The significant modulation of min. inhibitory concn. (MIC) against a Mtb strain overexpressing the Rv3790 gene suggested the target of pyrazolopyridones to be decaprenylphosphoryl-β-D-ribose-2'-epimerase (DprE1).  Genetic mapping of resistance mutation coupled with potent enzyme inhibition activity confirmed the mol. target.  Detailed biochem. characterization revealed the series to be a noncovalent inhibitor of DprE1.  Docking studies at the active site suggest that the series can be further diversified to improve the physicochem. properties without compromising the antimycobacterial activity.  The pyrazolopyridone class of inhibitors offers an attractive non-nitro lead series targeting the essential and vulnerable DprE1 enzyme for the discovery of novel antimycobacterial agents to treat both drug susceptible and drug resistant strains of Mtb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdYV8Pi2ynA7Vg90H21EOLACvtfcHk0lhZacWHjvqxCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVShtrw%253D&md5=dd3c1daf880d2f50d3187a0f9d1ab363</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm5002937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5002937%26sid%3Dliteratum%253Aachs%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DNagalapur%26aufirst%3DK.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DRudrapatna%26aufirst%3DS.%2BS.%26aulast%3DHosagrahara%26aufirst%3DV.%2BP.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DRaichurkar%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520Pyrazolopyridones%2520as%2520a%2520Novel%2520Class%2520of%2520Noncovalent%2520DprE1%2520Inhibitor%2520with%2520Potent%2520Anti-Mycobacterial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4761%26epage%3D4771%26doi%3D10.1021%2Fjm5002937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hameed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathula, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwas, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhury, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solapure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span> <span> </span><span class="NLM_article-title">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9701</span>– <span class="NLM_lpage">9708</span>, <span class="refDoi"> DOI: 10.1021/jm401382v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401382v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9701-9708&author=P.+S.+Shirudeauthor=R.+Shandilauthor=C.+Sadlerauthor=M.+Naikauthor=V.+Hosagraharaauthor=S.+Hameedauthor=V.+Shindeauthor=C.+Bathulaauthor=V.+Humnabadkarauthor=N.+Kumarauthor=J.+Reddyauthor=V.+Pandugaauthor=S.+Sharmaauthor=A.+Ambadyauthor=N.+Hegdeauthor=J.+Whiteakerauthor=R.+E.+McLaughlinauthor=H.+Gardnerauthor=P.+Madhavapeddiauthor=V.+Ramachandranauthor=P.+Kaurauthor=A.+Narayanauthor=S.+Gupthaauthor=D.+Awasthyauthor=C.+Narayanauthor=J.+Mahadevaswamyauthor=K.+G.+Vishwasauthor=V.+Ahujaauthor=A.+Srivastavaauthor=K.+R.+Prabhakarauthor=S.+Bharathauthor=R.+Kaleauthor=M.+Ramaiahauthor=N.+R.+Choudhuryauthor=V.+K.+Sambandamurthyauthor=S.+Solapureauthor=P.+S.+Iyerauthor=S.+Narayananauthor=M.+Chatterji&title=Azaindoles%3A+Noncovalent+DprE1+Inhibitors+from+Scaffold+Morphing+Efforts%2C+Kill+Mycobacterium+tuberculosis+and+Are+Efficacious+in+Vivo&doi=10.1021%2Fjm401382v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo</span></div><div class="casAuthors">Shirude, Pravin S.; Shandil, Radha; Sadler, Claire; Naik, Maruti; Hosagrahara, Vinayak; Hameed, Shahul; Shinde, Vikas; Bathula, Chandramohan; Humnabadkar, Vaishali; Kumar, Naveen; Reddy, Jitendar; Panduga, Vijender; Sharma, Sreevalli; Ambady, Anisha; Hegde, Naina; Whiteaker, James; McLaughlin, Robert E.; Gardner, Humphrey; Madhavapeddi, Prashanti; Ramachandran, Vasanthi; Kaur, Parvinder; Narayan, Ashwini; Guptha, Supreeth; Awasthy, Disha; Narayan, Chandan; Mahadevaswamy, Jyothi; Vishwas, K. G.; Ahuja, Vijaykamal; Srivastava, Abhishek; Prabhakar, K. R.; Bharath, Sowmya; Kale, Ramesh; Ramaiah, Manjunatha; Choudhury, Nilanjana Roy; Sambandamurthy, Vasan K.; Solapure, Suresh; Iyer, Pravin S.; Narayanan, Shridhar; Chatterji, Monalisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9701-9708</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report 1,4-azaindoles as a new inhibitor class that kills Mycobacterium tuberculosis in vitro and demonstrates efficacy in mouse tuberculosis models.  The series emerged from scaffold morphing efforts and was demonstrated to noncovalently inhibit decaprenylphosphoryl-β-d-ribose2'-epimerase (DprE1).  With "drug-like" properties and no expectation of pre-existing resistance in the clinic, this chem. class has the potential to be developed as a therapy for drug-sensitive and drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskQvJK4M2yrVg90H21EOLACvtfcHk0lj_cqw2JXCfzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM&md5=eba42d1952b164f66fd0ca620aaa4f19</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm401382v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401382v%26sid%3Dliteratum%253Aachs%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DHameed%26aufirst%3DS.%26aulast%3DShinde%26aufirst%3DV.%26aulast%3DBathula%26aufirst%3DC.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DMadhavapeddi%26aufirst%3DP.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DNarayan%26aufirst%3DC.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DVishwas%26aufirst%3DK.%2BG.%26aulast%3DAhuja%26aufirst%3DV.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DK.%2BR.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DKale%26aufirst%3DR.%26aulast%3DRamaiah%26aufirst%3DM.%26aulast%3DChoudhury%26aufirst%3DN.%2BR.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DSolapure%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DM.%26atitle%3DAzaindoles%253A%2520Noncovalent%2520DprE1%2520Inhibitors%2520from%2520Scaffold%2520Morphing%2520Efforts%252C%2520Kill%2520Mycobacterium%2520tuberculosis%2520and%2520Are%2520Efficacious%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9701%26epage%3D9708%26doi%3D10.1021%2Fjm401382v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanduri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravishankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mdluli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span> <span> </span><span class="NLM_article-title">Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5728</span>– <span class="NLM_lpage">5737</span>, <span class="refDoi"> DOI: 10.1021/jm500571f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500571f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWhsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5728-5737&author=P.+S.+Shirudeauthor=R.+K.+Shandilauthor=M.+R.+Manjunathaauthor=C.+Sadlerauthor=M.+Pandaauthor=V.+Pandugaauthor=J.+Reddyauthor=R.+Saralayaauthor=R.+Nanduriauthor=A.+Ambadyauthor=S.+Ravishankarauthor=V.+K.+Sambandamurthyauthor=V.+Humnabadkarauthor=L.+K.+Jenaauthor=R.+S.+Sureshauthor=A.+Srivastavaauthor=K.+R.+Prabhakarauthor=J.+Whiteakerauthor=R.+E.+McLaughlinauthor=S.+Sharmaauthor=C.+B.+Cooperauthor=K.+Mdluliauthor=S.+Butlerauthor=P.+S.+Iyerauthor=S.+Narayananauthor=M.+Chatterji&title=Lead+Optimization+of+1%2C4-Azaindoles+as+Antimycobacterial+Agents&doi=10.1021%2Fjm500571f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents</span></div><div class="casAuthors">Shirude, Pravin S.; Shandil, Radha K.; Manjunatha, M. R.; Sadler, Claire; Panda, Manoranjan; Panduga, Vijender; Reddy, Jitendar; Saralaya, Ramanatha; Nanduri, Robert; Ambady, Anisha; Ravishankar, Sudha; Sambandamurthy, Vasan K.; Humnabadkar, Vaishali; Jena, Lalit K.; Suresh, Rudrapatna S.; Srivastava, Abhishek; Prabhakar, K. R.; Whiteaker, James; McLaughlin, Robert E.; Sharma, Sreevalli; Cooper, Christopher B.; Mdluli, Khisi; Butler, Scott; Iyer, Pravin S.; Narayanan, Shridhar; Chatterji, Monalisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5728-5737</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a previous report, we described the discovery of 1,4-azaindoles, a chem. series with excellent in vitro and in vivo antimycobacterial potency through noncovalent inhibition of decaprenylphosphoryl-β-D-ribose-2'-epimerase (DprE1).  Nevertheless, high mouse metabolic turnover and phosphodiesterase 6 (PDE6) off-target activity limited its advancement.  Herein, we report lead optimization of this series, culminating in potent, metabolically stable compds. that have a robust pharmacokinetic profile without any PDE6 liability.  Furthermore, we demonstrate efficacy for 1,4-azaindoles in a rat chronic TB infection model.  We believe that compds. from the 1,4-azaindole series are suitable for in vivo combination and safety studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKixMAsGzDqrVg90H21EOLACvtfcHk0lj_cqw2JXCfzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWhsbY%253D&md5=058a48536ddeb1046e04a29ba68a3a17</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm500571f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500571f%26sid%3Dliteratum%253Aachs%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DShandil%26aufirst%3DR.%2BK.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DNanduri%26aufirst%3DR.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DRavishankar%26aufirst%3DS.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DJena%26aufirst%3DL.%2BK.%26aulast%3DSuresh%26aufirst%3DR.%2BS.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DK.%2BR.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DMdluli%26aufirst%3DK.%26aulast%3DButler%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DM.%26atitle%3DLead%2520Optimization%2520of%25201%252C4-Azaindoles%2520as%2520Antimycobacterial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5728%26epage%3D5737%26doi%3D10.1021%2Fjm500571f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawate, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwase, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wivagg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazyanskaya, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquadro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, D. T.</span></span> <span> </span><span class="NLM_article-title">Identification of Novel Inhibitors of <i>M. tuberculosi</i>s Growth Using Whole Cell Based High-Throughput Screening</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1377</span>– <span class="NLM_lpage">1384</span>, <span class="refDoi"> DOI: 10.1021/cb300151m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300151m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvV2guro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1377-1384&author=S.+A.+Stanleyauthor=S.+S.+Grantauthor=T.+Kawateauthor=N.+Iwaseauthor=M.+Shimizuauthor=C.+Wivaggauthor=M.+Silvisauthor=E.+Kazyanskayaauthor=J.+Aquadroauthor=A.+Golasauthor=M.+Fitzgeraldauthor=H.+Daiauthor=L.+Zhangauthor=D.+T.+Hung&title=Identification+of+Novel+Inhibitors+of+M.+tuberculosis+Growth+Using+Whole+Cell+Based+High-Throughput+Screening&doi=10.1021%2Fcb300151m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening</span></div><div class="casAuthors">Stanley, Sarah A.; Schmidt Grant, Sarah; Kawate, Tomohiko; Iwase, Noriaki; Shimizu, Motohisa; Wivagg, Carl; Silvis, Melanie; Kazyanskaya, Edward; Aquadro, John; Golas, Aaron; Fitzgerald, Michael; Dai, Huanqin; Zhang, Lixin; Hung, Deborah T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1377-1384</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite the urgent need for new antitubercular drugs, few are on the horizon.  To combat the problem of emerging drug resistance, structurally unique chem. entities that inhibit new targets will be required.  Here, we describe our investigations using whole cell screening of a diverse collection of small mols. as a methodol. for identifying novel inhibitors that target new pathways for Mycobacterium tuberculosis drug discovery.  We find that conducting primary screens using model mycobacterial species may limit the potential for identifying new inhibitors with efficacy against M. tuberculosis.  In addn., we confirm the importance of developing in vitro assay conditions that are reflective of in vivo biol. for maximizing the proportion of hits from whole cell screening that are likely to have activity in vivo.  Finally, we describe the identification and characterization of two novel inhibitors that target steps in M. tuberculosis cell wall biosynthesis.  The first is a novel benzimidazole, I, that targets mycobacterial membrane protein large 3 (MmpL3), a proposed transporter for cell wall mycolic acids.  The second is a nitro-triazole, II, that inhibits decaprenylphosphoryl-β-d-ribose 2'-epimerase (DprE1), an epimerase required for cell wall biosynthesis.  These proteins are both among the small no. of new targets that have been identified by forward chem. genetics using resistance generation coupled with genome sequencing.  This suggests that methodologies currently employed for screening and target identification may lead to a bias in target discovery and that alternative methods should be explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPUQqAYK8L3LVg90H21EOLACvtfcHk0ljCxJUC3PimrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvV2guro%253D&md5=7293e2cca5001af5bfcf5e1bb4fb1a70</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcb300151m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300151m%26sid%3Dliteratum%253Aachs%26aulast%3DStanley%26aufirst%3DS.%2BA.%26aulast%3DGrant%26aufirst%3DS.%2BS.%26aulast%3DKawate%26aufirst%3DT.%26aulast%3DIwase%26aufirst%3DN.%26aulast%3DShimizu%26aufirst%3DM.%26aulast%3DWivagg%26aufirst%3DC.%26aulast%3DSilvis%26aufirst%3DM.%26aulast%3DKazyanskaya%26aufirst%3DE.%26aulast%3DAquadro%26aufirst%3DJ.%26aulast%3DGolas%26aufirst%3DA.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHung%26aufirst%3DD.%2BT.%26atitle%3DIdentification%2520of%2520Novel%2520Inhibitors%2520of%2520M.%2520tuberculosis%2520Growth%2520Using%2520Whole%2520Cell%2520Based%2520High-Throughput%2520Screening%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D1377%26epage%3D1384%26doi%3D10.1021%2Fcb300151m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trefzer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mdluli, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikusova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fütterer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span> <span> </span><span class="NLM_article-title">Identification of a Small Molecule with Activity Against Drug-resistant and Persistent Tuberculosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">E2510</span>– <span class="NLM_lpage">E2517</span>, <span class="refDoi"> DOI: 10.1073/pnas.1309171110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1073%2Fpnas.1309171110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=23776209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E2510-E2517&author=F.+Wangauthor=D.+Sambandanauthor=R.+Halderauthor=J.+Wangauthor=S.+M.+Battauthor=B.+Weinrickauthor=I.+Ahmadauthor=P.+Yangauthor=Y.+Zhangauthor=J.+Kimauthor=M.+Hassaniauthor=S.+Huszarauthor=C.+Trefzerauthor=Z.+Maauthor=T.+Kanekoauthor=K.+E.+Mdluliauthor=S.+Franzblauauthor=A.+K.+Chatterjeeauthor=K.+Johnssonauthor=K.+Mikusovaauthor=G.+S.+Besraauthor=K.+F%C3%BCttererauthor=S.+H.+Robbinsauthor=S.+W.+Barnesauthor=J.+R.+Walkerauthor=W.+R.+Jacobsauthor=P.+G.+Schultz&title=Identification+of+a+Small+Molecule+with+Activity+Against+Drug-resistant+and+Persistent+Tuberculosis&doi=10.1073%2Fpnas.1309171110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a small molecule with activity against drug-resistant and persistent tuberculosis</span></div><div class="casAuthors">Wang, Feng; Sambandan, Dhinakaran; Halder, Rajkumar; Wang, Jianing; Batt, Sarah M.; Weinrick, Brian; Ahmad, Insha; Yang, Pengyu; Zhang, Yong; Kim, John; Hassani, Morad; Huszar, Stanislav; Trefzer, Claudia; Ma, Zhenkun; Kaneko, Takushi; Mdluli, Khisi E.; Franzblau, Scott; Chatterjee, Arnab K.; Johnsson, Kai; Mikusova, Katarina; Besra, Gurdyal S.; Fuetterer, Klaus; Robbins, Scott H.; Barnes, S. Whitney; Walker, John R.; Jacobs, William R., Jr.; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">E2510-E2517,SE2510/1-SE2510/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A cell-based phenotypic screen for inhibitors of biofilm formation in mycobacteria identified the small mol. TCA1, which has bactericidal activity against both drug-susceptible and -resistant Mycobacterium tuberculosis (Mtb) and sterilizes Mtb in vitro combined with rifampicin or isoniazid.  In addn., TCA1 has bactericidal activity against nonreplicating Mtb in vitro and is efficacious in acute and chronic Mtb infection mouse models both alone and combined with rifampicin or isoniazid.  Transcriptional anal. revealed that TCA1 down-regulates genes known to be involved in Mtb persistence.  Genetic and affinity-based methods identified decaprenyl-phosphoryl-β-D-ribofuranose oxidoreductase DprE1 and MoeW, enzymes involved in cell wall and molybdenum cofactor biosynthesis, resp., as targets responsible for the activity of TCA1.  These in vitro and in vivo results indicate that this compd. functions by a unique mechanism and suggest that TCA1 may lead to the development of a class of antituberculosis agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokxlddd-EfbbVg90H21EOLACvtfcHk0ljCxJUC3PimrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLnL&md5=caf496e25608bb98e61ab97bd603f2ab</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1309171110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1309171110%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DSambandan%26aufirst%3DD.%26aulast%3DHalder%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBatt%26aufirst%3DS.%2BM.%26aulast%3DWeinrick%26aufirst%3DB.%26aulast%3DAhmad%26aufirst%3DI.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DHuszar%26aufirst%3DS.%26aulast%3DTrefzer%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMdluli%26aufirst%3DK.%2BE.%26aulast%3DFranzblau%26aufirst%3DS.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DJohnsson%26aufirst%3DK.%26aulast%3DMikusova%26aufirst%3DK.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DF%25C3%25BCtterer%26aufirst%3DK.%26aulast%3DRobbins%26aufirst%3DS.%2BH.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DIdentification%2520of%2520a%2520Small%2520Molecule%2520with%2520Activity%2520Against%2520Drug-resistant%2520and%2520Persistent%2520Tuberculosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE2510%26epage%3DE2517%26doi%3D10.1073%2Fpnas.1309171110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chikhale, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barmade, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murumkar, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, M. R.</span></span> <span> </span><span class="NLM_article-title">Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8563</span>– <span class="NLM_lpage">8593</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00281</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00281" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVGjsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8563-8593&author=R.+V.+Chikhaleauthor=M.+A.+Barmadeauthor=P.+R.+Murumkarauthor=M.+R.+Yadav&title=Overview+of+the+Development+of+DprE1+Inhibitors+for+Combating+the+Menace+of+Tuberculosis&doi=10.1021%2Facs.jmedchem.8b00281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis</span></div><div class="casAuthors">Chikhale, Rupesh V.; Barmade, Mahesh A.; Murumkar, Prashant R.; Yadav, Mange Ram</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8563-8593</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1), a vital enzyme for cell wall synthesis, plays a crucial role in the formation of lipoarabinomannan and arabinogalactan.  It was first reported as a druggable target on the basis of inhibitors discovered in high throughput screening of a drug library.  Since then, inhibitors with different types of chem. scaffolds have been reported for their activity against this enzyme.  Formation of a covalent or noncovalent bond by the interacting ligand with the enzyme causes loss of its catalytic activity which ultimately leads to the death of the mycobacterium.  This Perspective describes various DprE1 inhibitors as anti-TB agents reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP3s3ks2Vmg7Vg90H21EOLACvtfcHk0ljCxJUC3PimrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVGjsrzO&md5=b057993247c1c6c208907c474191c1d0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00281%26sid%3Dliteratum%253Aachs%26aulast%3DChikhale%26aufirst%3DR.%2BV.%26aulast%3DBarmade%26aufirst%3DM.%2BA.%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26aulast%3DYadav%26aufirst%3DM.%2BR.%26atitle%3DOverview%2520of%2520the%2520Development%2520of%2520DprE1%2520Inhibitors%2520for%2520Combating%2520the%2520Menace%2520of%2520Tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8563%26epage%3D8593%26doi%3D10.1021%2Facs.jmedchem.8b00281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rogacki, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Roman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argyrou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco-Ruano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vande Velde, C. M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span> <span> </span><span class="NLM_article-title">Identification and Profiling of Hydantoins—A Novel Class of Potent Antimycobacterial DprE1 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11221</span>– <span class="NLM_lpage">11249</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01356</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlylsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11221-11249&author=M.+K.+Rogackiauthor=E.+Pittaauthor=O.+Balabonauthor=S.+Hussauthor=E.+M.+Lopez-Romanauthor=A.+Argyrouauthor=D.+Blanco-Ruanoauthor=M.+Cachoauthor=C.+M.+L.+Vande+Veldeauthor=K.+Augustynsauthor=L.+Ballellauthor=D.+Barrosauthor=R.+H.+Batesauthor=F.+Cunninghamauthor=P.+Van+der+Veken&title=Identification+and+Profiling+of+Hydantoins%E2%80%94A+Novel+Class+of+Potent+Antimycobacterial+DprE1+Inhibitors&doi=10.1021%2Facs.jmedchem.8b01356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors</span></div><div class="casAuthors">Rogacki, Maciej K.; Pitta, Eleni; Balabon, Olga; Huss, Sophie; Lopez-Roman, Eva Maria; Argyrou, Argyrides; Blanco-Ruano, Delia; Cacho, Monica; Vande Velde, Christophe M. L.; Augustyns, Koen; Ballell, Lluis; Barros, David; Bates, Robert H.; Cunningham, Fraser; Van der Veken, Pieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11221-11249</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tuberculosis is the leading cause of death worldwide from infectious diseases.  With the development of drug-resistant strains of Mycobacterium tuberculosis, there is an acute need for new medicines with novel modes of action.  Herein, we report the discovery and profiling of a novel hydantoin-based family of antimycobacterial inhibitors of the decaprenylphospho-β-D-ribofuranose 2-oxidase (DprE1).  In this study, we have prepd. a library of more than a 100 compds. and evaluated them for their biol. and physicochem. properties.  The series is characterized by high enzymic and whole-cell activity, low cytotoxicity, and a good overall physicochem. profile.  In addn., we show that the series acts via reversible inhibition of the DprE1 enzyme.  Overall, the novel compd. family forms an attractive base for progression to further stages of optimization and may provide a promising drug candidate in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMw2Vn8XKan7Vg90H21EOLACvtfcHk0ljyzGVW-TN9Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlylsLzE&md5=647fdfe146a1802016d7e38a8543e522</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01356%26sid%3Dliteratum%253Aachs%26aulast%3DRogacki%26aufirst%3DM.%2BK.%26aulast%3DPitta%26aufirst%3DE.%26aulast%3DBalabon%26aufirst%3DO.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DLopez-Roman%26aufirst%3DE.%2BM.%26aulast%3DArgyrou%26aufirst%3DA.%26aulast%3DBlanco-Ruano%26aufirst%3DD.%26aulast%3DCacho%26aufirst%3DM.%26aulast%3DVande%2BVelde%26aufirst%3DC.%2BM.%2BL.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DCunningham%26aufirst%3DF.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DIdentification%2520and%2520Profiling%2520of%2520Hydantoins%25E2%2580%2594A%2520Novel%2520Class%2520of%2520Potent%2520Antimycobacterial%2520DprE1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11221%26epage%3D11249%26doi%3D10.1021%2Facs.jmedchem.8b01356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelhart, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallach, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnappinger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manikkam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gac, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murgolo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutphin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiner, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Via, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span> <span> </span><span class="NLM_article-title">Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2′-Oxidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9952</span>– <span class="NLM_lpage">9965</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00883</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00883" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvV2rsrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9952-9965&author=S.+Ohauthor=Y.+Parkauthor=C.+A.+Engelhartauthor=J.+B.+Wallachauthor=D.+Schnappingerauthor=K.+Aroraauthor=M.+Manikkamauthor=B.+Gacauthor=H.+Wangauthor=N.+Murgoloauthor=D.+B.+Olsenauthor=M.+Goodwinauthor=M.+Sutphinauthor=D.+M.+Weinerauthor=L.+E.+Viaauthor=H.+I.+M.+Boshoffauthor=C.+E.+Barry&title=Discovery+and+Structure%E2%80%93Activity-Relationship+Study+of+N-Alkyl-5-hydroxypyrimidinone+Carboxamides+as+Novel+Antitubercular+Agents+Targeting+Decaprenylphosphoryl-%CE%B2-d-ribose+2%E2%80%B2-Oxidase&doi=10.1021%2Facs.jmedchem.8b00883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-D-ribose 2'-Oxidase</span></div><div class="casAuthors">Oh, Sangmi; Park, Yumi; Engelhart, Curtis A.; Wallach, Joshua B.; Schnappinger, Dirk; Arora, Kriti; Manikkam, Michelle; Gac, Brian; Wang, Hongwu; Murgolo, Nicholas; Olsen, David B.; Goodwin, Michael; Sutphin, Michelle; Weiner, Danielle M.; Via, Laura E.; Boshoff, Helena I. M.; Barry, Clifton E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9952-9965</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Magnesium plays an important role in infection with Mycobacterium tuberculosis (Mtb) as a signal of the extracellular environment, as a cofactor for many enzymes, and as a structural element in important macromols.  Raltegravir, an antiretroviral drug that inhibits HIV-1 integrase is known to derive its potency from selective sequestration of active-site magnesium ions in addn. to binding to a hydrophobic pocket.  In order to det. if essential Mtb-related phosphoryl transfers could be disrupted in a similar manner, a directed screen of known mols. with integrase inhibitor-like pharmacophores (N-alkyl-5-hydroxypyrimidinone carboxamides) was performed.  Initial hits afforded compds. with low-micromolar potency against Mtb, acceptable cytotoxicity and PK characteristics, and robust SAR.  Elucidation of the target of these compds. revealed that they lacked magnesium dependence and instead disappointingly inhibited a known promiscuous target in Mtb, decaprenylphosphoryl-β-D-ribose 2'-oxidase (DprE1, Rv3790).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOxHRHtAf2rbVg90H21EOLACvtfcHk0ljyzGVW-TN9Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvV2rsrfP&md5=5c8f50d73f857fcde7277ca80109fee9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00883%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DEngelhart%26aufirst%3DC.%2BA.%26aulast%3DWallach%26aufirst%3DJ.%2BB.%26aulast%3DSchnappinger%26aufirst%3DD.%26aulast%3DArora%26aufirst%3DK.%26aulast%3DManikkam%26aufirst%3DM.%26aulast%3DGac%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMurgolo%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DGoodwin%26aufirst%3DM.%26aulast%3DSutphin%26aufirst%3DM.%26aulast%3DWeiner%26aufirst%3DD.%2BM.%26aulast%3DVia%26aufirst%3DL.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DDiscovery%2520and%2520Structure%25E2%2580%2593Activity-Relationship%2520Study%2520of%2520N-Alkyl-5-hydroxypyrimidinone%2520Carboxamides%2520as%2520Novel%2520Antitubercular%2520Agents%2520Targeting%2520Decaprenylphosphoryl-%25CE%25B2-d-ribose%25202%25E2%2580%25B2-Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9952%26epage%3D9965%26doi%3D10.1021%2Facs.jmedchem.8b00883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraski, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krchñák, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colon-Martinez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. J.</span></span> <span> </span><span class="NLM_article-title">Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">3539</span>– <span class="NLM_lpage">3549</span>, <span class="refDoi"> DOI: 10.1021/ja311058q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja311058q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVCrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=3539-3549&author=R.+Tiwariauthor=G.+C.+Moraskiauthor=V.+Krch%C3%B1%C3%A1kauthor=P.+A.+Millerauthor=M.+Colon-Martinezauthor=E.+Herreroauthor=A.+G.+Oliverauthor=M.+J.+Miller&title=Thiolates+Chemically+Induce+Redox+Activation+of+BTZ043+and+Related+Potent+Nitroaromatic+Anti-Tuberculosis+Agents&doi=10.1021%2Fja311058q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents</span></div><div class="casAuthors">Tiwari, Rohit; Moraski, Garrett C.; Krchnak, Viktor; Miller, Patricia A.; Colon-Martinez, Mariangelli; Herrero, Eliza; Oliver, Allen G.; Miller, Marvin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3539-3549</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of multidrug resistant (MDR) and extensively drug resistant (XDR) forms of tuberculosis (TB) has stimulated research efforts globally to expand the new drug pipeline.  Nitroarom. compds., including 1,3-benzothiazin-4-ones (BTZs) and related agents, are a promising new class for the treatment of TB.  Research has shown that the nitroso intermediates of BTZs that are generated in vivo cause suicide inhibition of decaprenylphosphoryl-β-d-ribose 2' oxidase (DprE1), which is responsible for cell wall arabinogalactan biosynthesis.  We have designed and synthesized novel anti-TB agents inspired from BTZs and other nitroarom. compds.  Computational studies indicated that the unsubstituted arom. carbons of BTZ043 and related nitroarom. compds. are the most electron-deficient and might be prone to nucleophilic attack.  Our chem. studies on BTZ043 and the addnl. nitroarom. compds. synthesized by us and others confirmed the postulated reactivity.  The results indicate that nucleophiles such as thiolates, cyanide, and hydride induce nonenzymic redn. of the nitro groups present in these compds. to the corresponding nitroso intermediates by addn. at the unsubstituted electron-deficient arom. carbon present in these compds.  Furthermore, we demonstrate here that these compds. are good candidates for the classical von Richter reaction.  These chem. studies offer an alternate hypothesis for the mechanism of action of nitroarom. anti-TB agents, in that the cysteine thiol(ate) or a hydride source at the active site of DprE1 may trigger the redn. of the nitro groups in a manner similar to the von Richter reaction to the nitroso intermediates, to initiate the inhibition of DprE1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEXS_ZRRGRArVg90H21EOLACvtfcHk0ljyzGVW-TN9Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVCrsbY%253D&md5=e3671cfef9ef47c15087e8299d9db64e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja311058q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja311058q%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DMoraski%26aufirst%3DG.%2BC.%26aulast%3DKrch%25C3%25B1%25C3%25A1k%26aufirst%3DV.%26aulast%3DMiller%26aufirst%3DP.%2BA.%26aulast%3DColon-Martinez%26aufirst%3DM.%26aulast%3DHerrero%26aufirst%3DE.%26aulast%3DOliver%26aufirst%3DA.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DThiolates%2520Chemically%2520Induce%2520Redox%2520Activation%2520of%2520BTZ043%2520and%2520Related%2520Potent%2520Nitroaromatic%2520Anti-Tuberculosis%2520Agents%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D3539%26epage%3D3549%26doi%3D10.1021%2Fja311058q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span> </span><span class="NLM_article-title">A Single Ascending
Dose Study of BTZ043</span>. ClinicalTrials.gov (accessed
Dec. 9, <span class="NLM_year">2019</span><i>)</i>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Single+Ascending%0ADose+Study+of+BTZ043.+ClinicalTrials.gov+%28accessed%0ADec.+9%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Single%2520Ascending%250ADose%2520Study%2520of%2520BTZ043%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lupien, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foo, C. S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blattes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillon, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169)</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">e00840</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1128/AAC.00840-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1128%2FAAC.00840-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=30126954" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=e00840-18&author=A.+Lupienauthor=A.+Vocatauthor=C.+S.-Y.+Fooauthor=E.+Blattesauthor=J.-Y.+Gillonauthor=V.+Makarovauthor=S.+T.+Cole&title=Optimized+Background+Regimen+for+Treatment+of+Active+Tuberculosis+with+the+Next-Generation+Benzothiazinone+Macozinone+%28PBTZ169%29&doi=10.1128%2FAAC.00840-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.00840-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00840-18%26sid%3Dliteratum%253Aachs%26aulast%3DLupien%26aufirst%3DA.%26aulast%3DVocat%26aufirst%3DA.%26aulast%3DFoo%26aufirst%3DC.%2BS.-Y.%26aulast%3DBlattes%26aufirst%3DE.%26aulast%3DGillon%26aufirst%3DJ.-Y.%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DOptimized%2520Background%2520Regimen%2520for%2520Treatment%2520of%2520Active%2520Tuberculosis%2520with%2520the%2520Next-Generation%2520Benzothiazinone%2520Macozinone%2520%2528PBTZ169%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2018%26volume%3D62%26spage%3De00840%26epage%3D18%26doi%3D10.1128%2FAAC.00840-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span> </span><span class="NLM_article-title">A Phase 1 Study
to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371</span>. ClinicalTrials.gov (accessed Dec. 9, <span class="NLM_year">2019</span><i>)</i>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase+1+Study%0Ato+Evaluate+Safety%2C+Tolerability%2C+PK%2C+and+PK+Interactions+of+TBA-7371.+ClinicalTrials.gov+%28accessed+Dec.+9%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Phase%25201%2520Study%250Ato%2520Evaluate%2520Safety%252C%2520Tolerability%252C%2520PK%252C%2520and%2520PK%2520Interactions%2520of%2520TBA-7371%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span> </span><span class="NLM_article-title">A Phase 1/2 Trial
of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis</span>. ClinicalTrials.gov (accessed Dec. 9, <span class="NLM_year">2019</span><i>)</i>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase+1%2F2+Trial%0Aof+Multiple+Oral+Doses+of+OPC-167832+for+Uncomplicated+Pulmonary+Tuberculosis.+ClinicalTrials.gov+%28accessed+Dec.+9%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Phase%25201%252F2%2520Trial%250Aof%2520Multiple%2520Oral%2520Doses%2520of%2520OPC-167832%2520for%2520Uncomplicated%2520Pulmonary%2520Tuberculosis%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Gomez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Ruiz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escribano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Villarejo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Plaza, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebollo-Lopez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuiñan-Blanco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavandera, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo-Benito, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Bustos, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span> <span> </span><span class="NLM_article-title">Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1002%2Fcmdc.201200428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=23307663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls1Omug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=313-321&author=L.+Ballellauthor=R.+H.+Batesauthor=R.+J.+Youngauthor=D.+Alvarez-Gomezauthor=E.+Alvarez-Ruizauthor=V.+Barrosoauthor=D.+Blancoauthor=B.+Crespoauthor=J.+Escribanoauthor=R.+Gonz%C3%A1lezauthor=S.+Lozanoauthor=S.+Hussauthor=A.+Santos-Villarejoauthor=J.+J.+Mart%C3%ADn-Plazaauthor=A.+Mendozaauthor=M.+J.+Rebollo-Lopezauthor=M.+Remui%C3%B1an-Blancoauthor=J.+L.+Lavanderaauthor=E.+P%C3%A9rez-Herranauthor=F.+J.+Gamo-Benitoauthor=J.+F.+Garc%C3%ADa-Bustosauthor=D.+Barrosauthor=J.+P.+Castroauthor=N.+Cammack&title=Fueling+Open-Source+Drug+Discovery%3A+177+Small-Molecule+Leads+against+Tuberculosis&doi=10.1002%2Fcmdc.201200428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis</span></div><div class="casAuthors">Ballell, Lluis; Bates, Robert H.; Young, Rob J.; Alvarez-Gomez, Daniel; Alvarez-Ruiz, Emilio; Barroso, Vanessa; Blanco, Delia; Crespo, Benigno; Escribano, Jaime; Gonzalez, Ruben; Lozano, Sonia; Huss, Sophie; Santos-Villarejo, Angel; Martin-Plaza, Jose Julio; Mendoza, Alfonso; Rebollo-Lopez, Maria Jose; Remuinan-Blanco, Modesto; Lavandera, Jose Luis; Perez-Herran, Esther; Gamo-Benito, Francisco Javier; Garcia-Bustos, Jose Francisco; Barros, David; Castro, Julia P.; Cammack, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">With the aim of fuelling open-source, translational, early-stage drug discovery activities, the results of the recently completed antimycobacterial phenotypic screening campaign against Mycobacterium bovis BCG with hit confirmation in M. tuberculosis H37Rv were made publicly accessible.  A set of 177 potent non-cytotoxic H37Rv hits was identified and will be made available to maximize the potential impact of the compds. toward a chem. genetics/proteomics exercise, while at the same time providing a plethora of potential starting points for new synthetic lead-generation activities.  Two addnl. drug-discovery-relevant datasets are included: (a) a drug-like property anal. reflecting the latest lead-like guidelines and (b) an early lead-generation package of the most promising hits within the clusters identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUJ2sVPWfPALVg90H21EOLACvtfcHk0lgrXXZexLPgSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls1Omug%253D%253D&md5=32c975dbe183849358c701ca697681d3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200428%26sid%3Dliteratum%253Aachs%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DAlvarez-Gomez%26aufirst%3DD.%26aulast%3DAlvarez-Ruiz%26aufirst%3DE.%26aulast%3DBarroso%26aufirst%3DV.%26aulast%3DBlanco%26aufirst%3DD.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DEscribano%26aufirst%3DJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DR.%26aulast%3DLozano%26aufirst%3DS.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DSantos-Villarejo%26aufirst%3DA.%26aulast%3DMart%25C3%25ADn-Plaza%26aufirst%3DJ.%2BJ.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRebollo-Lopez%26aufirst%3DM.%2BJ.%26aulast%3DRemui%25C3%25B1an-Blanco%26aufirst%3DM.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%26aulast%3DP%25C3%25A9rez-Herran%26aufirst%3DE.%26aulast%3DGamo-Benito%26aufirst%3DF.%2BJ.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DCastro%26aufirst%3DJ.%2BP.%26aulast%3DCammack%26aufirst%3DN.%26atitle%3DFueling%2520Open-Source%2520Drug%2520Discovery%253A%2520177%2520Small-Molecule%2520Leads%2520against%2520Tuberculosis%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D313%26epage%3D321%26doi%3D10.1002%2Fcmdc.201200428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacho Izquierdo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro Pichel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela-Glez
Del Peral, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouzon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros Aguirre, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argyrou, A.</span></span> <span> </span><span class="NLM_article-title">Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.5b00065</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlemtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=615-626&author=S.+M.+Battauthor=M.+Cacho+Izquierdoauthor=J.+Castro+Pichelauthor=C.+J.+Stubbsauthor=L.+Vela-Glez%0ADel+Peralauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=N.+Dharauthor=B.+Mouzonauthor=M.+Reesauthor=J.+P.+Hutchinsonauthor=R.+J.+Youngauthor=J.+D.+McKinneyauthor=D.+Barros+Aguirreauthor=L.+Ballellauthor=G.+S.+Besraauthor=A.+Argyrou&title=Whole+Cell+Target+Engagement+Identifies+Novel+Inhibitors+of+Mycobacterium+tuberculosis+Decaprenylphosphoryl-%CE%B2-d-ribose+Oxidase&doi=10.1021%2Facsinfecdis.5b00065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-β-D-ribose Oxidase</span></div><div class="casAuthors">Batt, Sarah M.; Cacho Izquierdo, Monica; Castro Pichel, Julia; Stubbs, Christopher J.; Vela-Glez Del Peral, Laura; Perez-Herran, Esther; Dhar, Neeraj; Mouzon, Bernadette; Rees, Mike; Hutchinson, Jonathan P.; Young, Robert J.; McKinney, John D.; Barros Aguirre, David; Ballell, Lluis; Besra, Gurdyal S.; Argyrou, Argyrides</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">615-626</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have targeted the Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose oxidase (Mt-DprE1) for potential chemotherapeutic intervention of tuberculosis.  A multicopy suppression strategy that overexpressed Mt-DprE1 in M. bovis BCG was used to profile the publically available GlaxoSmithKline antimycobacterial compd. set, and one compd. (GSK710) was identified that showed an 8-fold higher min. inhibitory concn. relative to the control strain.  Analogs of GSK710 show a clear relationship between whole cell potency and in vitro activity using an enzymic assay employing recombinant Mt-DprE1, with binding affinity measured by fluorescence quenching of the flavin cofactor of the enzyme.  M. bovis BCG spontaneous resistant mutants to GSK710 and a closely related analog were isolated and sequencing of ten such mutants revealed a single point mutation at two sites, E221Q or G248S within DprE1, providing further evidence that DprE1 is the main target of these compds.  Finally, time-lapse microscopy expts. showed that exposure of M. tuberculosis to a compd. of this series arrests bacterial growth rapidly followed by a slower cytolysis phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1f7lU5LDERrVg90H21EOLACvtfcHk0lh4H6UsrHYD2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlemtbnE&md5=1e6d6ef29fb37d3e8535328368af2472</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00065%26sid%3Dliteratum%253Aachs%26aulast%3DBatt%26aufirst%3DS.%2BM.%26aulast%3DCacho%2BIzquierdo%26aufirst%3DM.%26aulast%3DCastro%2BPichel%26aufirst%3DJ.%26aulast%3DStubbs%26aufirst%3DC.%2BJ.%26aulast%3DVela-Glez%2BDel%2BPeral%26aufirst%3DL.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DMouzon%26aufirst%3DB.%26aulast%3DRees%26aufirst%3DM.%26aulast%3DHutchinson%26aufirst%3DJ.%2BP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DBarros%2BAguirre%26aufirst%3DD.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DArgyrou%26aufirst%3DA.%26atitle%3DWhole%2520Cell%2520Target%2520Engagement%2520Identifies%2520Novel%2520Inhibitors%2520of%2520Mycobacterium%2520tuberculosis%2520Decaprenylphosphoryl-%25CE%25B2-d-ribose%2520Oxidase%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2015%26volume%3D1%26spage%3D615%26epage%3D626%26doi%3D10.1021%2Facsinfecdis.5b00065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6421</span>– <span class="NLM_lpage">6467</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00180</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6421-6467&issue=15&author=R.+J.+Youngauthor=P.+D.+Leeson&title=Mapping+the+Efficiency+and+Physicochemical+Trajectories+of+Successful+Optimizations&doi=10.1021%2Facs.jmedchem.8b00180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations</span></div><div class="casAuthors">Young, Robert J.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6421-6467</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The practices and tactics employed in successful optimizations are examd., judged from the trajectories of ligand efficiency and property evolution.  A wide range of targets is analyzed, encompassing a variety of hit finding methods (HTS, fragments, encoded library technol.) and types of mols., including those beyond the rule of five.  The wider employment of efficiency metrics and lipophilicity control is evident in contemporary practice and the impact on quality demonstrable.  What is clear is that while targets are different, successful mols. are almost invariably among the most efficient for their target, even at the extremes.  Trajectory mapping, based on principles rather than rules, is useful in assessing quality and progress in optimizations while benchmarking against competitors and assessing property-dependent risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCQtcLKSk7q7Vg90H21EOLACvtfcHk0lh4H6UsrHYD2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmu7Y%253D&md5=f040ef02d161e070bb5021fde1585e66</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DMapping%2520the%2520Efficiency%2520and%2520Physicochemical%2520Trajectories%2520of%2520Successful%2520Optimizations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467%26doi%3D10.1021%2Facs.jmedchem.8b00180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">St.
Jean, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span> <span> </span><span class="NLM_article-title">Mitigating Heterocycle Metabolism in Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6002</span>– <span class="NLM_lpage">6020</span>, <span class="refDoi"> DOI: 10.1021/jm300343m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300343m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6002-6020&author=D.+J.+St.%0AJeanauthor=C.+Fotsch&title=Mitigating+Heterocycle+Metabolism+in+Drug+Discovery&doi=10.1021%2Fjm300343m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Mitigating Heterocycle Metabolism in Drug Discovery</span></div><div class="casAuthors">St. Jean, David J.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6002-6020</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Extensive data from metab. studies have allowed medicinal chemists to develop general principles for reducing compd. metab.  These methods include, but are not limited to, reducing lipophilicity, altering sterics and electronics, introducing a conformational constraint, and altering the stereochem. of their compds.  While no single method is able to solve every metabolic problem, these principles do give medicinal chemists guidance on how to improve the metabolic liabilities of their compds.  If the specific site of metab. is known, medicinal chemists block the site, typically with a fluorine, or replace the metabolically labile group with a bioisostere.  While several authors have reviewed these techniques for reducing metab., there is no review that summarizes different approaches to improving them metabolic stability of heterocycles.  In this review, we summarize examples where changes were made at or near the heterocycle to improve metabolic stability.  By summarizing these examples, we hope to provide a useful guide to medicinal chemists as they attempt to improve the metabolic profile of their own heterocyclic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQjdBBgXtPbVg90H21EOLACvtfcHk0lh4H6UsrHYD2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D&md5=48c262556b8a2cc7dc5539ff91a53a71</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm300343m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300343m%26sid%3Dliteratum%253Aachs%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DMitigating%2520Heterocycle%2520Metabolism%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6002%26epage%3D6020%26doi%3D10.1021%2Fjm300343m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rastogi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labrousse, V. r.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, K. S.</span></span> <span> </span><span class="NLM_article-title">In Vitro Activities of Fourteen Antimicrobial Agents Against Drug Susceptible and Resistant Clinical Isolates of Mycobacterium tuberculosis and Comparative Intracellular Activities Against the Virulent H37Rv Strain in Human Macrophages</span>. <i>Curr. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1007/s002849900095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1007%2Fs002849900095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=8672093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADyaK28Xlt1Grsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1996&pages=167-175&author=N.+Rastogiauthor=V.+r.+Labrousseauthor=K.+S.+Goh&title=In+Vitro+Activities+of+Fourteen+Antimicrobial+Agents+Against+Drug+Susceptible+and+Resistant+Clinical+Isolates+of+Mycobacterium+tuberculosis+and+Comparative+Intracellular+Activities+Against+the+Virulent+H37Rv+Strain+in+Human+Macrophages&doi=10.1007%2Fs002849900095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages</span></div><div class="casAuthors">Rastogi, Nalin; Labrousse, Valerie; Goh, Khye Seng</div><div class="citationInfo"><span class="NLM_cas:title">Current Microbiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-175</span>CODEN:
                <span class="NLM_cas:coden">CUMIDD</span>;
        ISSN:<span class="NLM_cas:issn">0343-8651</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Minimal inhibitory concn. (MICs) of 14 first and second-line antituberculous drugs against drug-susceptible and drug-resistant clin. isolates of Mycobacterium tuberculosis (including the multiple drug-resistant or MDR-TB isolates), as well as the type strain H37Rv, were detd. radiometrically by the Bactec 460-TB methodols.  MICs (μg/mL) of all the fourteen drugs were within an extremely narrow range in the case of susceptible strains; isoniazid (0.02-0.04), rifampin (0.2-0.4), ethambutol and streptomycin (0.5-2.0), ethionamide (0.25-0.5), D-cycloserine (25-75), capreomycin (1-2), kanamycin (2-4), amikacin (0.5-1.0), clofazimine (0.1-0.4), ofloxacin (0.5-1.0), ciprofloxacin (0.25-1.0), and sparfloxacin (0.1-0.4).  The activity of second-line drugs remained unaltered against MDR-TB isolates resistant to routine first-line drugs.  With peak serum level concns. (Cmax), the intracellular killing of the virulent H37Rv strain was studied in detail in cultured human macrophages.  Based on a decreasing order of bactericidal activity, our results showed the following spectrum of intracellular drug action: among the first-line drugs, rifampin > ethionamide = isoniazid > ethambutol > streptomycin > D-cycloserine; among second-line drugs, clofazimine = amikacin > kanamycin = capreomycin; among fluoroquinolones, sparfloxacin > ofloxacin > ciprofloxacin.  On the other hand, contrary to atypical mycobacteria, the macrolide drug clarithromycin was inactive against both extracellular and intracellular M. tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOt6t2bJoeBrVg90H21EOLACvtfcHk0lh2M7n5j7zWXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xlt1Grsr4%253D&md5=41f85ec3fbd24e830fb01f9f535fdbfe</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2Fs002849900095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002849900095%26sid%3Dliteratum%253Aachs%26aulast%3DRastogi%26aufirst%3DN.%26aulast%3DLabrousse%26aufirst%3DV.%2Br.%26aulast%3DGoh%26aufirst%3DK.%2BS.%26atitle%3DIn%2520Vitro%2520Activities%2520of%2520Fourteen%2520Antimicrobial%2520Agents%2520Against%2520Drug%2520Susceptible%2520and%2520Resistant%2520Clinical%2520Isolates%2520of%2520Mycobacterium%2520tuberculosis%2520and%2520Comparative%2520Intracellular%2520Activities%2520Against%2520the%2520Virulent%2520H37Rv%2520Strain%2520in%2520Human%2520Macrophages%26jtitle%3DCurr.%2520Microbiol.%26date%3D1996%26volume%3D33%26spage%3D167%26epage%3D175%26doi%3D10.1007%2Fs002849900095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rullas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltrán, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardona, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cáceres, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Bustos, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span> <span> </span><span class="NLM_article-title">Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against Tuberculosis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2262</span>– <span class="NLM_lpage">2264</span>, <span class="refDoi"> DOI: 10.1128/AAC.01423-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1128%2FAAC.01423-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=20160054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFeltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=2262-2264&author=J.+Rullasauthor=J.+I.+Garc%C3%ADaauthor=M.+Beltr%C3%A1nauthor=P.+J.+Cardonaauthor=N.+C%C3%A1ceresauthor=J.+F.+Garc%C3%ADa-Bustosauthor=I.+Angulo-Barturen&title=Fast+Standardized+Therapeutic-Efficacy+Assay+for+Drug+Discovery+against+Tuberculosis&doi=10.1128%2FAAC.01423-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis</span></div><div class="casAuthors">Rullas, Joaquin; Garcia, Juan Ignacio; Beltran, Manuela; Cardona, Pere-Joan; Caceres, Neus; Garcia-Bustos, Jose Francisco; Angulo-Barturen, Inigo</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2262-2264</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Murine models of Mycobacterium tuberculosis infection are essential tools in drug discovery.  Here we describe a fast standardized 9-day acute assay intended to measure the efficacy of drugs against M. tuberculosis growing in the lungs of immunocompetent mice.  This assay is highly reproducible, allows good throughput, and was validated for drug lead optimization using isoniazid, rifampin, ethambutol, pyrazinamide, linezolid, and moxifloxacin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpajX5TwxQ_E7Vg90H21EOLACvtfcHk0lh2M7n5j7zWXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFeltLo%253D&md5=c923fae175b34eab3778a0e4d8d51878</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FAAC.01423-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01423-09%26sid%3Dliteratum%253Aachs%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DJ.%2BI.%26aulast%3DBeltr%25C3%25A1n%26aufirst%3DM.%26aulast%3DCardona%26aufirst%3DP.%2BJ.%26aulast%3DC%25C3%25A1ceres%26aufirst%3DN.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26atitle%3DFast%2520Standardized%2520Therapeutic-Efficacy%2520Assay%2520for%2520Drug%2520Discovery%2520against%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D2262%26epage%3D2264%26doi%3D10.1128%2FAAC.01423-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pitta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogacki, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Roman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joossens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span> <span> </span><span class="NLM_article-title">Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6709</span>– <span class="NLM_lpage">6728</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00245</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6709-6728&author=E.+Pittaauthor=M.+K.+Rogackiauthor=O.+Balabonauthor=S.+Hussauthor=F.+Cunninghamauthor=E.+M.+Lopez-Romanauthor=J.+Joossensauthor=K.+Augustynsauthor=L.+Ballellauthor=R.+H.+Batesauthor=P.+Van+der+Veken&title=Searching+for+New+Leads+for+Tuberculosis%3A+Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel+2-Quinolin-4-yloxyacetamides&doi=10.1021%2Facs.jmedchem.6b00245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides</span></div><div class="casAuthors">Pitta, Eleni; Rogacki, Maciej K.; Balabon, Olga; Huss, Sophie; Cunningham, Fraser; Lopez-Roman, Eva Maria; Joossens, Jurgen; Augustyns, Koen; Ballell, Lluis; Bates, Robert H.; Van derVeken, Pieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6709-6728</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, a new series of more than 60 quinoline derivs. has been synthesized and evaluated against Mycobacterium tuberculosis (H37Rv).  Apart from the SAR exploration around the initial hits, the optimization process focused on the improvement of the physicochem. properties, cytotoxicity, and metabolic stability of the series.  The best compds. obtained exhibited MIC values in the low micromolar range, excellent intracellular antimycobacterial activity, and an improved physicochem. profile without cytotoxic effects.  Further investigation revealed that the amide bond was the source for the poor blood stability obsd., while some of the compds. exhibited hERG affinity.  Compd. I, which contains a benzoxazole ring instead of the amide group, was found to be a good alternative, with good blood stability and no hERG affinity, providing new opportunities for the series.  Overall, the obtained results suggest that further optimization of soly. and microsomal stability of the series could provide a strong lead for a new anti-TB drug development program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrjBguBpaWgbVg90H21EOLACvtfcHk0lh2M7n5j7zWXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKju7%252FE&md5=8b4cc0d1c032dde93c91811cdbba557b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00245%26sid%3Dliteratum%253Aachs%26aulast%3DPitta%26aufirst%3DE.%26aulast%3DRogacki%26aufirst%3DM.%2BK.%26aulast%3DBalabon%26aufirst%3DO.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DCunningham%26aufirst%3DF.%26aulast%3DLopez-Roman%26aufirst%3DE.%2BM.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DSearching%2520for%2520New%2520Leads%2520for%2520Tuberculosis%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%25202-Quinolin-4-yloxyacetamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6709%26epage%3D6728%26doi%3D10.1021%2Facs.jmedchem.6b00245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Pengxu Wang, Sarah M. Batt, Bin Wang, Lei Fu, Rongfei Qin, Yu Lu, Gang Li, Gurdyal S. Besra, <span class="NLM_string-name hlFld-ContribAuthor">Haihong Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 6241-6261. <a href="https://doi.org/10.1021/acs.jmedchem.1c00263" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00263</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00263%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BThiophene-arylamide%252BDerivatives%252Bas%252BDprE1%252BInhibitors%252Bwith%252BPotent%252BAntimycobacterial%252BActivities%26aulast%3DWang%26aufirst%3DPengxu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D10022021%26date%3D14042021%26volume%3D64%26issue%3D9%26spage%3D6241%26epage%3D6261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeelan Basha  N</span>, <span class="hlFld-ContribAuthor ">Naganna M.  Goudgaon</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review on pyrimidine analogs-versatile scaffold with medicinal and biological potential. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1246 </em>, 131168. <a href="https://doi.org/10.1016/j.molstruc.2021.131168" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.131168</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.131168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.131168%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DA%252Bcomprehensive%252Breview%252Bon%252Bpyrimidine%252Banalogs-versatile%252Bscaffold%252Bwith%252Bmedicinal%252Band%252Bbiological%252Bpotential%26aulast%3DN%26aufirst%3DJeelan%2BBasha%26date%3D2021%26volume%3D1246%26spage%3D131168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth  Fullam</span>, <span class="hlFld-ContribAuthor ">Robert J.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">Physicochemical properties and
              Mycobacterium tuberculosis
              transporters: keys to efficacious antitubercular drugs?. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 43-56. <a href="https://doi.org/10.1039/D0MD00265H" title="DOI URL">https://doi.org/10.1039/D0MD00265H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00265H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00265H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPhysicochemical%252Bproperties%252Band%252BMycobacterium%252Btuberculosis%252Btransporters%25253A%252Bkeys%252Bto%252Befficacious%252Bantitubercular%252Bdrugs%25253F%26aulast%3DFullam%26aufirst%3DElizabeth%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1%26spage%3D43%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catherine  Vilchèze</span>. </span><span class="cited-content_cbyCitation_article-title">Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs. </span><span class="cited-content_cbyCitation_journal-name">Applied Sciences</span><span> <strong>2020,</strong> <em>10 </em>
                                    (7)
                                     , 2278. <a href="https://doi.org/10.3390/app10072278" title="DOI URL">https://doi.org/10.3390/app10072278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/app10072278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fapp10072278%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Sciences%26atitle%3DMycobacterial%252BCell%252BWall%25253A%252BA%252BSource%252Bof%252BSuccessful%252BTargets%252Bfor%252BOld%252Band%252BNew%252BDrugs%26aulast%3DVilch%25C3%25A8ze%26aufirst%3DCatherine%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D7%26spage%3D2278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01561&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected published DprE1 inhibitors.<a onclick="showRef(event, 'ref4 ref9 ref23 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref4 ref9 ref23 ref27 ref28">(4,9,23,27,28)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01561&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of phenotypic screening hit <b>1</b> and analogues identified by substructure and similarity searching.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01561&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds Containing Replacements for Left Hand Side Piperidine<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01561&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Substituted piperidine (1.2 equiv), COMU (2 equiv), <i>N</i>,<i>N</i>-diisopropylethylamine (3 equiv), <i>N</i>,<i>N</i>-dimethylformamide, room temperature, 2–20 h; (b) hydrochloric acid (4 M in dioxane) (5 equiv), room temperature, 0.5–17 h, 91–100% over twp steps; (c) <i>N</i>,<i>N</i>-diisopropylethylamine (2 equiv), ethanol, microwave, 150 °C, 5 min; (d) amine (5 equiv), <i>N</i>,<i>N</i>-diisopropylethylamine (2 equiv), ethanol, microwave, 150 °C, 1 h, 19–43% over two steps.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/medium/jm9b01561_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0003.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Results from in vivo efficacy experiment for compounds <b>39</b> and <b>47</b>. (a) Calculated ED<sub>99</sub> values; dose response curves for (b) compound <b>39</b> and (c) compound <b>47</b>. CFU number in lungs of untreated mice: 5.8 logCFU.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01561/20200306/images/large/jm9b01561_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01561&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i109">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60523" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60523" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span> <i>WHO Global Tuberculosis Report
2018</i>, <a href="http://www.who.int/tb/publications/global_report/en/" class="extLink">http://www.who.int/tb/publications/global_report/en/</a> (accessed Nov 14, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+WHO+Global+Tuberculosis+Report%0A2018%2C+http%3A%2F%2Fwww.who.int%2Ftb%2Fpublications%2Fglobal_report%2Fen%2F+%28accessed+Nov+14%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DWHO%2520Global%2520Tuberculosis%2520Report%250A2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zumla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raviglione, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fordham von Reyn, C.</span></span> <span> </span><span class="NLM_article-title">Tuberculosis</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1056/NEJMra1200894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1056%2FNEJMra1200894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=23425167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFCntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=745-755&author=A.+Zumlaauthor=M.+Raviglioneauthor=R.+Hafnerauthor=C.+Fordham+von+Reyn&title=Tuberculosis&doi=10.1056%2FNEJMra1200894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculosis</span></div><div class="casAuthors">Zumla, Alimuddin; Raviglione, Mario; Hafner, Richard; von Reyn, Fordham</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">745-755</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozFC-N3T921LVg90H21EOLACvtfcHk0lhaIyEY6BHFVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFCntLY%253D&md5=97dccc7f98e02f4aac1f33c8209823e0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1200894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1200894%26sid%3Dliteratum%253Aachs%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DRaviglione%26aufirst%3DM.%26aulast%3DHafner%26aufirst%3DR.%26aulast%3DFordham%2Bvon%2BReyn%26aufirst%3DC.%26atitle%3DTuberculosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D368%26spage%3D745%26epage%3D755%26doi%3D10.1056%2FNEJMra1200894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zumla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakaya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mwaba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyirenda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mfinanga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelscher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeurer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliori, G. B.</span></span> <span> </span><span class="NLM_article-title">Tuberculosis Treatment and Management—an Update on Treatment Regimens, Trials, New Drugs, and Adjunct Therapies</span>. <i>Lancet Respir. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/S2213-2600(15)00063-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1016%2FS2213-2600%2815%2900063-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=25773212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A280%3ADC%252BC2MnktlWkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=220-234&author=A.+Zumlaauthor=J.+Chakayaauthor=R.+Centisauthor=L.+D%E2%80%99Ambrosioauthor=P.+Mwabaauthor=M.+Batesauthor=N.+Kapataauthor=T.+Nyirendaauthor=D.+Chandaauthor=S.+Mfinangaauthor=M.+Hoelscherauthor=M.+Maeurerauthor=G.+B.+Migliori&title=Tuberculosis+Treatment+and+Management%E2%80%94an+Update+on+Treatment+Regimens%2C+Trials%2C+New+Drugs%2C+and+Adjunct+Therapies&doi=10.1016%2FS2213-2600%2815%2900063-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies</span></div><div class="casAuthors">Zumla Alimuddin; Chakaya Jeremiah; Centis Rosella; D'Ambrosio Lia; Migliori Giovanni Battista; Mwaba Peter; Bates Matthew; Chanda Duncan; Kapata Nathan; Nyirenda Thomas; Mfinanga Sayoki; Hoelscher Michael; Maeurer Markus</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Respiratory medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">220-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">WHO estimates that 9 million people developed active tuberculosis in 2013 and 1·5 million people died from it.  Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis continue to spread worldwide with an estimated 480,000 new cases in 2013.  Treatment success rates of MDR and XDR tuberculosis are still low and development of new, more effective tuberculosis drugs and adjunct therapies to improve treatment outcomes are urgently needed.  Although standard therapy for drug-sensitive tuberculosis is highly effective, shorter, more effective treatment regimens are needed to reduce the burden of infectious cases.  We review the latest WHO guidelines and global recommendations for treatment and management of drug-sensitive and drug-resistant tuberculosis, and provide an update on new drug development, results of several phase 2 and phase 3 tuberculosis treatment trials, and other emerging adjunct therapeutic options for MDR and XDR tuberculosis.  The use of fluoroquinolone-containing (moxifloxacin and gatifloxacin) regimens have failed to shorten duration of therapy, and the new tuberculosis drug pipeline is sparse.  Scale-up of existing interventions with increased investments into tuberculosis health services, development of new antituberculosis drugs, adjunct therapies and vaccines, coupled with visionary political leadership, are still our best chance to change the unacceptable status quo of the tuberculosis situation worldwide and the growing problem of drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYne8pMAo195QHPYJuLg8TfW6udTcc2eYwb34jIQSqpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnktlWkug%253D%253D&md5=d96f8f052699089701997ec722e30e48</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS2213-2600%2815%2900063-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2213-2600%252815%252900063-6%26sid%3Dliteratum%253Aachs%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DChakaya%26aufirst%3DJ.%26aulast%3DCentis%26aufirst%3DR.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DL.%26aulast%3DMwaba%26aufirst%3DP.%26aulast%3DBates%26aufirst%3DM.%26aulast%3DKapata%26aufirst%3DN.%26aulast%3DNyirenda%26aufirst%3DT.%26aulast%3DChanda%26aufirst%3DD.%26aulast%3DMfinanga%26aufirst%3DS.%26aulast%3DHoelscher%26aufirst%3DM.%26aulast%3DMaeurer%26aufirst%3DM.%26aulast%3DMigliori%26aufirst%3DG.%2BB.%26atitle%3DTuberculosis%2520Treatment%2520and%2520Management%25E2%2580%2594an%2520Update%2520on%2520Treatment%2520Regimens%252C%2520Trials%252C%2520New%2520Drugs%252C%2520and%2520Adjunct%2520Therapies%26jtitle%3DLancet%2520Respir.%2520Med.%26date%3D2015%26volume%3D3%26spage%3D220%26epage%3D234%26doi%3D10.1016%2FS2213-2600%2815%2900063-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikusova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möllmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryabova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Joanis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucarelli, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dianiskova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordulakova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullam, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrethsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenkrands, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaonkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balganesh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosset, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Benzothiazinones Kill <i>Mycobacterium tuberculosis</i> by Blocking Arabinan Synthesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1126/science.1171583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1126%2Fscience.1171583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=19299584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVeksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=801-804&author=V.+Makarovauthor=G.+Maninaauthor=K.+Mikusovaauthor=U.+M%C3%B6llmannauthor=O.+Ryabovaauthor=B.+Saint-Joanisauthor=N.+Dharauthor=M.+R.+Pascaauthor=S.+Buroniauthor=A.+P.+Lucarelliauthor=A.+Milanoauthor=E.+De+Rossiauthor=M.+Belanovaauthor=A.+Bobovskaauthor=P.+Dianiskovaauthor=J.+Kordulakovaauthor=C.+Salaauthor=E.+Fullamauthor=P.+Schneiderauthor=J.+D.+McKinneyauthor=P.+Brodinauthor=T.+Christopheauthor=S.+Waddellauthor=P.+Butcherauthor=J.+Albrethsenauthor=I.+Rosenkrandsauthor=R.+Broschauthor=V.+Nandiauthor=S.+Bharathauthor=S.+Gaonkarauthor=R.+K.+Shandilauthor=V.+Balasubramanianauthor=T.+Balganeshauthor=S.+Tyagiauthor=J.+Grossetauthor=G.+Riccardiauthor=S.+T.+Cole&title=Benzothiazinones+Kill+Mycobacterium+tuberculosis+by+Blocking+Arabinan+Synthesis&doi=10.1126%2Fscience.1171583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis</span></div><div class="casAuthors">Makarov, Vadim; Manina, Giulia; Mikusova, Katarina; Moellmann, Ute; Ryabova, Olga; Saint-Joanis, Brigitte; Dhar, Neeraj; Pasca, Maria Rosalia; Buroni, Silvia; Lucarelli, Anna Paola; Milano, Anna; De Rossi, Edda; Belanova, Martina; Bobovska, Adela; Dianiskova, Petronela; Kordulakova, Jana; Sala, Claudia; Fullam, Elizabeth; Schneider, Patricia; McKinney, John D.; Brodin, Priscille; Christophe, Thierry; Waddell, Simon; Butcher, Philip; Albrethsen, Jakob; Rosenkrands, Ida; Brosch, Roland; Nandi, Vrinda; Bharath, Sowmya; Gaonkar, Sheshagiri; Shandil, Radha K.; Balasubramanian, Venkataraman; Balganesh, Tanjore; Tyagi, Sandeep; Grosset, Jacques; Riccardi, Giovanna; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5928</span>),
    <span class="NLM_cas:pages">801-804</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">New drugs are required to counter the tuberculosis (TB) pandemic.  Here, we describe the synthesis and characterization of 1,3-benzothiazin-4-ones (BTZs), a new class of antimycobacterial agents that kill Mycobacterium tuberculosis in vitro, ex vivo, and in mouse models of TB.  Using genetics and biochem., we identified the enzyme decaprenylphosphoryl-β-D-ribose 2'-epimerase as a major BTZ target.  Inhibition of this enzymic activity abolishes the formation of decaprenylphosphoryl arabinose, a key precursor that is required for the synthesis of the cell-wall arabinans, thus provoking cell lysis and bacterial death.  The most advanced compd., BTZ043, is a candidate for inclusion in combination therapies for both drug-sensitive and extensively drug-resistant TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZiVvk0T_DOrVg90H21EOLACvtfcHk0lj8Nh9mdNAdww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVeksrY%253D&md5=1d80f14ba88460ef5c8ea31793dbb592</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1171583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1171583%26sid%3Dliteratum%253Aachs%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DManina%26aufirst%3DG.%26aulast%3DMikusova%26aufirst%3DK.%26aulast%3DM%25C3%25B6llmann%26aufirst%3DU.%26aulast%3DRyabova%26aufirst%3DO.%26aulast%3DSaint-Joanis%26aufirst%3DB.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DLucarelli%26aufirst%3DA.%2BP.%26aulast%3DMilano%26aufirst%3DA.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DBelanova%26aufirst%3DM.%26aulast%3DBobovska%26aufirst%3DA.%26aulast%3DDianiskova%26aufirst%3DP.%26aulast%3DKordulakova%26aufirst%3DJ.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DFullam%26aufirst%3DE.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DWaddell%26aufirst%3DS.%26aulast%3DButcher%26aufirst%3DP.%26aulast%3DAlbrethsen%26aufirst%3DJ.%26aulast%3DRosenkrands%26aufirst%3DI.%26aulast%3DBrosch%26aufirst%3DR.%26aulast%3DNandi%26aufirst%3DV.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DGaonkar%26aufirst%3DS.%26aulast%3DShandil%26aufirst%3DR.%2BK.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DBalganesh%26aufirst%3DT.%26aulast%3DTyagi%26aufirst%3DS.%26aulast%3DGrosset%26aufirst%3DJ.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DBenzothiazinones%2520Kill%2520Mycobacterium%2520tuberculosis%2520by%2520Blocking%2520Arabinan%2520Synthesis%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D801%26epage%3D804%26doi%3D10.1126%2Fscience.1171583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Crellin, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brammananth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppel, R. L.</span></span> <span> </span><span class="NLM_article-title">Decaprenylphosphoryl-β-D-Ribose 2’-Epimerase, the Target of Benzothiazinones and Dinitrobenzamides, Is an Essential Enzyme in Mycobacterium smegmatis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e16869</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0016869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1371%2Fjournal.pone.0016869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=21346818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlOqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=P.+K.+Crellinauthor=R.+Brammananthauthor=R.+L.+Coppel&title=Decaprenylphosphoryl-%CE%B2-D-Ribose+2%E2%80%99-Epimerase%2C+the+Target+of+Benzothiazinones+and+Dinitrobenzamides%2C+Is+an+Essential+Enzyme+in+Mycobacterium+smegmatis&doi=10.1371%2Fjournal.pone.0016869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Decaprenylphosphoryl-β-D-ribose 2'-epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in Mycobacterium smegmatis</span></div><div class="casAuthors">Crellin, Paul K.; Brammananth, Rajini; Coppel, Ross L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e16869</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: The unique cell wall of bacteria of the suborder Corynebacterineae is essential for the growth and survival of significant human pathogens including Mycobacterium tuberculosis and Mycobacterium leprae.  Drug resistance in mycobacteria is an increasingly common development, making identification of new antimicrobials a priority.  Recent studies have revealed potent anti-mycobacterial compds., the benzothiazinones and dinitrobenzamides, active against DprE1, a subunit of decaprenylphosphoribose 2' epimerase which forms decaprenylphosphoryl arabinose, the arabinose donor for mycobacterial cell wall biosynthesis.  Despite the exploitation of Mycobacterium smegmatis in the identification of DprE1 as the target of these new antimicrobials and its use in the exploration of mechanisms of resistance, the essentiality of DprE1 in this species has never been examd.  Indeed, direct exptl. evidence of the essentiality of DprE1 has not been obtained in any species of mycobacterium.  Methodol./Principal Findings: In this study we constructed a conditional gene knockout strain targeting the ortholog of dprE1 in M. smegmatis, MSMEG_6382.  Disruption of the chromosomal copy of MSMEG_6382 was only possible in the presence of a plasmid-encoded copy of MSMEG_6382.  Curing of this "rescue" plasmid from the bacterial population resulted in a cessation of growth, demonstrating gene essentiality.  Conclusions/Significance: This study provides the first direct exptl. evidence for the essentiality of DprE1 in mycobacteria.  The essentiality of DprE1 in M. smegmatis, combined with its conservation in all sequenced mycobacterial genomes, suggests that decaprenylphosphoryl arabinose synthesis is essential in all mycobacteria.  Our findings indicate a lack of redundancy in decaprenylphosphoryl arabinose synthesis in M. smegmatis, despite the relatively large coding capacity of this species, and suggest that no alternative arabinose donors for cell wall biosynthesis exist.  Overall, this study further validates DprE1 as a promising target for new anti-mycobacterial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5G6QmgUM6bLVg90H21EOLACvtfcHk0lj8Nh9mdNAdww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlOqsbk%253D&md5=855e13cfb136098ff27265b10188bcd5</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0016869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0016869%26sid%3Dliteratum%253Aachs%26aulast%3DCrellin%26aufirst%3DP.%2BK.%26aulast%3DBrammananth%26aufirst%3DR.%26aulast%3DCoppel%26aufirst%3DR.%2BL.%26atitle%3DDecaprenylphosphoryl-%25CE%25B2-D-Ribose%25202%25E2%2580%2599-Epimerase%252C%2520the%2520Target%2520of%2520Benzothiazinones%2520and%2520Dinitrobenzamides%252C%2520Is%2520an%2520Essential%2520Enzyme%2520in%2520Mycobacterium%2520smegmatis%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0016869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jankute, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grover, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span> <span> </span><span class="NLM_article-title">Arabinogalactan and Lipoarabinomannan Biosynthesis: Structure, Biogenesis and their Potential as Drug Targets</span>. <i>Future Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.2217/fmb.11.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.2217%2Ffmb.11.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=22191451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Krsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=129-147&author=M.+Jankuteauthor=S.+Groverauthor=A.+K.+Ranaauthor=G.+S.+Besra&title=Arabinogalactan+and+Lipoarabinomannan+Biosynthesis%3A+Structure%2C+Biogenesis+and+their+Potential+as+Drug+Targets&doi=10.2217%2Ffmb.11.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Arabinogalactan and lipoarabinomannan biosynthesis: structure, biogenesis and their potential as drug targets</span></div><div class="casAuthors">Jankute, Monika; Grover, Shipra; Rana, Amrita K.; Besra, Gurdyal S.</div><div class="citationInfo"><span class="NLM_cas:title">Future Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-147</span>CODEN:
                <span class="NLM_cas:coden">FMUIAR</span>;
        ISSN:<span class="NLM_cas:issn">1746-0913</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Mycobacterium tuberculosis, the etiol. agent of TB, remains the leading cause of mortality from a single infectious organism.  The persistence of this human pathogen is assocd. with its distinctive lipid-rich cell wall structure that is highly impermeable to hydrophilic chem. drugs.  This highly complex and unique structure is crucial for the growth, viability and virulence of M. tuberculosis, thus representing an attractive target for vaccine and drug development.  It contains a large macromol. structure known as the mycolyl-arabinogalactan-peptidoglycan complex, as well as phosphatidyl-myo-inositol derived glycolipids with potent immunomodulatory activity, notably lipomannan and lipoarabinomannan.  These cell wall components are often the targets of effective chemotherapeutic agents against TB, such as ethambutol.  This review focuses on the structural details and biosynthetic pathways of both arabinogalactan and lipoarabinomannan, as well as the effects of potent drugs on these important (lipo)polysaccharides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1TB_NT8hva7Vg90H21EOLACvtfcHk0ljSStdhXPiZuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Krsr3J&md5=f4d1b91b46f65481d3dc992e699ec05c</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.2217%2Ffmb.11.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffmb.11.123%26sid%3Dliteratum%253Aachs%26aulast%3DJankute%26aufirst%3DM.%26aulast%3DGrover%26aufirst%3DS.%26aulast%3DRana%26aufirst%3DA.%2BK.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26atitle%3DArabinogalactan%2520and%2520Lipoarabinomannan%2520Biosynthesis%253A%2520Structure%252C%2520Biogenesis%2520and%2520their%2520Potential%2520as%2520Drug%2520Targets%26jtitle%3DFuture%2520Microbiol.%26date%3D2012%26volume%3D7%26spage%3D129%26epage%3D147%26doi%3D10.2217%2Ffmb.11.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faray-Kele, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, T.</span></span> <span> </span><span class="NLM_article-title">Identifying Vulnerable Pathways in <i>Mycobacterium tuberculosis</i> by Using a Knockdown Approach</span>. <i>Appl. Environ. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">5040</span>– <span class="NLM_lpage">5043</span>, <span class="refDoi"> DOI: 10.1128/AEM.02880-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1128%2FAEM.02880-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=21642404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWlsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=5040-5043&author=P.+Carrollauthor=M.+C.+Faray-Keleauthor=T.+Parish&title=Identifying+Vulnerable+Pathways+in+Mycobacterium+tuberculosis+by+Using+a+Knockdown+Approach&doi=10.1128%2FAEM.02880-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying vulnerable pathways in Mycobacterium tuberculosis by using a knockdown approach</span></div><div class="casAuthors">Carroll, Paul; Faray-Kele, Marie-Claire; Parish, Tanya</div><div class="citationInfo"><span class="NLM_cas:title">Applied and Environmental Microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5040-5043</span>CODEN:
                <span class="NLM_cas:coden">AEMIDF</span>;
        ISSN:<span class="NLM_cas:issn">0099-2240</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We constructed recombinant strains of Mycobacterium tuberculosis in which expression of specific genes was downregulated to identify vulnerable drug targets.  Growth phenotypes in macrophages and culture were used to rank targets: the dprE1, clpP1, and fadD32 operons were the best targets and glnA1, glnE, pknL, regX3, and senX3 were poor targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqaQyMyeiB27Vg90H21EOLACvtfcHk0ljSStdhXPiZuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWlsbjF&md5=d7c137d893dc8eb7b8b6c38a909fd16a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1128%2FAEM.02880-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAEM.02880-10%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DP.%26aulast%3DFaray-Kele%26aufirst%3DM.%2BC.%26aulast%3DParish%26aufirst%3DT.%26atitle%3DIdentifying%2520Vulnerable%2520Pathways%2520in%2520Mycobacterium%2520tuberculosis%2520by%2520Using%2520a%2520Knockdown%2520Approach%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D2011%26volume%3D77%26spage%3D5040%26epage%3D5043%26doi%3D10.1128%2FAEM.02880-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boldrin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Assessing the Essentiality of the Decaprenyl-phospho-d-arabinofuranose Pathway in <i>Mycobacterium tuberculosis</i> Using Conditional Mutants</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1111/mmi.12546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1111%2Fmmi.12546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=24517327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltVSgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2014&pages=194-211&author=G.+S.+Kollyauthor=F.+Boldrinauthor=C.+Salaauthor=N.+Dharauthor=R.+C.+Hartkoornauthor=M.+Venturaauthor=A.+Serafiniauthor=J.+D.+McKinneyauthor=R.+Manganelliauthor=S.+T.+Cole&title=Assessing+the+Essentiality+of+the+Decaprenyl-phospho-d-arabinofuranose+Pathway+in+Mycobacterium+tuberculosis+Using+Conditional+Mutants&doi=10.1111%2Fmmi.12546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the essentiality of the decaprenyl-phospho-D-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants</span></div><div class="casAuthors">Kolly, Gaelle S.; Boldrin, Francesca; Sala, Claudia; Dhar, Neeraj; Hartkoorn, Ruben C.; Ventura, Marcello; Serafini, Agnese; McKinney, John D.; Manganelli, Riccardo; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">194-211</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In Mycobacterium tuberculosis the decaprenyl-phospho-D-arabinofuranose (DPA) pathway is a validated target for the drugs ethambutol and benzothiazinones.  To identify other potential drug targets in the pathway, we generated conditional knock-down mutants of each gene involved using the TET-PIP OFF system.  DprE1, dprE2, ubiA, prsA, rv2361c, tkt and rpiB were confirmed to be essential under non-permissive conditions, whereas rv3807c was not required for survival.  In the most vulnerable group, DprE1-depleted cells died faster in vitro and intracellularly than those lacking UbiA and PrsA.  Downregulation of DprE1 and UbiA resulted in similar phenotypes, namely swelling of the bacteria, cell wall damage and lysis as obsd. at the single cell level, by real time microscopy and electron microscopy.  By contrast, depletion of PrsA led to cell elongation and implosion, which was suggestive of a more pleiotropic effect.  Drug sensitivity assays with known DPA-inhibitors supported the use of conditional knock-down strains for target-based whole-cell screens.  Together, our work provides strong evidence for the vulnerability of all but one of the enzymes in the DPA pathway and generates valuable tools for the identification of lead compds. targeting the different biosynthetic steps.  PrsA, phosphoribosyl-pyrophosphate synthetase, appears to be a particularly attractive new target for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvma-CyKwwdbVg90H21EOLACvtfcHk0ljSStdhXPiZuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltVSgtbw%253D&md5=ff61bee837cadb44e8688ebd907b927d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fmmi.12546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fmmi.12546%26sid%3Dliteratum%253Aachs%26aulast%3DKolly%26aufirst%3DG.%2BS.%26aulast%3DBoldrin%26aufirst%3DF.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DVentura%26aufirst%3DM.%26aulast%3DSerafini%26aufirst%3DA.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DManganelli%26aufirst%3DR.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DAssessing%2520the%2520Essentiality%2520of%2520the%2520Decaprenyl-phospho-d-arabinofuranose%2520Pathway%2520in%2520Mycobacterium%2520tuberculosis%2520Using%2520Conditional%2520Mutants%26jtitle%3DMol.%2520Microbiol.%26date%3D2014%26volume%3D92%26spage%3D194%26epage%3D211%26doi%3D10.1111%2Fmmi.12546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buroni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span> <span> </span><span class="NLM_article-title">Decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-Ribose 2′-Epimerase from <i>Mycobacterium tuberculosis</i> is a Magic Drug Target</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.2174/092986710791959693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.2174%2F092986710791959693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=20629622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtF2rtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=3099-3108&author=G.+Maninaauthor=R.+Pascaauthor=S.+Buroniauthor=E.+De+Rossiauthor=G.+Riccardi&title=Decaprenylphosphoryl-%CE%B2-d-Ribose+2%E2%80%B2-Epimerase+from+Mycobacterium+tuberculosis+is+a+Magic+Drug+Target&doi=10.2174%2F092986710791959693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Decaprenylphosphoryl-β-D-ribose 2'-epimerase from Mycobacterium tuberculosis is a magic drug target</span></div><div class="casAuthors">Manina, G.; Pasca, M. R.; Buroni, S.; De Rossi, E.; Riccardi, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3099-3108</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tuberculosis is still a leading cause of death in developing countries and a resurgent disease in developed countries.  The selection and soaring spread of Mycobacterium tuberculosis multidrug-resistant (MDR-TB) and extensively drug-resistant strains (XDR-TB) is a severe public health problem.  Currently, there is an urgent need of new drugs for tuberculosis treatment, with novel mechanisms of action and, moreover, the necessity to identify new drug targets.  Several enzymes involved in various metabolic processes have been described as potential targets for the development of new drugs.  Recently, two different classes of most promising drugs, the benzothiazinones (BTZ) and the dinitrobenzamide derivs. (DNB), have been found to be highly active against M. tuberculosis, including XDR-TB strains.  Both drugs have the same target: the heteromeric decaprenylphosphoryl-β-D-ribose 2'-epimerase encoded by dprE1 (Rv3790) and dprE2 (Rv3791) genes, resp.  DprE1 and DprE2 are involved in the biosynthesis of D-arabinose and, in particular, they are essential to perform the transformation of decaprenylphosphoryl-D-ribose to decaprenylphosphoryl-D-arabinose, which is a substrate for arabinosyltransferases in the synthesis of the cell-envelope arabinogalactan and liporabinomannan polysaccharides of mycobacteria.  Arabinogalactan is a fundamental component of the mycobacterial cell wall, which covalently binds the outer layer of mycolic acids to peptidoglycan.  The heteromeric decaprenylphosphoryl-β-D-ribose 2'-epimerase thus represents a valid vulnerable antimycobacterial drug target which could result "magic" for tuberculosis treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV5N5U2ufDWbVg90H21EOLACvtfcHk0lj8bD7pt4S_Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtF2rtbfN&md5=ea158a6785eca6c7ce4a98e4260100c7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F092986710791959693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791959693%26sid%3Dliteratum%253Aachs%26aulast%3DManina%26aufirst%3DG.%26aulast%3DPasca%26aufirst%3DR.%26aulast%3DBuroni%26aufirst%3DS.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DRiccardi%26aufirst%3DG.%26atitle%3DDecaprenylphosphoryl-%25CE%25B2-d-Ribose%25202%25E2%2580%25B2-Epimerase%2520from%2520Mycobacterium%2520tuberculosis%2520is%2520a%2520Magic%2520Drug%2520Target%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D3099%26epage%3D3108%26doi%3D10.2174%2F092986710791959693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solapure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KR, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mdluli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span> <span> </span><span class="NLM_article-title">1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5325</span>– <span class="NLM_lpage">5331</span>, <span class="refDoi"> DOI: 10.1128/AAC.03233-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1128%2FAAC.03233-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=24957839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eqsL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=5325-5331&author=M.+Chatterjiauthor=R.+Shandilauthor=M.+R.+Manjunathaauthor=S.+Solapureauthor=V.+Ramachandranauthor=N.+Kumarauthor=R.+Saralayaauthor=V.+Pandugaauthor=J.+Reddyauthor=P.+KRauthor=S.+Sharmaauthor=C.+Sadlerauthor=C.+B.+Cooperauthor=K.+Mdluliauthor=P.+S.+Iyerauthor=S.+Narayananauthor=P.+S.+Shirude&title=1%2C4-Azaindole%2C+a+Potential+Drug+Candidate+for+Treatment+of+Tuberculosis&doi=10.1128%2FAAC.03233-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-azaindole, a potential drug candidate for treatment of tuberculosis</span></div><div class="casAuthors">Chatterji, Monalisa; Shandil, Radha; Manjunatha, M. R.; Solapure, Suresh; Ramachandran, Vasanthi; Kumar, Naveen; Saralaya, Ramanatha; Panduga, Vijender; Reddy, Jitendar; Prabhakar, K. R.; Sharma, Sreevalli; Sadler, Claire; Cooper, Christopher B.; Mdluli, Khisi; Iyer, Pravin S.; Narayanan, Shridhar; Shirude, Pravin S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5325-5331, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">New therapeutic strategies against multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis are urgently required to combat the global tuberculosis (TB) threat.  Toward this end, we previously reported the identification of 1,4-azaindoles, a promising class of compds. with potent antitubercular activity through noncovalent inhibition of decaprenylphosphoryl-β-d-ribose 2'-epimerase (DprE1).  Further, this series was optimized to improve its physicochem. properties and pharmacokinetics in mice.  Here, we describe the short-listing of a potential clin. candidate, compd. 2, that has potent cellular activity, drug-like properties, efficacy in mouse and rat chronic TB infection models, and minimal in vitro safety risks.  We also demonstrate that the compds., including compd. 2, have no antagonistic activity with other anti-TB drugs.  Moreover, compd. 2 shows synergy with PA824 and TMC207 in vitro, and the synergy effect is translated in vivo with TMC207.  The series is predicted to have a low clearance in humans, and the predicted human dose for compd. 2 is ≤ 1 g/day.  Altogether, our data suggest that a 1,4-azaindole (compd. 2) is a promising candidate for the development of a novel anti-TB drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW_tEuW_mDx7Vg90H21EOLACvtfcHk0lj8bD7pt4S_Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eqsL7N&md5=992bbd235d99bb1f8f05612966f76bc9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FAAC.03233-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03233-14%26sid%3Dliteratum%253Aachs%26aulast%3DChatterji%26aufirst%3DM.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DSolapure%26aufirst%3DS.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DKR%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DMdluli%26aufirst%3DK.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DShirude%26aufirst%3DP.%2BS.%26atitle%3D1%252C4-Azaindole%252C%2520a%2520Potential%2520Drug%2520Candidate%2520for%2520Treatment%2520of%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D5325%26epage%3D5331%26doi%3D10.1128%2FAAC.03233-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenistein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras-Dominguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genovesio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carralot, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Škovierová, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsollier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joly-Guillou, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">No, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehrbass, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span> <span> </span><span class="NLM_article-title">High Content Screening Identifies Decaprenyl-Phosphoribose 2’ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e1000645</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1000645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1371%2Fjournal.ppat.1000645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=19876393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A280%3ADC%252BD1Mjis1GgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&author=T.+Christopheauthor=M.+Jacksonauthor=H.+K.+Jeonauthor=D.+Fenisteinauthor=M.+Contreras-Dominguezauthor=J.+Kimauthor=A.+Genovesioauthor=J.+P.+Carralotauthor=F.+Ewannauthor=E.+H.+Kimauthor=S.+Y.+Leeauthor=S.+Kangauthor=M.+J.+Seoauthor=E.+J.+Parkauthor=H.+%C5%A0kovierov%C3%A1author=H.+Phamauthor=G.+Riccardiauthor=J.+Y.+Namauthor=L.+Marsollierauthor=M.+Kempfauthor=M.+L.+Joly-Guillouauthor=T.+Ohauthor=W.+K.+Shinauthor=Z.+Noauthor=U.+Nehrbassauthor=R.+Broschauthor=S.+T.+Coleauthor=P.+Brodin&title=High+Content+Screening+Identifies+Decaprenyl-Phosphoribose+2%E2%80%99+Epimerase+as+a+Target+for+Intracellular+Antimycobacterial+Inhibitors&doi=10.1371%2Fjournal.ppat.1000645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors</span></div><div class="casAuthors">Christophe Thierry; Jackson Mary; Jeon Hee Kyoung; Fenistein Denis; Contreras-Dominguez Monica; Kim Jaeseung; Genovesio Auguste; Carralot Jean-Philippe; Ewann Fanny; Kim Eun Hye; Lee Sae Yeon; Kang Sunhee; Seo Min Jung; Park Eun Jung; Skovierova Henrieta; Pham Ha; Riccardi Giovanna; Nam Ji Youn; Marsollier Laurent; Kempf Marie; Joly-Guillou Marie-Laure; Oh Taegwon; Shin Won Kyung; No Zaesung; Nehrbass Ulf; Brosch Roland; Cole Stewart T; Brodin Priscille</div><div class="citationInfo"><span class="NLM_cas:title">PLoS pathogens</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1000645</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A critical feature of Mycobacterium tuberculosis, the causative agent of human tuberculosis (TB), is its ability to survive and multiply within macrophages, making these host cells an ideal niche for persisting microbes.  Killing the intracellular tubercle bacilli is a key requirement for efficient tuberculosis treatment, yet identifying potent inhibitors has been hampered by labor-intensive techniques and lack of validated targets.  Here, we present the development of a phenotypic cell-based assay that uses automated confocal fluorescence microscopy for high throughput screening of chemicals that interfere with the replication of M. tuberculosis within macrophages.  Screening a library of 57,000 small molecules led to the identification of 135 active compounds with potent intracellular anti-mycobacterial efficacy and no host cell toxicity.  Among these, the dinitrobenzamide derivatives (DNB) showed high activity against M. tuberculosis, including extensively drug resistant (XDR) strains.  More importantly, we demonstrate that incubation of M. tuberculosis with DNB inhibited the formation of both lipoarabinomannan and arabinogalactan, attributable to the inhibition of decaprenyl-phospho-arabinose synthesis catalyzed by the decaprenyl-phosphoribose 2' epimerase DprE1/DprE2.  Inhibition of this new target will likely contribute to new therapeutic solutions against emerging XDR-TB.  Beyond validating the high throughput/content screening approach, our results open new avenues for finding the next generation of antimicrobials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7NZPIQh0EAub6AVA-44PTfW6udTcc2eYf9_PIulMs6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mjis1GgsA%253D%253D&md5=0af29177a0462df467382d288161ef8c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1000645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1000645%26sid%3Dliteratum%253Aachs%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DM.%26aulast%3DJeon%26aufirst%3DH.%2BK.%26aulast%3DFenistein%26aufirst%3DD.%26aulast%3DContreras-Dominguez%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DGenovesio%26aufirst%3DA.%26aulast%3DCarralot%26aufirst%3DJ.%2BP.%26aulast%3DEwann%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DE.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DSeo%26aufirst%3DM.%2BJ.%26aulast%3DPark%26aufirst%3DE.%2BJ.%26aulast%3D%25C5%25A0kovierov%25C3%25A1%26aufirst%3DH.%26aulast%3DPham%26aufirst%3DH.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DNam%26aufirst%3DJ.%2BY.%26aulast%3DMarsollier%26aufirst%3DL.%26aulast%3DKempf%26aufirst%3DM.%26aulast%3DJoly-Guillou%26aufirst%3DM.%2BL.%26aulast%3DOh%26aufirst%3DT.%26aulast%3DShin%26aufirst%3DW.%2BK.%26aulast%3DNo%26aufirst%3DZ.%26aulast%3DNehrbass%26aufirst%3DU.%26aulast%3DBrosch%26aufirst%3DR.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DBrodin%26aufirst%3DP.%26atitle%3DHigh%2520Content%2520Screening%2520Identifies%2520Decaprenyl-Phosphoribose%25202%25E2%2580%2599%2520Epimerase%2520as%2520a%2520Target%2520for%2520Intracellular%2520Antimycobacterial%2520Inhibitors%26jtitle%3DPLoS%2520Pathog.%26date%3D2009%26volume%3D5%26doi%3D10.1371%2Fjournal.ppat.1000645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L. T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Structure Activity Relationships Evaluation of Benzothiazinone Derivatives as Potential Anti-tubercular Agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4919</span>– <span class="NLM_lpage">4922</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1016%2Fj.bmcl.2013.06.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=23886691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOitLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4919-4922&author=C.+Gaoauthor=T.+H.+Yeauthor=N.+Y.+Wangauthor=X.+X.+Zengauthor=L.+D.+Zhangauthor=Y.+Xiongauthor=X.+Y.+Youauthor=Y.+Xiaauthor=Y.+Xuauthor=C.+T.+Pengauthor=W.+Q.+Zuoauthor=Y.+Weiauthor=L.+T.+Yu&title=Synthesis+and+Structure+Activity+Relationships+Evaluation+of+Benzothiazinone+Derivatives+as+Potential+Anti-tubercular+Agents&doi=10.1016%2Fj.bmcl.2013.06.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents</span></div><div class="casAuthors">Gao, Chao; Ye, Ting-Hong; Wang, Ning-Yu; Zeng, Xiu-Xiu; Zhang, Li-Dan; Xiong, Ying; You, Xin-Yu; Xia, Yong; Xu, Ying; Peng, Cui-Ting; Zuo, Wei-Qiong; Wei, Yuquan; Yu, Luo-Ting</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4919-4922</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-Alkyl and heterocycle substituted 1,3-benzothiazin-4-ones I [R1 = H, Me; R2 = EtNH, PrNH, BuNH, etc.] were synthesized.  The antimycobacterial activities of these compds. were evaluated by detn. of minimal inhibitory concn. (MIC) for Mycobacterium tuberculosis H37Ra and M. tuberculosis H37Rv.  It was found that an extended or branched alkyl chain analog could enhance the potency, and activities of N-alkyl substituted I were not affected by either nitro or trifluoromethyl at 6-position.  Trifluoromethyl plays an important role in maintaining antitubercular activity in the piperazine or piperidine analogs.  Compd. II, which contains an azaspirodithiolane group, showed a MIC of 0.0001 μM against M. tuberculosis H37Rv, 20-fold more potent than BTZ043 racemate.  These results suggested that the vol. and lipophilicity of the substituents were important in maintaining activity.  In addn., compd. II was nontoxic to Vero cells and orally bioavailable in a preliminary pharmacokinetics study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWDReDIBDe1LVg90H21EOLACvtfcHk0lgDwp1rrMLNEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOitLrI&md5=2d5e4cf15479ac9fa7bb12b1da56b2b0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.069%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DT.%2BH.%26aulast%3DWang%26aufirst%3DN.%2BY.%26aulast%3DZeng%26aufirst%3DX.%2BX.%26aulast%3DZhang%26aufirst%3DL.%2BD.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DX.%2BY.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DC.%2BT.%26aulast%3DZuo%26aufirst%3DW.%2BQ.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%2BT.%26atitle%3DSynthesis%2520and%2520Structure%2520Activity%2520Relationships%2520Evaluation%2520of%2520Benzothiazinone%2520Derivatives%2520as%2520Potential%2520Anti-tubercular%2520Agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4919%26epage%3D4922%26doi%3D10.1016%2Fj.bmcl.2013.06.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Landge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullick, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagalapur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbulakshmi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellows, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachaspati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrapatna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balganesh, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarkar, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandodkar, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span> <span> </span><span class="NLM_article-title">Discovery of Benzothiazoles as Antimycobacterial Agents: Synthesis, Structure–activity Relationships and Binding Studies with Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose 2′-oxidase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7694</span>– <span class="NLM_lpage">7710</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.11.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1016%2Fj.bmc.2015.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=26643218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFerur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=7694-7710&author=S.+Landgeauthor=A.+B.+Mullickauthor=K.+Nagalapurauthor=J.+Neresauthor=V.+Subbulakshmiauthor=K.+Muruganauthor=A.+Ghoshauthor=C.+Sadlerauthor=M.+D.+Fellowsauthor=V.+Humnabadkarauthor=J.+Mahadevaswamyauthor=P.+Vachaspatiauthor=S.+Sharmaauthor=P.+Kaurauthor=M.+Mallyaauthor=S.+Rudrapatnaauthor=D.+Awasthyauthor=V.+K.+Sambandamurthyauthor=F.+Pojerauthor=S.+T.+Coleauthor=T.+S.+Balganeshauthor=B.+G.+Ugarkarauthor=V.+Balasubramanianauthor=B.+S.+Bandodkarauthor=M.+Pandaauthor=V.+Ramachandran&title=Discovery+of+Benzothiazoles+as+Antimycobacterial+Agents%3A+Synthesis%2C+Structure%E2%80%93activity+Relationships+and+Binding+Studies+with+Mycobacterium+tuberculosis+Decaprenylphosphoryl-%CE%B2-d-ribose+2%E2%80%B2-oxidase&doi=10.1016%2Fj.bmc.2015.11.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase</span></div><div class="casAuthors">Landge, Sudhir; Mullick, Amrita B.; Nagalapur, Kavitha; Neres, Joao; Subbulakshmi, Venkita; Murugan, Kannan; Ghosh, Anirban; Sadler, Claire; Fellows, Mick D.; Humnabadkar, Vaishali; Mahadevaswamy, Jyothi; Vachaspati, Prakash; Sharma, Sreevalli; Kaur, Parvinder; Mallya, Meenakshi; Rudrapatna, Suresh; Awasthy, Disha; Sambandamurthy, Vasan K.; Pojer, Florence; Cole, Stewart T.; Balganesh, Tanjore S.; Ugarkar, Bheemarao G.; Balasubramanian, V.; Bandodkar, Balachandra S.; Panda, Manoranjan; Ramachandran, Vasanthi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7694-7710</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the discovery of benzothiazoles, a novel anti-mycobacterial series, identified from a whole cell based screening campaign.  Benzothiazoles exert their bactericidal activity against Mycobacterium tuberculosis (Mtb) through potent inhibition of decaprenylphosphoryl-β-D-ribose 2'-oxidase (DprE1), the key enzyme involved in arabinogalactan synthesis.  Specific target linkage and mode of binding were established using co-crystn. and protein mass spectrometry studies.  Most importantly, the current study provides insights on the utilization of systematic medicinal chem. approaches to mitigate safety liabilities while improving potency during progression from an initial genotoxic hit, the benzothiazole N-oxides (BTOs) to the lead-like AMES neg., crowded benzothiazoles (cBTs).  These findings offer opportunities for development of safe clin. candidates against tuberculosis.  The design strategy adopted could find potential application in discovery of safe drugs in other therapy areas too.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS7rEts75x7bVg90H21EOLACvtfcHk0lgDwp1rrMLNEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFerur3E&md5=cea6212afa6aee18530c45717f98b5c6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DLandge%26aufirst%3DS.%26aulast%3DMullick%26aufirst%3DA.%2BB.%26aulast%3DNagalapur%26aufirst%3DK.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DSubbulakshmi%26aufirst%3DV.%26aulast%3DMurugan%26aufirst%3DK.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DFellows%26aufirst%3DM.%2BD.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DVachaspati%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DMallya%26aufirst%3DM.%26aulast%3DRudrapatna%26aufirst%3DS.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DBalganesh%26aufirst%3DT.%2BS.%26aulast%3DUgarkar%26aufirst%3DB.%2BG.%26aulast%3DBalasubramanian%26aufirst%3DV.%26aulast%3DBandodkar%26aufirst%3DB.%2BS.%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DRamachandran%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520Benzothiazoles%2520as%2520Antimycobacterial%2520Agents%253A%2520Synthesis%252C%2520Structure%25E2%2580%2593activity%2520Relationships%2520and%2520Binding%2520Studies%2520with%2520Mycobacterium%2520tuberculosis%2520Decaprenylphosphoryl-%25CE%25B2-d-ribose%25202%25E2%2580%25B2-oxidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D7694%26epage%3D7710%26doi%3D10.1016%2Fj.bmc.2015.11.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lechartier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Sar, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raadsen, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryabova, O. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decosterd, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widmer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buclin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitter, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andries, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Towards a New Combination Therapy for Tuberculosis with Next Generation Benzothiazinones</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1002/emmm.201303575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1002%2Femmm.201303575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=24500695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvVyjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=372-383&author=V.+Makarovauthor=B.+Lechartierauthor=M.+Zhangauthor=J.+Neresauthor=A.+M.+van+der%0ASarauthor=S.+A.+Raadsenauthor=R.+C.+Hartkoornauthor=O.+B.+Ryabovaauthor=A.+Vocatauthor=L.+A.+Decosterdauthor=N.+Widmerauthor=T.+Buclinauthor=W.+Bitterauthor=K.+Andriesauthor=F.+Pojerauthor=P.+J.+Dysonauthor=S.+T.+Cole&title=Towards+a+New+Combination+Therapy+for+Tuberculosis+with+Next+Generation+Benzothiazinones&doi=10.1002%2Femmm.201303575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a new combination therapy for tuberculosis with next generation benzothiazinones</span></div><div class="casAuthors">Makarov, Vadim; Lechartier, Benoit; Zhang, Ming; Neres, Joao; van der Sar, Astrid M.; Raadsen, Susanne A.; Hartkoorn, Ruben C.; Ryabova, Olga B.; Vocat, Anthony; Decosterd, Laurent A.; Widmer, Nicolas; Buclin, Thierry; Bitter, Wilbert; Andries, Koen; Pojer, Florence; Dyson, Paul J.; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">372-383</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The benzothiazinone lead compd., BTZ043, kills Mycobacterium tuberculosis by inhibiting the essential flavo-enzyme DprE1, decaprenylphosphoryl-beta-D-ribose 2-epimerase.  Here, we synthesized a new series of piperazine-contg. benzothiazinones (PBTZ) and show that, like BTZ043, the preclin. candidate PBTZ169 binds covalently to DprE1.  The crystal structure of the DprE1-PBTZ169 complex reveals formation of a semimercaptal adduct with Cys387 in the active site and explains the irreversible inactivation of the enzyme.  Compared to BTZ043, PBTZ169 has improved potency, safety and efficacy in zebrafish and mouse models of tuberculosis (TB).  When combined with other TB drugs, PBTZ169 showed additive activity against M. tuberculosis in vitro except with bedaquiline (BDQ) where synergy was obsd.  A new regimen comprising PBTZ169, BDQ and pyrazinamide was found to be more efficacious than the std. three drug treatment in a murine model of chronic disease.  PBTZ169 is thus an attractive drug candidate to treat TB in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_BD_M46wCiLVg90H21EOLACvtfcHk0lj0dlguNsYENA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvVyjtLw%253D&md5=5393e68ca6f35be17ae10a397b443907</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Femmm.201303575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201303575%26sid%3Dliteratum%253Aachs%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DLechartier%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BSar%26aufirst%3DA.%2BM.%26aulast%3DRaadsen%26aufirst%3DS.%2BA.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DRyabova%26aufirst%3DO.%2BB.%26aulast%3DVocat%26aufirst%3DA.%26aulast%3DDecosterd%26aufirst%3DL.%2BA.%26aulast%3DWidmer%26aufirst%3DN.%26aulast%3DBuclin%26aufirst%3DT.%26aulast%3DBitter%26aufirst%3DW.%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DTowards%2520a%2520New%2520Combination%2520Therapy%2520for%2520Tuberculosis%2520with%2520Next%2520Generation%2520Benzothiazinones%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D372%26epage%3D383%26doi%3D10.1002%2Femmm.201303575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tantry, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjrekar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, L. k.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koushik, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanbhag, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jatheendranath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathula, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrapatna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravishankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorino-Gelo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinesh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghorpade, S. R.</span></span> <span> </span><span class="NLM_article-title">4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5419</span>– <span class="NLM_lpage">5434</span>, <span class="refDoi"> DOI: 10.1021/jm5005978</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5005978" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Wqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5419-5434&author=M.+Naikauthor=V.+Humnabadkarauthor=S.+J.+Tantryauthor=M.+Pandaauthor=A.+Narayanauthor=S.+Gupthaauthor=V.+Pandugaauthor=P.+Manjrekarauthor=L.+k.+Jenaauthor=K.+Koushikauthor=G.+Shanbhagauthor=S.+Jatheendranathauthor=M.+R.+Manjunathaauthor=G.+Goraiauthor=C.+Bathulaauthor=S.+Rudrapatnaauthor=V.+Acharauthor=S.+Sharmaauthor=A.+Ambadyauthor=N.+Hegdeauthor=J.+Mahadevaswamyauthor=P.+Kaurauthor=V.+K.+Sambandamurthyauthor=D.+Awasthyauthor=C.+Narayanauthor=S.+Ravishankarauthor=P.+Madhavapeddiauthor=J.+Reddyauthor=K.+R.+Prabhakarauthor=R.+Saralayaauthor=M.+Chatterjiauthor=J.+Whiteakerauthor=B.+McLaughlinauthor=L.+R.+Chiarelliauthor=G.+Riccardiauthor=M.+R.+Pascaauthor=C.+Bindaauthor=J.+Neresauthor=N.+Dharauthor=F.+Signorino-Geloauthor=J.+D.+McKinneyauthor=V.+Ramachandranauthor=R.+Shandilauthor=R.+Tommasiauthor=P.+S.+Iyerauthor=S.+Narayananauthor=V.+Hosagraharaauthor=S.+Kavanaghauthor=N.+Dineshauthor=S.+R.+Ghorpade&title=4-Aminoquinolone+Piperidine+Amides%3A+Noncovalent+Inhibitors+of+DprE1+with+Long+Residence+Time+and+Potent+Antimycobacterial+Activity&doi=10.1021%2Fjm5005978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity</span></div><div class="casAuthors">Naik, Maruti; Humnabadkar, Vaishali; Tantry, Subramanyam J.; Panda, Manoranjan; Narayan, Ashwini; Guptha, Supreeth; Panduga, Vijender; Manjrekar, Praveena; Jena, Lalit kumar; Koushik, Krishna; Shanbhag, Gajanan; Jatheendranath, Sandesh; Manjunatha, M. R.; Gorai, Gopinath; Bathula, Chandramohan; Rudrapatna, Suresh; Achar, Vijayashree; Sharma, Sreevalli; Ambady, Anisha; Hegde, Naina; Mahadevaswamy, Jyothi; Kaur, Parvinder; Sambandamurthy, Vasan K.; Awasthy, Disha; Narayan, Chandan; Ravishankar, Sudha; Madhavapeddi, Prashanti; Reddy, Jitendar; Prabhakar, K. R.; Saralaya, Ramanatha; Chatterji, Monalisa; Whiteaker, James; McLaughlin, Bob; Chiarelli, Laurent R.; Riccardi, Giovanna; Pasca, Maria Rosalia; Binda, Claudia; Neres, Joao; Dhar, Neeraj; Signorino-Gelo, Francois; McKinney, John D.; Ramachandran, Vasanthi; Shandil, Radha; Tommasi, Ruben; Iyer, Pravin S.; Narayanan, Shridhar; Hosagrahara, Vinayak; Kavanagh, Stefan; Dinesh, Neela; Ghorpade, Sandeep R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5419-5434</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4-Aminoquinolone piperidine amides (AQs) were identified as a novel scaffold starting from a whole cell screen, with potent cidality on Mycobacterium tuberculosis (Mtb).  Evaluation of the min. inhibitory concns., followed by whole genome sequencing of mutants raised against AQs, identified decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1) as the primary target responsible for the antitubercular activity.  Mass spectrometry and enzyme kinetic studies indicated that AQs are noncovalent, reversible inhibitors of DprE1 with slow on rates and long residence times of ∼100 min on the enzyme.  In general, AQs have excellent leadlike properties and good in vitro secondary pharmacol. profile.  Although the scaffold started off as a single active compd. with moderate potency from the whole cell screen, structure-activity relationship optimization of the scaffold led to compds. with potent DprE1 inhibition (IC50 < 10 nM) along with potent cellular activity (MIC = 60 nM) against Mtb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo427Eycvs4I7Vg90H21EOLACvtfcHk0lj0dlguNsYENA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Wqt7g%253D&md5=05e9a7f75679397a124088023762fe20</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm5005978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5005978%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DTantry%26aufirst%3DS.%2BJ.%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DManjrekar%26aufirst%3DP.%26aulast%3DJena%26aufirst%3DL.%2Bk.%26aulast%3DKoushik%26aufirst%3DK.%26aulast%3DShanbhag%26aufirst%3DG.%26aulast%3DJatheendranath%26aufirst%3DS.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DGorai%26aufirst%3DG.%26aulast%3DBathula%26aufirst%3DC.%26aulast%3DRudrapatna%26aufirst%3DS.%26aulast%3DAchar%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DNarayan%26aufirst%3DC.%26aulast%3DRavishankar%26aufirst%3DS.%26aulast%3DMadhavapeddi%26aufirst%3DP.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPrabhakar%26aufirst%3DK.%2BR.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DChatterji%26aufirst%3DM.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DB.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DSignorino-Gelo%26aufirst%3DF.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DKavanagh%26aufirst%3DS.%26aulast%3DDinesh%26aufirst%3DN.%26aulast%3DGhorpade%26aufirst%3DS.%2BR.%26atitle%3D4-Aminoquinolone%2520Piperidine%2520Amides%253A%2520Noncovalent%2520Inhibitors%2520of%2520DprE1%2520with%2520Long%2520Residence%2520Time%2520and%2520Potent%2520Antimycobacterial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5419%26epage%3D5434%26doi%3D10.1021%2Fjm5005978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarelli, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadupudi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venturelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delorme, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jesus Lopes Ribeiro, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rossi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1021/cb5007163</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5007163" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyqt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=705-714&author=J.+Neresauthor=R.+C.+Hartkoornauthor=L.+R.+Chiarelliauthor=R.+Gadupudiauthor=M.+R.+Pascaauthor=G.+Moriauthor=A.+Venturelliauthor=S.+Savinaauthor=V.+Makarovauthor=G.+S.+Kollyauthor=E.+Molteniauthor=C.+Bindaauthor=N.+Dharauthor=S.+Ferrariauthor=P.+Brodinauthor=V.+Delormeauthor=V.+Landryauthor=A.+L.+de+Jesus+Lopes+Ribeiroauthor=D.+Farinaauthor=P.+Saxenaauthor=F.+Pojerauthor=A.+Cartaauthor=R.+Lucianiauthor=A.+Portaauthor=G.+Zanoniauthor=E.+De+Rossiauthor=M.+P.+Costiauthor=G.+Riccardiauthor=S.+T.+Cole&title=2-Carboxyquinoxalines+Kill+Mycobacterium+tuberculosis+through+Noncovalent+Inhibition+of+DprE1&doi=10.1021%2Fcb5007163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1</span></div><div class="casAuthors">Neres, Joao; Hartkoorn, Ruben C.; Chiarelli, Laurent R.; Gadupudi, Ramakrishna; Pasca, Maria Rosalia; Mori, Giorgia; Venturelli, Alberto; Savina, Svetlana; Makarov, Vadim; Kolly, Gaelle S.; Molteni, Elisabetta; Binda, Claudia; Dhar, Neeraj; Ferrari, Stefania; Brodin, Priscille; Delorme, Vincent; Landry, Valerie; de Jesus Lopes Ribeiro, Ana Luisa; Farina, Davide; Saxena, Puneet; Pojer, Florence; Carta, Antonio; Luciani, Rosaria; Porta, Alessio; Zanoni, Giuseppe; De Rossi, Edda; Costi, Maria Paola; Riccardi, Giovanna; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">705-714</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phenotypic screening of a quinoxaline library against replicating Mycobacterium tuberculosis led to the identification of lead compd. Ty38c (3-((4-methoxybenzyl)amino)-6-(trifluoromethyl)quinoxaline-2-carboxylic acid).  With an MIC99 and MBC of 3.1 μM, Ty38c is bactericidal and active against intracellular bacteria.  To investigate its mechanism of action, we isolated mutants resistant to Ty38c and sequenced their genomes.  Mutations were found in rv3405c, coding for the transcriptional repressor of the divergently expressed rv3406 gene.  Biochem. studies clearly showed that Rv3406 decarboxylates Ty38c into its inactive keto metabolite.  The actual target was then identified by isolating Ty38c-resistant mutants of an M. tuberculosis strain lacking rv3406.  Here, mutations were found in dprE1, encoding the decaprenylphosphoryl-D-ribose oxidase DprE1, essential for biogenesis of the mycobacterial cell wall.  Genetics, biochem. validation, and X-ray crystallog. revealed Ty38c to be a noncovalent, noncompetitive DprE1 inhibitor.  Structure-activity relationship studies generated a family of DprE1 inhibitors with a range of IC50's and bactericidal activity.  Co-crystal structures of DprE1 in complex with eight different quinoxaline analogs provided a high-resoln. interaction map of the active site of this extremely vulnerable target in M. tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUParezeusZ7Vg90H21EOLACvtfcHk0liw8f6s63xHIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyqt7rL&md5=83e64a019613003778c80079e4f8b978</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcb5007163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5007163%26sid%3Dliteratum%253Aachs%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DChiarelli%26aufirst%3DL.%2BR.%26aulast%3DGadupudi%26aufirst%3DR.%26aulast%3DPasca%26aufirst%3DM.%2BR.%26aulast%3DMori%26aufirst%3DG.%26aulast%3DVenturelli%26aufirst%3DA.%26aulast%3DSavina%26aufirst%3DS.%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DKolly%26aufirst%3DG.%2BS.%26aulast%3DMolteni%26aufirst%3DE.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DDelorme%26aufirst%3DV.%26aulast%3DLandry%26aufirst%3DV.%26aulast%3Dde%2BJesus%2BLopes%2BRibeiro%26aufirst%3DA.%2BL.%26aulast%3DFarina%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DP.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DCarta%26aufirst%3DA.%26aulast%3DLuciani%26aufirst%3DR.%26aulast%3DPorta%26aufirst%3DA.%26aulast%3DZanoni%26aufirst%3DG.%26aulast%3DDe%2BRossi%26aufirst%3DE.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DRiccardi%26aufirst%3DG.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3D2-Carboxyquinoxalines%2520Kill%2520Mycobacterium%2520tuberculosis%2520through%2520Noncovalent%2520Inhibition%2520of%2520DprE1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D705%26epage%3D714%26doi%3D10.1021%2Fcb5007163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagalapur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudrapatna, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raichurkar, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4761</span>– <span class="NLM_lpage">4771</span>, <span class="refDoi"> DOI: 10.1021/jm5002937</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5002937" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVShtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4761-4771&author=M.+Pandaauthor=S.+Ramachandranauthor=V.+Ramachandranauthor=P.+S.+Shirudeauthor=V.+Humnabadkarauthor=K.+Nagalapurauthor=S.+Sharmaauthor=P.+Kaurauthor=S.+Gupthaauthor=A.+Narayanauthor=J.+Mahadevaswamyauthor=A.+Ambadyauthor=N.+Hegdeauthor=S.+S.+Rudrapatnaauthor=V.+P.+Hosagraharaauthor=V.+K.+Sambandamurthyauthor=A.+Raichurkar&title=Discovery+of+Pyrazolopyridones+as+a+Novel+Class+of+Noncovalent+DprE1+Inhibitor+with+Potent+Anti-Mycobacterial+Activity&doi=10.1021%2Fjm5002937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity</span></div><div class="casAuthors">Panda, Manoranjan; Ramachandran, Sreekanth; Ramachandran, Vasanthi; Shirude, Pravin S.; Humnabadkar, Vaishali; Nagalapur, Kavitha; Sharma, Sreevalli; Kaur, Parvinder; Guptha, Supreeth; Narayan, Ashwini; Mahadevaswamy, Jyothi; Ambady, Anisha; Hegde, Naina; Rudrapatna, Suresh S.; Hosagrahara, Vinayak P.; Sambandamurthy, Vasan K.; Raichurkar, Anandkumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4761-4771</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel pyrazolopyridone class of inhibitors was identified from whole cell screening against Mycobacterium tuberculosis (Mtb).  The series exhibits excellent bactericidality in vitro, resulting in a 4 log redn. in colony forming units following compd. exposure.  The significant modulation of min. inhibitory concn. (MIC) against a Mtb strain overexpressing the Rv3790 gene suggested the target of pyrazolopyridones to be decaprenylphosphoryl-β-D-ribose-2'-epimerase (DprE1).  Genetic mapping of resistance mutation coupled with potent enzyme inhibition activity confirmed the mol. target.  Detailed biochem. characterization revealed the series to be a noncovalent inhibitor of DprE1.  Docking studies at the active site suggest that the series can be further diversified to improve the physicochem. properties without compromising the antimycobacterial activity.  The pyrazolopyridone class of inhibitors offers an attractive non-nitro lead series targeting the essential and vulnerable DprE1 enzyme for the discovery of novel antimycobacterial agents to treat both drug susceptible and drug resistant strains of Mtb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdYV8Pi2ynA7Vg90H21EOLACvtfcHk0lhgfBOzNHEUBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVShtrw%253D&md5=dd3c1daf880d2f50d3187a0f9d1ab363</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm5002937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5002937%26sid%3Dliteratum%253Aachs%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DRamachandran%26aufirst%3DS.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DNagalapur%26aufirst%3DK.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DRudrapatna%26aufirst%3DS.%2BS.%26aulast%3DHosagrahara%26aufirst%3DV.%2BP.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DRaichurkar%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520Pyrazolopyridones%2520as%2520a%2520Novel%2520Class%2520of%2520Noncovalent%2520DprE1%2520Inhibitor%2520with%2520Potent%2520Anti-Mycobacterial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4761%26epage%3D4771%26doi%3D10.1021%2Fjm5002937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosagrahara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hameed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathula, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavapeddi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guptha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awasthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevaswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwas, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharath, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhury, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solapure, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span> <span> </span><span class="NLM_article-title">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9701</span>– <span class="NLM_lpage">9708</span>, <span class="refDoi"> DOI: 10.1021/jm401382v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401382v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9701-9708&author=P.+S.+Shirudeauthor=R.+Shandilauthor=C.+Sadlerauthor=M.+Naikauthor=V.+Hosagraharaauthor=S.+Hameedauthor=V.+Shindeauthor=C.+Bathulaauthor=V.+Humnabadkarauthor=N.+Kumarauthor=J.+Reddyauthor=V.+Pandugaauthor=S.+Sharmaauthor=A.+Ambadyauthor=N.+Hegdeauthor=J.+Whiteakerauthor=R.+E.+McLaughlinauthor=H.+Gardnerauthor=P.+Madhavapeddiauthor=V.+Ramachandranauthor=P.+Kaurauthor=A.+Narayanauthor=S.+Gupthaauthor=D.+Awasthyauthor=C.+Narayanauthor=J.+Mahadevaswamyauthor=K.+G.+Vishwasauthor=V.+Ahujaauthor=A.+Srivastavaauthor=K.+R.+Prabhakarauthor=S.+Bharathauthor=R.+Kaleauthor=M.+Ramaiahauthor=N.+R.+Choudhuryauthor=V.+K.+Sambandamurthyauthor=S.+Solapureauthor=P.+S.+Iyerauthor=S.+Narayananauthor=M.+Chatterji&title=Azaindoles%3A+Noncovalent+DprE1+Inhibitors+from+Scaffold+Morphing+Efforts%2C+Kill+Mycobacterium+tuberculosis+and+Are+Efficacious+in+Vivo&doi=10.1021%2Fjm401382v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo</span></div><div class="casAuthors">Shirude, Pravin S.; Shandil, Radha; Sadler, Claire; Naik, Maruti; Hosagrahara, Vinayak; Hameed, Shahul; Shinde, Vikas; Bathula, Chandramohan; Humnabadkar, Vaishali; Kumar, Naveen; Reddy, Jitendar; Panduga, Vijender; Sharma, Sreevalli; Ambady, Anisha; Hegde, Naina; Whiteaker, James; McLaughlin, Robert E.; Gardner, Humphrey; Madhavapeddi, Prashanti; Ramachandran, Vasanthi; Kaur, Parvinder; Narayan, Ashwini; Guptha, Supreeth; Awasthy, Disha; Narayan, Chandan; Mahadevaswamy, Jyothi; Vishwas, K. G.; Ahuja, Vijaykamal; Srivastava, Abhishek; Prabhakar, K. R.; Bharath, Sowmya; Kale, Ramesh; Ramaiah, Manjunatha; Choudhury, Nilanjana Roy; Sambandamurthy, Vasan K.; Solapure, Suresh; Iyer, Pravin S.; Narayanan, Shridhar; Chatterji, Monalisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9701-9708</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report 1,4-azaindoles as a new inhibitor class that kills Mycobacterium tuberculosis in vitro and demonstrates efficacy in mouse tuberculosis models.  The series emerged from scaffold morphing efforts and was demonstrated to noncovalently inhibit decaprenylphosphoryl-β-d-ribose2'-epimerase (DprE1).  With "drug-like" properties and no expectation of pre-existing resistance in the clinic, this chem. class has the potential to be developed as a therapy for drug-sensitive and drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskQvJK4M2yrVg90H21EOLACvtfcHk0lhgfBOzNHEUBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM&md5=eba42d1952b164f66fd0ca620aaa4f19</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm401382v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401382v%26sid%3Dliteratum%253Aachs%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DHameed%26aufirst%3DS.%26aulast%3DShinde%26aufirst%3DV.%26aulast%3DBathula%26aufirst%3DC.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DMadhavapeddi%26aufirst%3DP.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DNarayan%26aufirst%3DC.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DVishwas%26aufirst%3DK.%2BG.%26aulast%3DAhuja%26aufirst%3DV.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DK.%2BR.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DKale%26aufirst%3DR.%26aulast%3DRamaiah%26aufirst%3DM.%26aulast%3DChoudhury%26aufirst%3DN.%2BR.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DSolapure%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DM.%26atitle%3DAzaindoles%253A%2520Noncovalent%2520DprE1%2520Inhibitors%2520from%2520Scaffold%2520Morphing%2520Efforts%252C%2520Kill%2520Mycobacterium%2520tuberculosis%2520and%2520Are%2520Efficacious%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9701%26epage%3D9708%26doi%3D10.1021%2Fjm401382v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirude, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shandil, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduga, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanduri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravishankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandamurthy, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humnabadkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suresh, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteaker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mdluli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, M.</span></span> <span> </span><span class="NLM_article-title">Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5728</span>– <span class="NLM_lpage">5737</span>, <span class="refDoi"> DOI: 10.1021/jm500571f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500571f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWhsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5728-5737&author=P.+S.+Shirudeauthor=R.+K.+Shandilauthor=M.+R.+Manjunathaauthor=C.+Sadlerauthor=M.+Pandaauthor=V.+Pandugaauthor=J.+Reddyauthor=R.+Saralayaauthor=R.+Nanduriauthor=A.+Ambadyauthor=S.+Ravishankarauthor=V.+K.+Sambandamurthyauthor=V.+Humnabadkarauthor=L.+K.+Jenaauthor=R.+S.+Sureshauthor=A.+Srivastavaauthor=K.+R.+Prabhakarauthor=J.+Whiteakerauthor=R.+E.+McLaughlinauthor=S.+Sharmaauthor=C.+B.+Cooperauthor=K.+Mdluliauthor=S.+Butlerauthor=P.+S.+Iyerauthor=S.+Narayananauthor=M.+Chatterji&title=Lead+Optimization+of+1%2C4-Azaindoles+as+Antimycobacterial+Agents&doi=10.1021%2Fjm500571f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents</span></div><div class="casAuthors">Shirude, Pravin S.; Shandil, Radha K.; Manjunatha, M. R.; Sadler, Claire; Panda, Manoranjan; Panduga, Vijender; Reddy, Jitendar; Saralaya, Ramanatha; Nanduri, Robert; Ambady, Anisha; Ravishankar, Sudha; Sambandamurthy, Vasan K.; Humnabadkar, Vaishali; Jena, Lalit K.; Suresh, Rudrapatna S.; Srivastava, Abhishek; Prabhakar, K. R.; Whiteaker, James; McLaughlin, Robert E.; Sharma, Sreevalli; Cooper, Christopher B.; Mdluli, Khisi; Butler, Scott; Iyer, Pravin S.; Narayanan, Shridhar; Chatterji, Monalisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5728-5737</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a previous report, we described the discovery of 1,4-azaindoles, a chem. series with excellent in vitro and in vivo antimycobacterial potency through noncovalent inhibition of decaprenylphosphoryl-β-D-ribose-2'-epimerase (DprE1).  Nevertheless, high mouse metabolic turnover and phosphodiesterase 6 (PDE6) off-target activity limited its advancement.  Herein, we report lead optimization of this series, culminating in potent, metabolically stable compds. that have a robust pharmacokinetic profile without any PDE6 liability.  Furthermore, we demonstrate efficacy for 1,4-azaindoles in a rat chronic TB infection model.  We believe that compds. from the 1,4-azaindole series are suitable for in vivo combination and safety studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKixMAsGzDqrVg90H21EOLACvtfcHk0lhgfBOzNHEUBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWhsbY%253D&md5=058a48536ddeb1046e04a29ba68a3a17</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm500571f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500571f%26sid%3Dliteratum%253Aachs%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DShandil%26aufirst%3DR.%2BK.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DPanda%26aufirst%3DM.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DNanduri%26aufirst%3DR.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DRavishankar%26aufirst%3DS.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DJena%26aufirst%3DL.%2BK.%26aulast%3DSuresh%26aufirst%3DR.%2BS.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DK.%2BR.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DMdluli%26aufirst%3DK.%26aulast%3DButler%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DM.%26atitle%3DLead%2520Optimization%2520of%25201%252C4-Azaindoles%2520as%2520Antimycobacterial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5728%26epage%3D5737%26doi%3D10.1021%2Fjm500571f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawate, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwase, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wivagg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazyanskaya, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquadro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, D. T.</span></span> <span> </span><span class="NLM_article-title">Identification of Novel Inhibitors of <i>M. tuberculosi</i>s Growth Using Whole Cell Based High-Throughput Screening</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1377</span>– <span class="NLM_lpage">1384</span>, <span class="refDoi"> DOI: 10.1021/cb300151m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300151m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvV2guro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1377-1384&author=S.+A.+Stanleyauthor=S.+S.+Grantauthor=T.+Kawateauthor=N.+Iwaseauthor=M.+Shimizuauthor=C.+Wivaggauthor=M.+Silvisauthor=E.+Kazyanskayaauthor=J.+Aquadroauthor=A.+Golasauthor=M.+Fitzgeraldauthor=H.+Daiauthor=L.+Zhangauthor=D.+T.+Hung&title=Identification+of+Novel+Inhibitors+of+M.+tuberculosis+Growth+Using+Whole+Cell+Based+High-Throughput+Screening&doi=10.1021%2Fcb300151m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening</span></div><div class="casAuthors">Stanley, Sarah A.; Schmidt Grant, Sarah; Kawate, Tomohiko; Iwase, Noriaki; Shimizu, Motohisa; Wivagg, Carl; Silvis, Melanie; Kazyanskaya, Edward; Aquadro, John; Golas, Aaron; Fitzgerald, Michael; Dai, Huanqin; Zhang, Lixin; Hung, Deborah T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1377-1384</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite the urgent need for new antitubercular drugs, few are on the horizon.  To combat the problem of emerging drug resistance, structurally unique chem. entities that inhibit new targets will be required.  Here, we describe our investigations using whole cell screening of a diverse collection of small mols. as a methodol. for identifying novel inhibitors that target new pathways for Mycobacterium tuberculosis drug discovery.  We find that conducting primary screens using model mycobacterial species may limit the potential for identifying new inhibitors with efficacy against M. tuberculosis.  In addn., we confirm the importance of developing in vitro assay conditions that are reflective of in vivo biol. for maximizing the proportion of hits from whole cell screening that are likely to have activity in vivo.  Finally, we describe the identification and characterization of two novel inhibitors that target steps in M. tuberculosis cell wall biosynthesis.  The first is a novel benzimidazole, I, that targets mycobacterial membrane protein large 3 (MmpL3), a proposed transporter for cell wall mycolic acids.  The second is a nitro-triazole, II, that inhibits decaprenylphosphoryl-β-d-ribose 2'-epimerase (DprE1), an epimerase required for cell wall biosynthesis.  These proteins are both among the small no. of new targets that have been identified by forward chem. genetics using resistance generation coupled with genome sequencing.  This suggests that methodologies currently employed for screening and target identification may lead to a bias in target discovery and that alternative methods should be explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPUQqAYK8L3LVg90H21EOLACvtfcHk0lhCec6-zS4vuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvV2guro%253D&md5=7293e2cca5001af5bfcf5e1bb4fb1a70</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcb300151m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300151m%26sid%3Dliteratum%253Aachs%26aulast%3DStanley%26aufirst%3DS.%2BA.%26aulast%3DGrant%26aufirst%3DS.%2BS.%26aulast%3DKawate%26aufirst%3DT.%26aulast%3DIwase%26aufirst%3DN.%26aulast%3DShimizu%26aufirst%3DM.%26aulast%3DWivagg%26aufirst%3DC.%26aulast%3DSilvis%26aufirst%3DM.%26aulast%3DKazyanskaya%26aufirst%3DE.%26aulast%3DAquadro%26aufirst%3DJ.%26aulast%3DGolas%26aufirst%3DA.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHung%26aufirst%3DD.%2BT.%26atitle%3DIdentification%2520of%2520Novel%2520Inhibitors%2520of%2520M.%2520tuberculosis%2520Growth%2520Using%2520Whole%2520Cell%2520Based%2520High-Throughput%2520Screening%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D1377%26epage%3D1384%26doi%3D10.1021%2Fcb300151m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambandan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huszar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trefzer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mdluli, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikusova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fütterer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span> <span> </span><span class="NLM_article-title">Identification of a Small Molecule with Activity Against Drug-resistant and Persistent Tuberculosis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">E2510</span>– <span class="NLM_lpage">E2517</span>, <span class="refDoi"> DOI: 10.1073/pnas.1309171110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1073%2Fpnas.1309171110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=23776209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E2510-E2517&author=F.+Wangauthor=D.+Sambandanauthor=R.+Halderauthor=J.+Wangauthor=S.+M.+Battauthor=B.+Weinrickauthor=I.+Ahmadauthor=P.+Yangauthor=Y.+Zhangauthor=J.+Kimauthor=M.+Hassaniauthor=S.+Huszarauthor=C.+Trefzerauthor=Z.+Maauthor=T.+Kanekoauthor=K.+E.+Mdluliauthor=S.+Franzblauauthor=A.+K.+Chatterjeeauthor=K.+Johnssonauthor=K.+Mikusovaauthor=G.+S.+Besraauthor=K.+F%C3%BCttererauthor=S.+H.+Robbinsauthor=S.+W.+Barnesauthor=J.+R.+Walkerauthor=W.+R.+Jacobsauthor=P.+G.+Schultz&title=Identification+of+a+Small+Molecule+with+Activity+Against+Drug-resistant+and+Persistent+Tuberculosis&doi=10.1073%2Fpnas.1309171110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a small molecule with activity against drug-resistant and persistent tuberculosis</span></div><div class="casAuthors">Wang, Feng; Sambandan, Dhinakaran; Halder, Rajkumar; Wang, Jianing; Batt, Sarah M.; Weinrick, Brian; Ahmad, Insha; Yang, Pengyu; Zhang, Yong; Kim, John; Hassani, Morad; Huszar, Stanislav; Trefzer, Claudia; Ma, Zhenkun; Kaneko, Takushi; Mdluli, Khisi E.; Franzblau, Scott; Chatterjee, Arnab K.; Johnsson, Kai; Mikusova, Katarina; Besra, Gurdyal S.; Fuetterer, Klaus; Robbins, Scott H.; Barnes, S. Whitney; Walker, John R.; Jacobs, William R., Jr.; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">E2510-E2517,SE2510/1-SE2510/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A cell-based phenotypic screen for inhibitors of biofilm formation in mycobacteria identified the small mol. TCA1, which has bactericidal activity against both drug-susceptible and -resistant Mycobacterium tuberculosis (Mtb) and sterilizes Mtb in vitro combined with rifampicin or isoniazid.  In addn., TCA1 has bactericidal activity against nonreplicating Mtb in vitro and is efficacious in acute and chronic Mtb infection mouse models both alone and combined with rifampicin or isoniazid.  Transcriptional anal. revealed that TCA1 down-regulates genes known to be involved in Mtb persistence.  Genetic and affinity-based methods identified decaprenyl-phosphoryl-β-D-ribofuranose oxidoreductase DprE1 and MoeW, enzymes involved in cell wall and molybdenum cofactor biosynthesis, resp., as targets responsible for the activity of TCA1.  These in vitro and in vivo results indicate that this compd. functions by a unique mechanism and suggest that TCA1 may lead to the development of a class of antituberculosis agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokxlddd-EfbbVg90H21EOLACvtfcHk0lhCec6-zS4vuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejsLnL&md5=caf496e25608bb98e61ab97bd603f2ab</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1309171110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1309171110%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DSambandan%26aufirst%3DD.%26aulast%3DHalder%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBatt%26aufirst%3DS.%2BM.%26aulast%3DWeinrick%26aufirst%3DB.%26aulast%3DAhmad%26aufirst%3DI.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DHuszar%26aufirst%3DS.%26aulast%3DTrefzer%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMdluli%26aufirst%3DK.%2BE.%26aulast%3DFranzblau%26aufirst%3DS.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DJohnsson%26aufirst%3DK.%26aulast%3DMikusova%26aufirst%3DK.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DF%25C3%25BCtterer%26aufirst%3DK.%26aulast%3DRobbins%26aufirst%3DS.%2BH.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DJacobs%26aufirst%3DW.%2BR.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DIdentification%2520of%2520a%2520Small%2520Molecule%2520with%2520Activity%2520Against%2520Drug-resistant%2520and%2520Persistent%2520Tuberculosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE2510%26epage%3DE2517%26doi%3D10.1073%2Fpnas.1309171110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chikhale, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barmade, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murumkar, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, M. R.</span></span> <span> </span><span class="NLM_article-title">Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8563</span>– <span class="NLM_lpage">8593</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00281</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00281" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVGjsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8563-8593&author=R.+V.+Chikhaleauthor=M.+A.+Barmadeauthor=P.+R.+Murumkarauthor=M.+R.+Yadav&title=Overview+of+the+Development+of+DprE1+Inhibitors+for+Combating+the+Menace+of+Tuberculosis&doi=10.1021%2Facs.jmedchem.8b00281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis</span></div><div class="casAuthors">Chikhale, Rupesh V.; Barmade, Mahesh A.; Murumkar, Prashant R.; Yadav, Mange Ram</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8563-8593</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Decaprenylphosphoryl-β-D-ribose 2'-epimerase (DprE1), a vital enzyme for cell wall synthesis, plays a crucial role in the formation of lipoarabinomannan and arabinogalactan.  It was first reported as a druggable target on the basis of inhibitors discovered in high throughput screening of a drug library.  Since then, inhibitors with different types of chem. scaffolds have been reported for their activity against this enzyme.  Formation of a covalent or noncovalent bond by the interacting ligand with the enzyme causes loss of its catalytic activity which ultimately leads to the death of the mycobacterium.  This Perspective describes various DprE1 inhibitors as anti-TB agents reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP3s3ks2Vmg7Vg90H21EOLACvtfcHk0lhjiMcjqoDPYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVGjsrzO&md5=b057993247c1c6c208907c474191c1d0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00281%26sid%3Dliteratum%253Aachs%26aulast%3DChikhale%26aufirst%3DR.%2BV.%26aulast%3DBarmade%26aufirst%3DM.%2BA.%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26aulast%3DYadav%26aufirst%3DM.%2BR.%26atitle%3DOverview%2520of%2520the%2520Development%2520of%2520DprE1%2520Inhibitors%2520for%2520Combating%2520the%2520Menace%2520of%2520Tuberculosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8563%26epage%3D8593%26doi%3D10.1021%2Facs.jmedchem.8b00281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rogacki, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Roman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argyrou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco-Ruano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vande Velde, C. M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span> <span> </span><span class="NLM_article-title">Identification and Profiling of Hydantoins—A Novel Class of Potent Antimycobacterial DprE1 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11221</span>– <span class="NLM_lpage">11249</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01356</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlylsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11221-11249&author=M.+K.+Rogackiauthor=E.+Pittaauthor=O.+Balabonauthor=S.+Hussauthor=E.+M.+Lopez-Romanauthor=A.+Argyrouauthor=D.+Blanco-Ruanoauthor=M.+Cachoauthor=C.+M.+L.+Vande+Veldeauthor=K.+Augustynsauthor=L.+Ballellauthor=D.+Barrosauthor=R.+H.+Batesauthor=F.+Cunninghamauthor=P.+Van+der+Veken&title=Identification+and+Profiling+of+Hydantoins%E2%80%94A+Novel+Class+of+Potent+Antimycobacterial+DprE1+Inhibitors&doi=10.1021%2Facs.jmedchem.8b01356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors</span></div><div class="casAuthors">Rogacki, Maciej K.; Pitta, Eleni; Balabon, Olga; Huss, Sophie; Lopez-Roman, Eva Maria; Argyrou, Argyrides; Blanco-Ruano, Delia; Cacho, Monica; Vande Velde, Christophe M. L.; Augustyns, Koen; Ballell, Lluis; Barros, David; Bates, Robert H.; Cunningham, Fraser; Van der Veken, Pieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11221-11249</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tuberculosis is the leading cause of death worldwide from infectious diseases.  With the development of drug-resistant strains of Mycobacterium tuberculosis, there is an acute need for new medicines with novel modes of action.  Herein, we report the discovery and profiling of a novel hydantoin-based family of antimycobacterial inhibitors of the decaprenylphospho-β-D-ribofuranose 2-oxidase (DprE1).  In this study, we have prepd. a library of more than a 100 compds. and evaluated them for their biol. and physicochem. properties.  The series is characterized by high enzymic and whole-cell activity, low cytotoxicity, and a good overall physicochem. profile.  In addn., we show that the series acts via reversible inhibition of the DprE1 enzyme.  Overall, the novel compd. family forms an attractive base for progression to further stages of optimization and may provide a promising drug candidate in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMw2Vn8XKan7Vg90H21EOLACvtfcHk0lhjiMcjqoDPYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlylsLzE&md5=647fdfe146a1802016d7e38a8543e522</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01356%26sid%3Dliteratum%253Aachs%26aulast%3DRogacki%26aufirst%3DM.%2BK.%26aulast%3DPitta%26aufirst%3DE.%26aulast%3DBalabon%26aufirst%3DO.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DLopez-Roman%26aufirst%3DE.%2BM.%26aulast%3DArgyrou%26aufirst%3DA.%26aulast%3DBlanco-Ruano%26aufirst%3DD.%26aulast%3DCacho%26aufirst%3DM.%26aulast%3DVande%2BVelde%26aufirst%3DC.%2BM.%2BL.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DCunningham%26aufirst%3DF.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DIdentification%2520and%2520Profiling%2520of%2520Hydantoins%25E2%2580%2594A%2520Novel%2520Class%2520of%2520Potent%2520Antimycobacterial%2520DprE1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11221%26epage%3D11249%26doi%3D10.1021%2Facs.jmedchem.8b01356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelhart, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallach, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnappinger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manikkam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gac, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murgolo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutphin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiner, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Via, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span> <span> </span><span class="NLM_article-title">Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2′-Oxidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9952</span>– <span class="NLM_lpage">9965</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00883</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00883" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvV2rsrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9952-9965&author=S.+Ohauthor=Y.+Parkauthor=C.+A.+Engelhartauthor=J.+B.+Wallachauthor=D.+Schnappingerauthor=K.+Aroraauthor=M.+Manikkamauthor=B.+Gacauthor=H.+Wangauthor=N.+Murgoloauthor=D.+B.+Olsenauthor=M.+Goodwinauthor=M.+Sutphinauthor=D.+M.+Weinerauthor=L.+E.+Viaauthor=H.+I.+M.+Boshoffauthor=C.+E.+Barry&title=Discovery+and+Structure%E2%80%93Activity-Relationship+Study+of+N-Alkyl-5-hydroxypyrimidinone+Carboxamides+as+Novel+Antitubercular+Agents+Targeting+Decaprenylphosphoryl-%CE%B2-d-ribose+2%E2%80%B2-Oxidase&doi=10.1021%2Facs.jmedchem.8b00883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-D-ribose 2'-Oxidase</span></div><div class="casAuthors">Oh, Sangmi; Park, Yumi; Engelhart, Curtis A.; Wallach, Joshua B.; Schnappinger, Dirk; Arora, Kriti; Manikkam, Michelle; Gac, Brian; Wang, Hongwu; Murgolo, Nicholas; Olsen, David B.; Goodwin, Michael; Sutphin, Michelle; Weiner, Danielle M.; Via, Laura E.; Boshoff, Helena I. M.; Barry, Clifton E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9952-9965</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Magnesium plays an important role in infection with Mycobacterium tuberculosis (Mtb) as a signal of the extracellular environment, as a cofactor for many enzymes, and as a structural element in important macromols.  Raltegravir, an antiretroviral drug that inhibits HIV-1 integrase is known to derive its potency from selective sequestration of active-site magnesium ions in addn. to binding to a hydrophobic pocket.  In order to det. if essential Mtb-related phosphoryl transfers could be disrupted in a similar manner, a directed screen of known mols. with integrase inhibitor-like pharmacophores (N-alkyl-5-hydroxypyrimidinone carboxamides) was performed.  Initial hits afforded compds. with low-micromolar potency against Mtb, acceptable cytotoxicity and PK characteristics, and robust SAR.  Elucidation of the target of these compds. revealed that they lacked magnesium dependence and instead disappointingly inhibited a known promiscuous target in Mtb, decaprenylphosphoryl-β-D-ribose 2'-oxidase (DprE1, Rv3790).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOxHRHtAf2rbVg90H21EOLACvtfcHk0lhjiMcjqoDPYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvV2rsrfP&md5=5c8f50d73f857fcde7277ca80109fee9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00883%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DEngelhart%26aufirst%3DC.%2BA.%26aulast%3DWallach%26aufirst%3DJ.%2BB.%26aulast%3DSchnappinger%26aufirst%3DD.%26aulast%3DArora%26aufirst%3DK.%26aulast%3DManikkam%26aufirst%3DM.%26aulast%3DGac%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMurgolo%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DGoodwin%26aufirst%3DM.%26aulast%3DSutphin%26aufirst%3DM.%26aulast%3DWeiner%26aufirst%3DD.%2BM.%26aulast%3DVia%26aufirst%3DL.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DDiscovery%2520and%2520Structure%25E2%2580%2593Activity-Relationship%2520Study%2520of%2520N-Alkyl-5-hydroxypyrimidinone%2520Carboxamides%2520as%2520Novel%2520Antitubercular%2520Agents%2520Targeting%2520Decaprenylphosphoryl-%25CE%25B2-d-ribose%25202%25E2%2580%25B2-Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9952%26epage%3D9965%26doi%3D10.1021%2Facs.jmedchem.8b00883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraski, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krchñák, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colon-Martinez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. J.</span></span> <span> </span><span class="NLM_article-title">Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">3539</span>– <span class="NLM_lpage">3549</span>, <span class="refDoi"> DOI: 10.1021/ja311058q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja311058q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVCrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=3539-3549&author=R.+Tiwariauthor=G.+C.+Moraskiauthor=V.+Krch%C3%B1%C3%A1kauthor=P.+A.+Millerauthor=M.+Colon-Martinezauthor=E.+Herreroauthor=A.+G.+Oliverauthor=M.+J.+Miller&title=Thiolates+Chemically+Induce+Redox+Activation+of+BTZ043+and+Related+Potent+Nitroaromatic+Anti-Tuberculosis+Agents&doi=10.1021%2Fja311058q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents</span></div><div class="casAuthors">Tiwari, Rohit; Moraski, Garrett C.; Krchnak, Viktor; Miller, Patricia A.; Colon-Martinez, Mariangelli; Herrero, Eliza; Oliver, Allen G.; Miller, Marvin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3539-3549</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of multidrug resistant (MDR) and extensively drug resistant (XDR) forms of tuberculosis (TB) has stimulated research efforts globally to expand the new drug pipeline.  Nitroarom. compds., including 1,3-benzothiazin-4-ones (BTZs) and related agents, are a promising new class for the treatment of TB.  Research has shown that the nitroso intermediates of BTZs that are generated in vivo cause suicide inhibition of decaprenylphosphoryl-β-d-ribose 2' oxidase (DprE1), which is responsible for cell wall arabinogalactan biosynthesis.  We have designed and synthesized novel anti-TB agents inspired from BTZs and other nitroarom. compds.  Computational studies indicated that the unsubstituted arom. carbons of BTZ043 and related nitroarom. compds. are the most electron-deficient and might be prone to nucleophilic attack.  Our chem. studies on BTZ043 and the addnl. nitroarom. compds. synthesized by us and others confirmed the postulated reactivity.  The results indicate that nucleophiles such as thiolates, cyanide, and hydride induce nonenzymic redn. of the nitro groups present in these compds. to the corresponding nitroso intermediates by addn. at the unsubstituted electron-deficient arom. carbon present in these compds.  Furthermore, we demonstrate here that these compds. are good candidates for the classical von Richter reaction.  These chem. studies offer an alternate hypothesis for the mechanism of action of nitroarom. anti-TB agents, in that the cysteine thiol(ate) or a hydride source at the active site of DprE1 may trigger the redn. of the nitro groups in a manner similar to the von Richter reaction to the nitroso intermediates, to initiate the inhibition of DprE1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEXS_ZRRGRArVg90H21EOLACvtfcHk0lhjiMcjqoDPYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVCrsbY%253D&md5=e3671cfef9ef47c15087e8299d9db64e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja311058q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja311058q%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DMoraski%26aufirst%3DG.%2BC.%26aulast%3DKrch%25C3%25B1%25C3%25A1k%26aufirst%3DV.%26aulast%3DMiller%26aufirst%3DP.%2BA.%26aulast%3DColon-Martinez%26aufirst%3DM.%26aulast%3DHerrero%26aufirst%3DE.%26aulast%3DOliver%26aufirst%3DA.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DThiolates%2520Chemically%2520Induce%2520Redox%2520Activation%2520of%2520BTZ043%2520and%2520Related%2520Potent%2520Nitroaromatic%2520Anti-Tuberculosis%2520Agents%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D3539%26epage%3D3549%26doi%3D10.1021%2Fja311058q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span> </span><span class="NLM_article-title">A Single Ascending
Dose Study of BTZ043</span>. ClinicalTrials.gov (accessed
Dec. 9, <span class="NLM_year">2019</span><i>)</i>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Single+Ascending%0ADose+Study+of+BTZ043.+ClinicalTrials.gov+%28accessed%0ADec.+9%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Single%2520Ascending%250ADose%2520Study%2520of%2520BTZ043%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lupien, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foo, C. S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blattes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillon, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makarov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span> <span> </span><span class="NLM_article-title">Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169)</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">e00840</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1128/AAC.00840-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1128%2FAAC.00840-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=30126954" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=e00840-18&author=A.+Lupienauthor=A.+Vocatauthor=C.+S.-Y.+Fooauthor=E.+Blattesauthor=J.-Y.+Gillonauthor=V.+Makarovauthor=S.+T.+Cole&title=Optimized+Background+Regimen+for+Treatment+of+Active+Tuberculosis+with+the+Next-Generation+Benzothiazinone+Macozinone+%28PBTZ169%29&doi=10.1128%2FAAC.00840-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.00840-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00840-18%26sid%3Dliteratum%253Aachs%26aulast%3DLupien%26aufirst%3DA.%26aulast%3DVocat%26aufirst%3DA.%26aulast%3DFoo%26aufirst%3DC.%2BS.-Y.%26aulast%3DBlattes%26aufirst%3DE.%26aulast%3DGillon%26aufirst%3DJ.-Y.%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DOptimized%2520Background%2520Regimen%2520for%2520Treatment%2520of%2520Active%2520Tuberculosis%2520with%2520the%2520Next-Generation%2520Benzothiazinone%2520Macozinone%2520%2528PBTZ169%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2018%26volume%3D62%26spage%3De00840%26epage%3D18%26doi%3D10.1128%2FAAC.00840-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span> </span><span class="NLM_article-title">A Phase 1 Study
to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371</span>. ClinicalTrials.gov (accessed Dec. 9, <span class="NLM_year">2019</span><i>)</i>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase+1+Study%0Ato+Evaluate+Safety%2C+Tolerability%2C+PK%2C+and+PK+Interactions+of+TBA-7371.+ClinicalTrials.gov+%28accessed+Dec.+9%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Phase%25201%2520Study%250Ato%2520Evaluate%2520Safety%252C%2520Tolerability%252C%2520PK%252C%2520and%2520PK%2520Interactions%2520of%2520TBA-7371%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span> </span><span class="NLM_article-title">A Phase 1/2 Trial
of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis</span>. ClinicalTrials.gov (accessed Dec. 9, <span class="NLM_year">2019</span><i>)</i>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase+1%2F2+Trial%0Aof+Multiple+Oral+Doses+of+OPC-167832+for+Uncomplicated+Pulmonary+Tuberculosis.+ClinicalTrials.gov+%28accessed+Dec.+9%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Phase%25201%252F2%2520Trial%250Aof%2520Multiple%2520Oral%2520Doses%2520of%2520OPC-167832%2520for%2520Uncomplicated%2520Pulmonary%2520Tuberculosis%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Gomez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Ruiz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escribano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos-Villarejo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martín-Plaza, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebollo-Lopez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuiñan-Blanco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavandera, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo-Benito, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Bustos, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, N.</span></span> <span> </span><span class="NLM_article-title">Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1002%2Fcmdc.201200428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=23307663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls1Omug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=313-321&author=L.+Ballellauthor=R.+H.+Batesauthor=R.+J.+Youngauthor=D.+Alvarez-Gomezauthor=E.+Alvarez-Ruizauthor=V.+Barrosoauthor=D.+Blancoauthor=B.+Crespoauthor=J.+Escribanoauthor=R.+Gonz%C3%A1lezauthor=S.+Lozanoauthor=S.+Hussauthor=A.+Santos-Villarejoauthor=J.+J.+Mart%C3%ADn-Plazaauthor=A.+Mendozaauthor=M.+J.+Rebollo-Lopezauthor=M.+Remui%C3%B1an-Blancoauthor=J.+L.+Lavanderaauthor=E.+P%C3%A9rez-Herranauthor=F.+J.+Gamo-Benitoauthor=J.+F.+Garc%C3%ADa-Bustosauthor=D.+Barrosauthor=J.+P.+Castroauthor=N.+Cammack&title=Fueling+Open-Source+Drug+Discovery%3A+177+Small-Molecule+Leads+against+Tuberculosis&doi=10.1002%2Fcmdc.201200428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis</span></div><div class="casAuthors">Ballell, Lluis; Bates, Robert H.; Young, Rob J.; Alvarez-Gomez, Daniel; Alvarez-Ruiz, Emilio; Barroso, Vanessa; Blanco, Delia; Crespo, Benigno; Escribano, Jaime; Gonzalez, Ruben; Lozano, Sonia; Huss, Sophie; Santos-Villarejo, Angel; Martin-Plaza, Jose Julio; Mendoza, Alfonso; Rebollo-Lopez, Maria Jose; Remuinan-Blanco, Modesto; Lavandera, Jose Luis; Perez-Herran, Esther; Gamo-Benito, Francisco Javier; Garcia-Bustos, Jose Francisco; Barros, David; Castro, Julia P.; Cammack, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">With the aim of fuelling open-source, translational, early-stage drug discovery activities, the results of the recently completed antimycobacterial phenotypic screening campaign against Mycobacterium bovis BCG with hit confirmation in M. tuberculosis H37Rv were made publicly accessible.  A set of 177 potent non-cytotoxic H37Rv hits was identified and will be made available to maximize the potential impact of the compds. toward a chem. genetics/proteomics exercise, while at the same time providing a plethora of potential starting points for new synthetic lead-generation activities.  Two addnl. drug-discovery-relevant datasets are included: (a) a drug-like property anal. reflecting the latest lead-like guidelines and (b) an early lead-generation package of the most promising hits within the clusters identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUJ2sVPWfPALVg90H21EOLACvtfcHk0lgOrHpKJWp6xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls1Omug%253D%253D&md5=32c975dbe183849358c701ca697681d3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200428%26sid%3Dliteratum%253Aachs%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DAlvarez-Gomez%26aufirst%3DD.%26aulast%3DAlvarez-Ruiz%26aufirst%3DE.%26aulast%3DBarroso%26aufirst%3DV.%26aulast%3DBlanco%26aufirst%3DD.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DEscribano%26aufirst%3DJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DR.%26aulast%3DLozano%26aufirst%3DS.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DSantos-Villarejo%26aufirst%3DA.%26aulast%3DMart%25C3%25ADn-Plaza%26aufirst%3DJ.%2BJ.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRebollo-Lopez%26aufirst%3DM.%2BJ.%26aulast%3DRemui%25C3%25B1an-Blanco%26aufirst%3DM.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%26aulast%3DP%25C3%25A9rez-Herran%26aufirst%3DE.%26aulast%3DGamo-Benito%26aufirst%3DF.%2BJ.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DCastro%26aufirst%3DJ.%2BP.%26aulast%3DCammack%26aufirst%3DN.%26atitle%3DFueling%2520Open-Source%2520Drug%2520Discovery%253A%2520177%2520Small-Molecule%2520Leads%2520against%2520Tuberculosis%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D313%26epage%3D321%26doi%3D10.1002%2Fcmdc.201200428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacho Izquierdo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro Pichel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vela-Glez
Del Peral, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouzon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros Aguirre, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besra, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argyrou, A.</span></span> <span> </span><span class="NLM_article-title">Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.5b00065</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlemtbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=615-626&author=S.+M.+Battauthor=M.+Cacho+Izquierdoauthor=J.+Castro+Pichelauthor=C.+J.+Stubbsauthor=L.+Vela-Glez%0ADel+Peralauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=N.+Dharauthor=B.+Mouzonauthor=M.+Reesauthor=J.+P.+Hutchinsonauthor=R.+J.+Youngauthor=J.+D.+McKinneyauthor=D.+Barros+Aguirreauthor=L.+Ballellauthor=G.+S.+Besraauthor=A.+Argyrou&title=Whole+Cell+Target+Engagement+Identifies+Novel+Inhibitors+of+Mycobacterium+tuberculosis+Decaprenylphosphoryl-%CE%B2-d-ribose+Oxidase&doi=10.1021%2Facsinfecdis.5b00065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-β-D-ribose Oxidase</span></div><div class="casAuthors">Batt, Sarah M.; Cacho Izquierdo, Monica; Castro Pichel, Julia; Stubbs, Christopher J.; Vela-Glez Del Peral, Laura; Perez-Herran, Esther; Dhar, Neeraj; Mouzon, Bernadette; Rees, Mike; Hutchinson, Jonathan P.; Young, Robert J.; McKinney, John D.; Barros Aguirre, David; Ballell, Lluis; Besra, Gurdyal S.; Argyrou, Argyrides</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">615-626</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have targeted the Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose oxidase (Mt-DprE1) for potential chemotherapeutic intervention of tuberculosis.  A multicopy suppression strategy that overexpressed Mt-DprE1 in M. bovis BCG was used to profile the publically available GlaxoSmithKline antimycobacterial compd. set, and one compd. (GSK710) was identified that showed an 8-fold higher min. inhibitory concn. relative to the control strain.  Analogs of GSK710 show a clear relationship between whole cell potency and in vitro activity using an enzymic assay employing recombinant Mt-DprE1, with binding affinity measured by fluorescence quenching of the flavin cofactor of the enzyme.  M. bovis BCG spontaneous resistant mutants to GSK710 and a closely related analog were isolated and sequencing of ten such mutants revealed a single point mutation at two sites, E221Q or G248S within DprE1, providing further evidence that DprE1 is the main target of these compds.  Finally, time-lapse microscopy expts. showed that exposure of M. tuberculosis to a compd. of this series arrests bacterial growth rapidly followed by a slower cytolysis phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1f7lU5LDERrVg90H21EOLACvtfcHk0lhGDIgW3GcSZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlemtbnE&md5=1e6d6ef29fb37d3e8535328368af2472</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00065%26sid%3Dliteratum%253Aachs%26aulast%3DBatt%26aufirst%3DS.%2BM.%26aulast%3DCacho%2BIzquierdo%26aufirst%3DM.%26aulast%3DCastro%2BPichel%26aufirst%3DJ.%26aulast%3DStubbs%26aufirst%3DC.%2BJ.%26aulast%3DVela-Glez%2BDel%2BPeral%26aufirst%3DL.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DMouzon%26aufirst%3DB.%26aulast%3DRees%26aufirst%3DM.%26aulast%3DHutchinson%26aufirst%3DJ.%2BP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DBarros%2BAguirre%26aufirst%3DD.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DArgyrou%26aufirst%3DA.%26atitle%3DWhole%2520Cell%2520Target%2520Engagement%2520Identifies%2520Novel%2520Inhibitors%2520of%2520Mycobacterium%2520tuberculosis%2520Decaprenylphosphoryl-%25CE%25B2-d-ribose%2520Oxidase%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2015%26volume%3D1%26spage%3D615%26epage%3D626%26doi%3D10.1021%2Facsinfecdis.5b00065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6421</span>– <span class="NLM_lpage">6467</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00180</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6421-6467&issue=15&author=R.+J.+Youngauthor=P.+D.+Leeson&title=Mapping+the+Efficiency+and+Physicochemical+Trajectories+of+Successful+Optimizations&doi=10.1021%2Facs.jmedchem.8b00180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations</span></div><div class="casAuthors">Young, Robert J.; Leeson, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6421-6467</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The practices and tactics employed in successful optimizations are examd., judged from the trajectories of ligand efficiency and property evolution.  A wide range of targets is analyzed, encompassing a variety of hit finding methods (HTS, fragments, encoded library technol.) and types of mols., including those beyond the rule of five.  The wider employment of efficiency metrics and lipophilicity control is evident in contemporary practice and the impact on quality demonstrable.  What is clear is that while targets are different, successful mols. are almost invariably among the most efficient for their target, even at the extremes.  Trajectory mapping, based on principles rather than rules, is useful in assessing quality and progress in optimizations while benchmarking against competitors and assessing property-dependent risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCQtcLKSk7q7Vg90H21EOLACvtfcHk0lhGDIgW3GcSZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVCmu7Y%253D&md5=f040ef02d161e070bb5021fde1585e66</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3DMapping%2520the%2520Efficiency%2520and%2520Physicochemical%2520Trajectories%2520of%2520Successful%2520Optimizations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467%26doi%3D10.1021%2Facs.jmedchem.8b00180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">St.
Jean, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span> <span> </span><span class="NLM_article-title">Mitigating Heterocycle Metabolism in Drug Discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6002</span>– <span class="NLM_lpage">6020</span>, <span class="refDoi"> DOI: 10.1021/jm300343m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300343m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6002-6020&author=D.+J.+St.%0AJeanauthor=C.+Fotsch&title=Mitigating+Heterocycle+Metabolism+in+Drug+Discovery&doi=10.1021%2Fjm300343m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Mitigating Heterocycle Metabolism in Drug Discovery</span></div><div class="casAuthors">St. Jean, David J.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6002-6020</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Extensive data from metab. studies have allowed medicinal chemists to develop general principles for reducing compd. metab.  These methods include, but are not limited to, reducing lipophilicity, altering sterics and electronics, introducing a conformational constraint, and altering the stereochem. of their compds.  While no single method is able to solve every metabolic problem, these principles do give medicinal chemists guidance on how to improve the metabolic liabilities of their compds.  If the specific site of metab. is known, medicinal chemists block the site, typically with a fluorine, or replace the metabolically labile group with a bioisostere.  While several authors have reviewed these techniques for reducing metab., there is no review that summarizes different approaches to improving them metabolic stability of heterocycles.  In this review, we summarize examples where changes were made at or near the heterocycle to improve metabolic stability.  By summarizing these examples, we hope to provide a useful guide to medicinal chemists as they attempt to improve the metabolic profile of their own heterocyclic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQjdBBgXtPbVg90H21EOLACvtfcHk0lhGDIgW3GcSZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D&md5=48c262556b8a2cc7dc5539ff91a53a71</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm300343m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300343m%26sid%3Dliteratum%253Aachs%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DMitigating%2520Heterocycle%2520Metabolism%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6002%26epage%3D6020%26doi%3D10.1021%2Fjm300343m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rastogi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labrousse, V. r.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, K. S.</span></span> <span> </span><span class="NLM_article-title">In Vitro Activities of Fourteen Antimicrobial Agents Against Drug Susceptible and Resistant Clinical Isolates of Mycobacterium tuberculosis and Comparative Intracellular Activities Against the Virulent H37Rv Strain in Human Macrophages</span>. <i>Curr. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1007/s002849900095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1007%2Fs002849900095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=8672093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADyaK28Xlt1Grsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1996&pages=167-175&author=N.+Rastogiauthor=V.+r.+Labrousseauthor=K.+S.+Goh&title=In+Vitro+Activities+of+Fourteen+Antimicrobial+Agents+Against+Drug+Susceptible+and+Resistant+Clinical+Isolates+of+Mycobacterium+tuberculosis+and+Comparative+Intracellular+Activities+Against+the+Virulent+H37Rv+Strain+in+Human+Macrophages&doi=10.1007%2Fs002849900095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages</span></div><div class="casAuthors">Rastogi, Nalin; Labrousse, Valerie; Goh, Khye Seng</div><div class="citationInfo"><span class="NLM_cas:title">Current Microbiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-175</span>CODEN:
                <span class="NLM_cas:coden">CUMIDD</span>;
        ISSN:<span class="NLM_cas:issn">0343-8651</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Minimal inhibitory concn. (MICs) of 14 first and second-line antituberculous drugs against drug-susceptible and drug-resistant clin. isolates of Mycobacterium tuberculosis (including the multiple drug-resistant or MDR-TB isolates), as well as the type strain H37Rv, were detd. radiometrically by the Bactec 460-TB methodols.  MICs (μg/mL) of all the fourteen drugs were within an extremely narrow range in the case of susceptible strains; isoniazid (0.02-0.04), rifampin (0.2-0.4), ethambutol and streptomycin (0.5-2.0), ethionamide (0.25-0.5), D-cycloserine (25-75), capreomycin (1-2), kanamycin (2-4), amikacin (0.5-1.0), clofazimine (0.1-0.4), ofloxacin (0.5-1.0), ciprofloxacin (0.25-1.0), and sparfloxacin (0.1-0.4).  The activity of second-line drugs remained unaltered against MDR-TB isolates resistant to routine first-line drugs.  With peak serum level concns. (Cmax), the intracellular killing of the virulent H37Rv strain was studied in detail in cultured human macrophages.  Based on a decreasing order of bactericidal activity, our results showed the following spectrum of intracellular drug action: among the first-line drugs, rifampin > ethionamide = isoniazid > ethambutol > streptomycin > D-cycloserine; among second-line drugs, clofazimine = amikacin > kanamycin = capreomycin; among fluoroquinolones, sparfloxacin > ofloxacin > ciprofloxacin.  On the other hand, contrary to atypical mycobacteria, the macrolide drug clarithromycin was inactive against both extracellular and intracellular M. tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOt6t2bJoeBrVg90H21EOLACvtfcHk0lhGDIgW3GcSZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xlt1Grsr4%253D&md5=41f85ec3fbd24e830fb01f9f535fdbfe</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2Fs002849900095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002849900095%26sid%3Dliteratum%253Aachs%26aulast%3DRastogi%26aufirst%3DN.%26aulast%3DLabrousse%26aufirst%3DV.%2Br.%26aulast%3DGoh%26aufirst%3DK.%2BS.%26atitle%3DIn%2520Vitro%2520Activities%2520of%2520Fourteen%2520Antimicrobial%2520Agents%2520Against%2520Drug%2520Susceptible%2520and%2520Resistant%2520Clinical%2520Isolates%2520of%2520Mycobacterium%2520tuberculosis%2520and%2520Comparative%2520Intracellular%2520Activities%2520Against%2520the%2520Virulent%2520H37Rv%2520Strain%2520in%2520Human%2520Macrophages%26jtitle%3DCurr.%2520Microbiol.%26date%3D1996%26volume%3D33%26spage%3D167%26epage%3D175%26doi%3D10.1007%2Fs002849900095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rullas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltrán, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardona, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cáceres, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Bustos, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span> <span> </span><span class="NLM_article-title">Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against Tuberculosis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2262</span>– <span class="NLM_lpage">2264</span>, <span class="refDoi"> DOI: 10.1128/AAC.01423-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=10.1128%2FAAC.01423-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=20160054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFeltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=2262-2264&author=J.+Rullasauthor=J.+I.+Garc%C3%ADaauthor=M.+Beltr%C3%A1nauthor=P.+J.+Cardonaauthor=N.+C%C3%A1ceresauthor=J.+F.+Garc%C3%ADa-Bustosauthor=I.+Angulo-Barturen&title=Fast+Standardized+Therapeutic-Efficacy+Assay+for+Drug+Discovery+against+Tuberculosis&doi=10.1128%2FAAC.01423-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis</span></div><div class="casAuthors">Rullas, Joaquin; Garcia, Juan Ignacio; Beltran, Manuela; Cardona, Pere-Joan; Caceres, Neus; Garcia-Bustos, Jose Francisco; Angulo-Barturen, Inigo</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2262-2264</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Murine models of Mycobacterium tuberculosis infection are essential tools in drug discovery.  Here we describe a fast standardized 9-day acute assay intended to measure the efficacy of drugs against M. tuberculosis growing in the lungs of immunocompetent mice.  This assay is highly reproducible, allows good throughput, and was validated for drug lead optimization using isoniazid, rifampin, ethambutol, pyrazinamide, linezolid, and moxifloxacin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpajX5TwxQ_E7Vg90H21EOLACvtfcHk0lgTEj5HQNv0Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFeltLo%253D&md5=c923fae175b34eab3778a0e4d8d51878</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FAAC.01423-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01423-09%26sid%3Dliteratum%253Aachs%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DJ.%2BI.%26aulast%3DBeltr%25C3%25A1n%26aufirst%3DM.%26aulast%3DCardona%26aufirst%3DP.%2BJ.%26aulast%3DC%25C3%25A1ceres%26aufirst%3DN.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26atitle%3DFast%2520Standardized%2520Therapeutic-Efficacy%2520Assay%2520for%2520Drug%2520Discovery%2520against%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D2262%26epage%3D2264%26doi%3D10.1128%2FAAC.01423-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pitta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogacki, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Roman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joossens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span> <span> </span><span class="NLM_article-title">Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6709</span>– <span class="NLM_lpage">6728</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00245</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6709-6728&author=E.+Pittaauthor=M.+K.+Rogackiauthor=O.+Balabonauthor=S.+Hussauthor=F.+Cunninghamauthor=E.+M.+Lopez-Romanauthor=J.+Joossensauthor=K.+Augustynsauthor=L.+Ballellauthor=R.+H.+Batesauthor=P.+Van+der+Veken&title=Searching+for+New+Leads+for+Tuberculosis%3A+Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel+2-Quinolin-4-yloxyacetamides&doi=10.1021%2Facs.jmedchem.6b00245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides</span></div><div class="casAuthors">Pitta, Eleni; Rogacki, Maciej K.; Balabon, Olga; Huss, Sophie; Cunningham, Fraser; Lopez-Roman, Eva Maria; Joossens, Jurgen; Augustyns, Koen; Ballell, Lluis; Bates, Robert H.; Van derVeken, Pieter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6709-6728</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, a new series of more than 60 quinoline derivs. has been synthesized and evaluated against Mycobacterium tuberculosis (H37Rv).  Apart from the SAR exploration around the initial hits, the optimization process focused on the improvement of the physicochem. properties, cytotoxicity, and metabolic stability of the series.  The best compds. obtained exhibited MIC values in the low micromolar range, excellent intracellular antimycobacterial activity, and an improved physicochem. profile without cytotoxic effects.  Further investigation revealed that the amide bond was the source for the poor blood stability obsd., while some of the compds. exhibited hERG affinity.  Compd. I, which contains a benzoxazole ring instead of the amide group, was found to be a good alternative, with good blood stability and no hERG affinity, providing new opportunities for the series.  Overall, the obtained results suggest that further optimization of soly. and microsomal stability of the series could provide a strong lead for a new anti-TB drug development program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrjBguBpaWgbVg90H21EOLACvtfcHk0lgTEj5HQNv0Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKju7%252FE&md5=8b4cc0d1c032dde93c91811cdbba557b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00245%26sid%3Dliteratum%253Aachs%26aulast%3DPitta%26aufirst%3DE.%26aulast%3DRogacki%26aufirst%3DM.%2BK.%26aulast%3DBalabon%26aufirst%3DO.%26aulast%3DHuss%26aufirst%3DS.%26aulast%3DCunningham%26aufirst%3DF.%26aulast%3DLopez-Roman%26aufirst%3DE.%2BM.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBates%26aufirst%3DR.%2BH.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DSearching%2520for%2520New%2520Leads%2520for%2520Tuberculosis%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%25202-Quinolin-4-yloxyacetamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6709%26epage%3D6728%26doi%3D10.1021%2Facs.jmedchem.6b00245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i101"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01561">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11166"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01561?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01561</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings for all compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01561/suppl_file/jm9b01561_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01561/suppl_file/jm9b01561_si_001.csv">jm9b01561_si_001.csv (3.45 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01561&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01561%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01561" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799bf0e6fc13cdc","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
